[
{"_id": "32295184|None", "id": "32295184", "infons": {}, "passages": [{"infons": {"journal": "Int J Mol Sci; 2020 Apr 14 ; 21 (8) . doi:10.3390/ijms21082714", "year": "2020", "type": "title", "authors": "Olivera GG, Y\u00e1\u00f1ez Y, Gargallo P, Sendra L, Ali\u00f1o SF, Segura V, Sanz M\u00c1, Ca\u00f1ete A, Castel V, Font De Mora J, Herv\u00e1s D, Berlanga P, Herrero MJ, ", "section": "Title"}, "offset": 0, "text": "MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "4524", "type": "Gene", "ncbi_homologene": "4349"}, "text": "MTHFR", "locations": [{"offset": 0, "length": 5}]}, {"id": "6", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "VDR", "locations": [{"offset": 10, "length": 3}]}, {"id": "7", "infons": {"identifier": "4613", "type": "Gene", "ncbi_homologene": "3922"}, "text": "MYCN", "locations": [{"offset": 60, "length": 4}]}, {"id": "8", "infons": {"identifier": "MESH:D009447", "type": "Disease"}, "text": "Neuroblastoma", "locations": [{"offset": 95, "length": 13}]}, {"id": "9", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 109, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 119, "text": "Single nucleotide polymorphisms (SNPs) in Pharmacogenetics can play an important role in the outcomes of the chemotherapy treatment in Neuroblastoma, helping doctors maximize efficacy and minimize toxicity. Employing AgenaBioscience MassArray, 96 SNPs were genotyped in 95 patients looking for associations of SNP with response to induction therapy (RIT) and grade 3-4 toxicities, in High Risk patients. Associations of SNPs with overall (OS) and event-free (EFS) survival in the whole cohort were also explored. Cox and logistic regression models with Elastic net penalty were employed. Association with grade 3-4 gastrointestinal and infectious toxicities was found for 8 different SNPs. Better RIT was correlated with rs726501 AG, rs3740066 GG, rs2010963 GG and rs1143684 TT (OR = 2.87, 1.79, 1.23, 1.14, respectively). EFS was affected by rs2032582, rs4880, rs3814058, rs45511401, rs1544410 and rs6539870. OS was influenced by rs 1801133, rs7186128 and rs1544410. Remarkably, rs1801133 in MTHFR (p = 0.02) and rs1544410 in VDR (p = 0.006) also added an important predictive value for OS to the MYCN status, with a more accurate substratification of the patients. Although validation studies in independent cohorts will be required, the data obtained supports the utility of Pharmacogenetics for predicting Neuroblastoma treatment outcomes.", "sentences": [], "annotations": [{"id": "36", "infons": {"identifier": "MESH:D009447", "type": "Disease"}, "text": "Neuroblastoma", "locations": [{"offset": 254, "length": 13}]}, {"id": "37", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 316, "length": 8}]}, {"id": "38", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 392, "length": 8}]}, {"id": "39", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicities", "locations": [{"offset": 488, "length": 10}]}, {"id": "40", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 513, "length": 8}]}, {"id": "41", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicities", "locations": [{"offset": 766, "length": 10}]}, {"id": "42", "infons": {"identifier": "rs726501", "type": "Mutation", "subtype": "SNP"}, "text": "rs726501", "locations": [{"offset": 840, "length": 8}]}, {"id": "43", "infons": {"identifier": "rs3740066", "type": "Mutation", "subtype": "SNP"}, "text": "rs3740066", "locations": [{"offset": 853, "length": 9}]}, {"id": "44", "infons": {"identifier": "rs2010963", "type": "Mutation", "subtype": "SNP"}, "text": "rs2010963", "locations": [{"offset": 867, "length": 9}]}, {"id": "45", "infons": {"identifier": "rs1143684", "type": "Mutation", "subtype": "SNP"}, "text": "rs1143684", "locations": [{"offset": 884, "length": 9}]}, {"id": "46", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 962, "length": 9}]}, {"id": "47", "infons": {"identifier": "rs4880", "type": "Mutation", "subtype": "SNP"}, "text": "rs4880", "locations": [{"offset": 973, "length": 6}]}, {"id": "48", "infons": {"identifier": "rs3814058", "type": "Mutation", "subtype": "SNP"}, "text": "rs3814058", "locations": [{"offset": 981, "length": 9}]}, {"id": "49", "infons": {"identifier": "rs45511401", "type": "Mutation", "subtype": "SNP"}, "text": "rs45511401", "locations": [{"offset": 992, "length": 10}]}, {"id": "50", "infons": {"identifier": "rs1544410", "type": "Mutation", "subtype": "SNP"}, "text": "rs1544410", "locations": [{"offset": 1004, "length": 9}]}, {"id": "51", "infons": {"identifier": "rs6539870", "type": "Mutation", "subtype": "SNP"}, "text": "rs6539870", "locations": [{"offset": 1018, "length": 9}]}, {"id": "52", "infons": {"identifier": "rs 1801133", "type": "Mutation", "subtype": "SNP"}, "text": "rs 1801133", "locations": [{"offset": 1050, "length": 10}]}, {"id": "53", "infons": {"identifier": "rs7186128", "type": "Mutation", "subtype": "SNP"}, "text": "rs7186128", "locations": [{"offset": 1062, "length": 9}]}, {"id": "54", "infons": {"identifier": "rs1544410", "type": "Mutation", "subtype": "SNP"}, "text": "rs1544410", "locations": [{"offset": 1076, "length": 9}]}, {"id": "55", "infons": {"identifier": "rs1801133", "type": "Mutation", "subtype": "SNP"}, "text": "rs1801133", "locations": [{"offset": 1099, "length": 9}]}, {"id": "56", "infons": {"identifier": "4524", "type": "Gene", "ncbi_homologene": "4349"}, "text": "MTHFR", "locations": [{"offset": 1112, "length": 5}]}, {"id": "57", "infons": {"identifier": "rs1544410", "type": "Mutation", "subtype": "SNP"}, "text": "rs1544410", "locations": [{"offset": 1133, "length": 9}]}, {"id": "58", "infons": {"identifier": "7421", "type": "Gene", "ncbi_homologene": "37297"}, "text": "VDR", "locations": [{"offset": 1146, "length": 3}]}, {"id": "59", "infons": {"identifier": "4613", "type": "Gene", "ncbi_homologene": "3922"}, "text": "MYCN", "locations": [{"offset": 1217, "length": 4}]}, {"id": "60", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1276, "length": 8}]}, {"id": "61", "infons": {"identifier": "MESH:D009447", "type": "Disease"}, "text": "Neuroblastoma", "locations": [{"offset": 1429, "length": 13}]}], "relations": []}], "relations": [], "pmid": 32295184, "pmcid": null, "created": {"$date": 1592771113165}, "accessions": ["mutation@rs726501", "mutation@rs1143684", "mutation@rs6539870", "disease@MESH:D009447", "mutation@rs7186128", "mutation@rs1544410", "species@9606", "mutation@rs45511401", "mutation@rs2032582", "mutation@rs3740066", "mutation@rs 1801133", "mutation@rs2010963", "mutation@rs4880", "disease@MESH:D064420", "mutation@rs3814058", "gene@4524", "gene@4613", "mutation@rs1801133", "gene@7421"], "journal": "Int J Mol Sci", "year": 2020, "authors": ["Olivera GG", "Y\u00e1\u00f1ez Y", "Gargallo P", "Sendra L", "Ali\u00f1o SF", "Segura V", "Sanz M\u00c1", "Ca\u00f1ete A", "Castel V", "Font De Mora J", "Herv\u00e1s D", "Berlanga P", "Herrero MJ"]},
{"_id": "31391850|None", "id": "31391850", "infons": {}, "passages": [{"infons": {"journal": "J Oncol. 2019 Jul 17;2019:6425708. doi: 10.1155/2019/6425708. eCollection 2019.", "year": "2019", "article-id_pmc": "PMC6662487", "type": "title", "authors": "Al-Eitan LN, Rababa'h DM, Alghamdi MA, Khasawneh RH", "section": "Title"}, "offset": 0, "text": "Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "Breast Cancer", "locations": [{"offset": 72, "length": 13}]}, {"id": "3", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 99, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 109, "text": "Breast cancer pharmacogenetics is increasingly being explored due to chemotherapy resistance among certain classes of patients. The ATP binding cassette (ABC) transporter genes have been previously implicated in breast cancer progression and drug response. In the present study, single nucleotide polymorphisms (SNPs) from the ABCC1, ABCC2, ABCB1, and ABCG2 genes were screened in breast cancer patients and healthy volunteers from the Jordanian-Arab population. Only the ABCB1 SNPs showed a significant association with BC in Jordanian-Arab patients, and the ABCB1 SNP rs2032582 exhibited a strong genotypic association with BC. With regard to the clinical characteristics of BC, the ABCC2 SNPs rs2273697 and rs717620 were found to be significantly associated with age at breast cancer diagnosis and breastfeeding status, while the ABCB1 SNP rs1045642 was significantly associated with age at breast cancer diagnosis. In terms of pathological characteristics, the ABCC1 SNP rs35628 and the ABCB1 SNP rs2032582 were significantly associated with tumor size, the ABCC2 SNP rs2273697 was significantly associated with estrogen receptor status, and the ABCG2 SNP rs2231142 was significantly associated with axillary lymph node status. In this current study, we assume that significant genetic variants within the ABC superfamily may increase the risk of breast cancer among Jordanian women. Furthermore, these variants might be responsible for worse BC prognosis.", "sentences": [], "annotations": [{"id": "35", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "Breast cancer", "locations": [{"offset": 109, "length": 13}]}, {"id": "36", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 227, "length": 8}]}, {"id": "37", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast cancer", "locations": [{"offset": 321, "length": 13}]}, {"id": "38", "infons": {"identifier": "4363", "type": "Gene", "ncbi_homologene": "133779"}, "text": "ABCC1", "locations": [{"offset": 436, "length": 5}]}, {"id": "39", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 443, "length": 5}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 450, "length": 5}]}, {"id": "41", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 461, "length": 5}]}, {"id": "42", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast cancer", "locations": [{"offset": 490, "length": 13}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 504, "length": 8}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 581, "length": 5}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 651, "length": 8}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 669, "length": 5}]}, {"id": "47", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 679, "length": 9}]}, {"id": "48", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 794, "length": 5}]}, {"id": "49", "infons": {"identifier": "rs2273697", "type": "Mutation", "subtype": "SNP"}, "text": "rs2273697", "locations": [{"offset": 805, "length": 9}]}, {"id": "50", "infons": {"identifier": "rs717620", "type": "Mutation", "subtype": "SNP"}, "text": "rs717620", "locations": [{"offset": 819, "length": 8}]}, {"id": "51", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast cancer", "locations": [{"offset": 882, "length": 13}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 942, "length": 5}]}, {"id": "53", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 952, "length": 9}]}, {"id": "54", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast cancer", "locations": [{"offset": 1003, "length": 13}]}, {"id": "55", "infons": {"identifier": "4363", "type": "Gene", "ncbi_homologene": "133779"}, "text": "ABCC1", "locations": [{"offset": 1074, "length": 5}]}, {"id": "56", "infons": {"identifier": "rs35628", "type": "Mutation", "subtype": "SNP"}, "text": "rs35628", "locations": [{"offset": 1084, "length": 7}]}, {"id": "57", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1100, "length": 5}]}, {"id": "58", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1110, "length": 9}]}, {"id": "59", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1155, "length": 5}]}, {"id": "60", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 1171, "length": 5}]}, {"id": "61", "infons": {"identifier": "rs2273697", "type": "Mutation", "subtype": "SNP"}, "text": "rs2273697", "locations": [{"offset": 1181, "length": 9}]}, {"id": "62", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 1259, "length": 5}]}, {"id": "63", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "SNP"}, "text": "rs2231142", "locations": [{"offset": 1269, "length": 9}]}, {"id": "64", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast cancer", "locations": [{"offset": 1460, "length": 13}]}, {"id": "65", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 1490, "length": 5}]}], "relations": []}], "relations": [], "pmid": 31391850, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs717620", "mutation@rs35628", "gene@1244", "species@9606", "gene@4363", "mutation@rs2032582", "disease@MESH:D001943", "mutation@rs2273697", "gene@5243", "mutation@rs1045642", "mutation@rs2231142", "gene@9429", "disease@MESH:D009369"], "journal": "J Oncol. 2019 Jul 17", "year": 2019, "authors": ["Al-Eitan LN", "Rababa'h DM", "Alghamdi MA", "Khasawneh RH"]},
{"_id": "30996113|None", "id": "30996113", "infons": {}, "passages": [{"infons": {"journal": "Biosci Rep. 2019 May 14;39(5). pii: BSR20190024. doi: 10.1042/BSR20190024. Print ", "year": "2019", "article-id_pmc": "PMC6522878", "type": "title", "authors": "Yang J, Jing M, Yang X", "section": "Title"}, "offset": 0, "text": "Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D010020", "type": "Disease"}, "text": "osteonecrosis", "locations": [{"offset": 46, "length": 13}]}, {"id": "3", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 63, "length": 7}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 149, "text": "Steroid treatment has become recognized as an important risk factor for avascular osteonecrosis of the femoral head. However, not all patients who receive long-term, high-dose steroids develop osteonecrosis, indicating that there are individual differences in occurrence.We explored the relationship between polymorphisms and steroid-induced osteonecrosis of the femoral head (SONFH) incidence with variables. We used a multilevel mixed-effects logistic regression model, which is an expansion of logistic regression, for each type of steroid, primary disease, drug dose, applied duration, and single-nucleotide polymorphism (SNP). We also conducted a dose-response meta-analysis to analyze the cumulative dosage and SONFH risk in mutation carriers. There were significant correlations between the ABCB1 rs1045642 mutant and SONFH in the prednisone-use and methylprednisolone/prednisone-use populations. The ABCB1 rs2032582 mutant homozygote had a protective effect in the methylprednisolone/prednisolone renal transplant population. For ApoB rs693, mutation increased the incidence of SONFH in prednisone-use and methylprednisolone/prednisolone-use populations and renal transplant patients. For ApoB rs1042031, mutation increased the risk of SONFH in the prednisone-use population. The PAI-1 rs1799768 mutation had a protective effect on the SONFH risk prednisone-use and renal transplant populations. ABCB1 rs1045642 mutations have a protective effect against SONFH, and ApoB rs693 and rs1042031 increase the SONFH risk. Cumulative dosage and treatment duration had little effect on the results. In addition, there was a dose-effect correlation in ABCB1 rs1045642 and rs2032582 mutation carriers.", "sentences": [], "annotations": [{"id": "41", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "Steroid", "locations": [{"offset": 149, "length": 7}]}, {"id": "42", "infons": {"identifier": "MESH:D010020", "type": "Disease"}, "text": "avascular osteonecrosis", "locations": [{"offset": 221, "length": 23}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 283, "length": 8}]}, {"id": "44", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroids", "locations": [{"offset": 325, "length": 8}]}, {"id": "45", "infons": {"identifier": "MESH:D010020", "type": "Disease"}, "text": "osteonecrosis", "locations": [{"offset": 342, "length": 13}]}, {"id": "46", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 475, "length": 7}]}, {"id": "47", "infons": {"identifier": "MESH:D005271", "type": "Disease"}, "text": "osteonecrosis of the femoral", "locations": [{"offset": 491, "length": 28}]}, {"id": "48", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 684, "length": 7}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 947, "length": 5}]}, {"id": "50", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 953, "length": 9}]}, {"id": "51", "infons": {"identifier": "MESH:D011241", "type": "Chemical"}, "text": "prednisone", "locations": [{"offset": 987, "length": 10}]}, {"id": "52", "infons": {"identifier": "MESH:D008775", "type": "Chemical"}, "text": "methylprednisolone", "locations": [{"offset": 1006, "length": 18}]}, {"id": "53", "infons": {"identifier": "MESH:D011241", "type": "Chemical"}, "text": "prednisone", "locations": [{"offset": 1025, "length": 10}]}, {"id": "54", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1057, "length": 5}]}, {"id": "55", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1063, "length": 9}]}, {"id": "56", "infons": {"identifier": "MESH:D008775", "type": "Chemical"}, "text": "methylprednisolone", "locations": [{"offset": 1122, "length": 18}]}, {"id": "57", "infons": {"identifier": "MESH:D011239", "type": "Chemical"}, "text": "prednisolone", "locations": [{"offset": 1141, "length": 12}]}, {"id": "58", "infons": {"identifier": "338", "type": "Gene", "ncbi_homologene": "328"}, "text": "ApoB", "locations": [{"offset": 1187, "length": 4}]}, {"id": "59", "infons": {"identifier": "rs693", "type": "Mutation", "subtype": "SNP"}, "text": "rs693", "locations": [{"offset": 1192, "length": 5}]}, {"id": "60", "infons": {"identifier": "MESH:D011241", "type": "Chemical"}, "text": "prednisone", "locations": [{"offset": 1244, "length": 10}]}, {"id": "61", "infons": {"identifier": "MESH:D008775", "type": "Chemical"}, "text": "methylprednisolone", "locations": [{"offset": 1263, "length": 18}]}, {"id": "62", "infons": {"identifier": "MESH:D011239", "type": "Chemical"}, "text": "prednisolone", "locations": [{"offset": 1282, "length": 12}]}, {"id": "63", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1332, "length": 8}]}, {"id": "64", "infons": {"identifier": "338", "type": "Gene", "ncbi_homologene": "328"}, "text": "ApoB", "locations": [{"offset": 1346, "length": 4}]}, {"id": "65", "infons": {"identifier": "rs1042031", "type": "Mutation", "subtype": "SNP"}, "text": "rs1042031", "locations": [{"offset": 1351, "length": 9}]}, {"id": "66", "infons": {"identifier": "MESH:D011241", "type": "Chemical"}, "text": "prednisone", "locations": [{"offset": 1406, "length": 10}]}, {"id": "67", "infons": {"identifier": "5054", "type": "Gene", "ncbi_homologene": "68070"}, "text": "PAI-1", "locations": [{"offset": 1437, "length": 5}]}, {"id": "68", "infons": {"identifier": "rs1799768", "type": "Mutation", "subtype": "SNP"}, "text": "rs1799768", "locations": [{"offset": 1443, "length": 9}]}, {"id": "69", "infons": {"identifier": "MESH:D011241", "type": "Chemical"}, "text": "prednisone", "locations": [{"offset": 1504, "length": 10}]}, {"id": "70", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1553, "length": 5}]}, {"id": "71", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1559, "length": 9}]}, {"id": "72", "infons": {"identifier": "338", "type": "Gene", "ncbi_homologene": "328"}, "text": "ApoB", "locations": [{"offset": 1623, "length": 4}]}, {"id": "73", "infons": {"identifier": "rs693", "type": "Mutation", "subtype": "SNP"}, "text": "rs693", "locations": [{"offset": 1628, "length": 5}]}, {"id": "74", "infons": {"identifier": "rs1042031", "type": "Mutation", "subtype": "SNP"}, "text": "rs1042031", "locations": [{"offset": 1638, "length": 9}]}, {"id": "75", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1800, "length": 5}]}, {"id": "76", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1806, "length": 9}]}, {"id": "77", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1820, "length": 9}]}], "relations": []}], "relations": [], "pmid": 30996113, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@5054", "mutation@rs1799768", "chemical@MESH:D011239", "gene@338", "mutation@rs693", "species@9606", "mutation@rs1042031", "chemical@MESH:D011241", "chemical@MESH:D008775", "mutation@rs2032582", "disease@MESH:D005271", "gene@5243", "mutation@rs1045642", "disease@MESH:D010020", "chemical@MESH:D013256"], "journal": "Biosci Rep. 2019 May 14", "year": 2019, "authors": ["Yang J", "Jing M", "Yang X"]},
{"_id": "30213564|None", "id": "30213564", "infons": {}, "passages": [{"infons": {"journal": "Pharmacol Res. 2018 Oct;136:133-139. doi: 10.1016/j.phrs.2018.08.026. Epub 2018", "year": "2018", "type": "title", "authors": "Salvador-Martin S, Garcia-Gonzalez X, Garcia MI, Blanco C, Garcia-Alfonso P, Robles L, Gravalos C, Pachon V, Longo F, Martinez V, Sanjurjo-Saez M, Lopez-Fernandez LA", "section": "Title"}, "offset": 0, "text": "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 20, "length": 5}]}, {"id": "4", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 52, "length": 8}]}, {"id": "5", "infons": {"identifier": "MESH:D000077146", "type": "Chemical"}, "text": "irinotecan", "locations": [{"offset": 79, "length": 10}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 91, "text": "Preventing severe irinotecan-induced adverse reactions would allow us to offer better treatment and improve patients' quality of life. Transporters, metabolizing enzymes, and genes involved in the folate pathway have been associated with irinotecan-induced toxicity. We analyzed 12 polymorphisms in UGT1A1, ABCB1, ABCG2, ABCC4, ABCC5, and MTHFR in 158 patients with metastatic colorectal cancer treated with irinotecan and studied the association with grade &gt;2 adverse reactions (CTCAE). Among the most frequent ADRs, the SNPs rs1128503, rs2032582, and rs1045642 in ABCB1 and rs1801133 in MTHFR were associated with hematological toxicity and overall toxicity. The SNP rs11568678 in ABCC4 was also associated with overall toxicity. After correction of P values using a false discovery rate, only ABCB1 variants remained statistically significant. Haplotype analysis in ABCB1 showed an 11.3-fold and 4.6-fold increased risk of hematological toxicity (95% CI, 1.459-88.622) and overall toxicity (95% CI, 2.283-9.386), respectively. Consequently, genotyping of the three SNPs in ABCB1 can predict overall toxicity and hematological toxicity with a diagnostic odds ratio of 4.40 and 9.94, respectively. Genotyping of ABCB1 variants can help to prevent severe adverse reactions to irinotecan-based treatments in colorectal cancer.", "sentences": [], "annotations": [{"id": "41", "infons": {"identifier": "MESH:D000077146", "type": "Chemical"}, "text": "irinotecan", "locations": [{"offset": 109, "length": 10}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 199, "length": 8}]}, {"id": "43", "infons": {"identifier": "MESH:D005492", "type": "Chemical"}, "text": "folate", "locations": [{"offset": 288, "length": 6}]}, {"id": "44", "infons": {"identifier": "MESH:D000077146", "type": "Chemical"}, "text": "irinotecan", "locations": [{"offset": 329, "length": 10}]}, {"id": "45", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 348, "length": 8}]}, {"id": "46", "infons": {"identifier": "54658", "type": "Gene", "ncbi_homologene": "128034"}, "text": "UGT1A1", "locations": [{"offset": 390, "length": 6}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 398, "length": 5}]}, {"id": "48", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 405, "length": 5}]}, {"id": "49", "infons": {"identifier": "10257", "type": "Gene", "ncbi_homologene": "74563"}, "text": "ABCC4", "locations": [{"offset": 412, "length": 5}]}, {"id": "50", "infons": {"identifier": "10057", "type": "Gene", "ncbi_homologene": "21164"}, "text": "ABCC5", "locations": [{"offset": 419, "length": 5}]}, {"id": "51", "infons": {"identifier": "4524", "type": "Gene", "ncbi_homologene": "4349"}, "text": "MTHFR", "locations": [{"offset": 430, "length": 5}]}, {"id": "52", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 443, "length": 8}]}, {"id": "53", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 468, "length": 17}]}, {"id": "54", "infons": {"identifier": "MESH:D000077146", "type": "Chemical"}, "text": "irinotecan", "locations": [{"offset": 499, "length": 10}]}, {"id": "55", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 621, "length": 9}]}, {"id": "56", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 632, "length": 9}]}, {"id": "57", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 647, "length": 9}]}, {"id": "58", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 660, "length": 5}]}, {"id": "59", "infons": {"identifier": "rs1801133", "type": "Mutation", "subtype": "SNP"}, "text": "rs1801133", "locations": [{"offset": 670, "length": 9}]}, {"id": "60", "infons": {"identifier": "4524", "type": "Gene", "ncbi_homologene": "4349"}, "text": "MTHFR", "locations": [{"offset": 683, "length": 5}]}, {"id": "61", "infons": {"identifier": "MESH:D006402", "type": "Disease"}, "text": "hematological toxicity", "locations": [{"offset": 710, "length": 22}]}, {"id": "62", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 745, "length": 8}]}, {"id": "63", "infons": {"identifier": "rs11568678", "type": "Mutation", "subtype": "SNP"}, "text": "rs11568678", "locations": [{"offset": 763, "length": 10}]}, {"id": "64", "infons": {"identifier": "10257", "type": "Gene", "ncbi_homologene": "74563"}, "text": "ABCC4", "locations": [{"offset": 777, "length": 5}]}, {"id": "65", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 816, "length": 8}]}, {"id": "66", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 890, "length": 5}]}, {"id": "67", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 963, "length": 5}]}, {"id": "68", "infons": {"identifier": "MESH:D006402", "type": "Disease"}, "text": "hematological toxicity", "locations": [{"offset": 1020, "length": 22}]}, {"id": "69", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 1078, "length": 8}]}, {"id": "70", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1170, "length": 5}]}, {"id": "71", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 1196, "length": 8}]}, {"id": "72", "infons": {"identifier": "MESH:D006402", "type": "Disease"}, "text": "hematological toxicity", "locations": [{"offset": 1209, "length": 22}]}, {"id": "73", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1307, "length": 5}]}, {"id": "74", "infons": {"identifier": "MESH:D000077146", "type": "Chemical"}, "text": "irinotecan", "locations": [{"offset": 1370, "length": 10}]}, {"id": "75", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 1401, "length": 17}]}], "relations": []}], "relations": [], "pmid": 30213564, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@10057", "disease@MESH:D064420", "species@9606", "disease@MESH:D015179", "mutation@rs2032582", "chemical@MESH:D000077146", "mutation@rs1801133", "gene@4524", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D006402", "gene@54658", "mutation@rs11568678", "gene@10257", "gene@9429", "chemical@MESH:D005492"], "journal": "Pharmacol Res. 2018 Oct", "year": 2018, "authors": ["Salvador-Martin S", "Garcia-Gonzalez X", "Garcia MI", "Blanco C", "Garcia-Alfonso P", "Robles L", "Gravalos C", "Pachon V", "Longo F", "Martinez V", "Sanjurjo-Saez M", "Lopez-Fernandez LA"]},
{"_id": "29491071|None", "id": "29491071", "infons": {}, "passages": [{"infons": {"journal": "Anticancer Res.; 2018 03; 38(3) 1455-1459", "year": "2018", "type": "title", "authors": "Fiszer-Maliszewska \u0141, \u0141aczma\u0144ski \u0141, Doli\u0144ska A, Jagas M, Ko\u0142odziejska E, Jankowska M, Ku\u015bnierczyk P", "section": "Title"}, "offset": 0, "text": "Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 17, "length": 5}]}, {"id": "5", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 24, "length": 6}]}, {"id": "6", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 35, "length": 6}]}, {"id": "7", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "Ovarian Cancer", "locations": [{"offset": 51, "length": 14}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 99, "text": "BACKGROUND/AIM: Ovarian cancer is a lethal gynecological malignancy, with 5-year survival of only about one third of patients. The ABCB1 gene encodes the P-glycoprotein which is one of the multidrug efflux pumps. Its decreased activity may result in multidrug resistance of cancer cells. Drug-metabolizing enzymes Cyp3A4 and Cyp3A5 may affect success of chemotherapy. In this study we attempted to examine the effects of 12 single nucleotide polymorphisms (SNPs) of the ABCB1 gene and one SNP in each of CYP3A4 and CYP3A5 genes on the incidence of ovarian cancer in Polish women and their response to treatment. MATERIALS AND METHODS: Our study included 276 patients and 369 healthy control women. RESULTS: The results showed no significant differences between patients and controls in allele frequencies of the tested SNPs, with one exception: rs2157926T allele decreased cancer risk by 99.4% (odds ratio, 0.006). Moreover, rs2032582T increased fourfold the risk of metastasis. Finally, rs1128503CC genotype prolonged survival (p=0.024778). CONCLUSION: These findings may contribute to a better prediction of therapy outcome.", "sentences": [], "annotations": [{"id": "26", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "Ovarian cancer", "locations": [{"offset": 115, "length": 14}]}, {"id": "27", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "malignancy", "locations": [{"offset": 156, "length": 10}]}, {"id": "28", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 216, "length": 8}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 230, "length": 5}]}, {"id": "30", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 373, "length": 6}]}, {"id": "31", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "Cyp3A4", "locations": [{"offset": 413, "length": 6}]}, {"id": "32", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "Cyp3A5", "locations": [{"offset": 424, "length": 6}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 569, "length": 5}]}, {"id": "34", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 603, "length": 6}]}, {"id": "35", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 614, "length": 6}]}, {"id": "36", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "ovarian cancer", "locations": [{"offset": 647, "length": 14}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 672, "length": 5}]}, {"id": "38", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 757, "length": 8}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 790, "length": 5}]}, {"id": "40", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 860, "length": 8}]}, {"id": "41", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 972, "length": 6}]}, {"id": "42", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1024, "length": 9}]}, {"id": "43", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1087, "length": 9}]}], "relations": []}], "relations": [], "pmid": 29491071, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@1576", "disease@MESH:D010051", "species@9606", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "gene@1577", "disease@MESH:D009369"], "journal": "Anticancer Res.", "year": 2018, "authors": ["Fiszer-Maliszewska \u0141", "\u0141aczma\u0144ski \u0141", "Doli\u0144ska A", "Jagas M", "Ko\u0142odziejska E", "Jankowska M", "Ku\u015bnierczyk P"]},
{"_id": "28792718|None", "id": "28792718", "infons": {}, "passages": [{"infons": {"journal": "Clin. Lab.; 2017 Jul 01; 63(7) 1233-1242. doi:10.7754/Clin.Lab.2017.170203", "year": "2017", "type": "title", "authors": "Moussa A, Mabrouk S, Hamdouni H, Ajmi M, Tfifha M, Omezzine A, Abroug S, Bouslama A", "section": "Title"}, "offset": 0, "text": "MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results).", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR-1", "locations": [{"offset": 0, "length": 5}]}, {"id": "5", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 10, "length": 6}]}, {"id": "6", "infons": {"identifier": "MESH:C535761", "type": "Disease"}, "text": "Pediatric Idiopathic Nephrotic Syndrome", "locations": [{"offset": 34, "length": 39}]}, {"id": "7", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "Steroids", "locations": [{"offset": 116, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 148, "text": "BACKGROUND: Oral steroid treatment is the first line of therapy for childhood nephrotic syndrome (NS). However, resistance to this treatment has been observed in some patients. Here, we investigated the association of two steroid metabolism-related genes with susceptibility to childhood NS and the steroid response. METHODS: We genotyped the single nucleotide polymorphisms (SNP) of MDR-1 [C1236T (rs1128503), G2677T/A (rs2032582), and C3435T (rs1045642)] and the CYP3A5 gene (A6986G) in 63 NS patients and 110 age and gender matched controls by PCR-RFLP. RESULTS: Based on multivariate logistic regression analysis carrying the G2677A A allele seemed to multiply both the risk of NS and the risk of developing glucocorticoid (GC) resistance by three-fold (OR = 3.50, [1.37 - 7.06] , p &lt; 0.001, OR = 3.07, [1.06 - 26.10], p = 0.048, respectively). When combined into haplotype, the TAT (1236_T, 2677_A, and 3435_T) haplotype conferred a two-fold NS risk (OR = 2.26, [1.11 - 4.58], p = 0.023) and almost three-fold risk to develop resistance to GC (OR = 2.69, [1.12 - 8.79], p = 0.044). However, TAT carriers seemed to have less risk to develop NS at late age (OR = 0.34, [0.12 - 0.92], p = 0.037). The C1236T (MDR-1) and the A6986G (CYP3A5) polymorphisms showed a trend of association to GC resistance but these associations did not reach the statistical significance (OR = 2.83, [0.54 - 14.67], p = 0.294), (OR = 2.11, [0.53 - 8.38], p = 0.28), respectively. CONCLUSIONS: Here we report that only the G2677A polymorphism was associated to NS susceptibility and steroid resistance. The TAT haplotype was associated with NS susceptibility especially at an early age and with steroid resistance.", "sentences": [], "annotations": [{"id": "39", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 165, "length": 7}]}, {"id": "40", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "nephrotic syndrome", "locations": [{"offset": 226, "length": 18}]}, {"id": "41", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 246, "length": 2}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 315, "length": 8}]}, {"id": "43", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 370, "length": 7}]}, {"id": "44", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 436, "length": 2}]}, {"id": "45", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 447, "length": 7}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR-1", "locations": [{"offset": 532, "length": 5}]}, {"id": "47", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 539, "length": 6}]}, {"id": "48", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 547, "length": 9}]}, {"id": "49", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 559, "length": 8}]}, {"id": "50", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 569, "length": 9}]}, {"id": "51", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 585, "length": 6}]}, {"id": "52", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 593, "length": 9}]}, {"id": "53", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 613, "length": 6}]}, {"id": "54", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.6986A>G;RS#:776746", "hgvs": "g.6986A>G", "identifiers": ["rs776746"]}, "text": "A6986G", "locations": [{"offset": 626, "length": 6}]}, {"id": "55", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 640, "length": 2}]}, {"id": "56", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 643, "length": 8}]}, {"id": "57", "infons": {"identifier": "rs1289543302", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>A;RS#:1289543302", "hgvs": "c.2677G>A", "identifiers": ["rs1289543302"]}, "text": "G2677A", "locations": [{"offset": 778, "length": 6}]}, {"id": "58", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 830, "length": 2}]}, {"id": "59", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 1098, "length": 2}]}, {"id": "60", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 1296, "length": 2}]}, {"id": "61", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 1354, "length": 6}]}, {"id": "62", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR-1", "locations": [{"offset": 1362, "length": 5}]}, {"id": "63", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.6986A>G;RS#:776746", "hgvs": "g.6986A>G", "identifiers": ["rs776746"]}, "text": "A6986G", "locations": [{"offset": 1377, "length": 6}]}, {"id": "64", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1385, "length": 6}]}, {"id": "65", "infons": {"identifier": "rs1289543302", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>A;RS#:1289543302", "hgvs": "c.2677G>A", "identifiers": ["rs1289543302"]}, "text": "G2677A", "locations": [{"offset": 1654, "length": 6}]}, {"id": "66", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 1692, "length": 2}]}, {"id": "67", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1714, "length": 7}]}, {"id": "68", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 1772, "length": 2}]}, {"id": "69", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1826, "length": 7}]}], "relations": []}], "relations": [], "pmid": 28792718, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D009404", "mutation@rs1289543302", "species@9606", "mutation@c.2677G>T,A", "mutation@rs2032582", "mutation@rs776746", "gene@5243", "mutation@rs1128503", "gene@1577", "mutation@rs1045642", "chemical@MESH:D013256", "disease@MESH:C535761"], "journal": "Clin. Lab.", "year": 2017, "authors": ["Moussa A", "Mabrouk S", "Hamdouni H", "Ajmi M", "Tfifha M", "Omezzine A", "Abroug S", "Bouslama A"]},
{"_id": "28608314|None", "id": "28608314", "infons": {}, "passages": [{"infons": {"journal": "Acta Neurol Belg; 2017 Dec; 117(4) 849-855. doi:10.1007/s13760-017-0808-5", "year": "2017", "type": "title", "authors": "Smolarz B, Skalski D, Rysz A, Marchel A, Romanowicz H, Makowska M", "section": "Title"}, "offset": 0, "text": "Polymorphism of the multidrug resistance 1 gene MDR1 G2677T/A (rs2032582) and the risk of drug-resistant epilepsy in the Polish adult population.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "multidrug resistance 1", "locations": [{"offset": 20, "length": 22}]}, {"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 48, "length": 4}]}, {"id": "7", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 53, "length": 8}]}, {"id": "8", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 63, "length": 9}]}, {"id": "9", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 105, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 146, "text": "The aim of this study was to analyse the frequency of genotypes and alleles of single-nucleotide polymorphism (SNP)-G2677T/A (rs2032582) of MDR1 gene and to investigate the significance this genetic variation exerts on drug-resistant epilepsy (DRE) in the Polish adult population. The study comprised 340 patients treated for DRE and 240 patients treated for drug-responsive epilepsy. Three hundred and sixty disease-free individuals were used as controls. Genomic DNA was isolated, and the SNP G2677T/A of MDR1 was determined by High-Resolution Melter technique. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele. In this paper, we have demonstrated that A allele of SNP G2677T/A of MDR1 may reduce the risk of DRE (OR 0.44; 95% CI 0.33-0.58, p &lt; 0.0001), whereas allele G itself may be a risk factor for this disease. No differences were found in the distribution of the genotypes and alleles in the studied groups, depending on sex as well as on concomitant diseases (p &gt; 0.05). G2677T/A polymorphism of MDR1 may play a significant role in the development of DRE in the Polish patients.", "sentences": [], "annotations": [{"id": "24", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 262, "length": 8}]}, {"id": "25", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 272, "length": 9}]}, {"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 286, "length": 4}]}, {"id": "27", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 380, "length": 8}]}, {"id": "28", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 451, "length": 8}]}, {"id": "29", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 484, "length": 8}]}, {"id": "30", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 521, "length": 8}]}, {"id": "31", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 641, "length": 8}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 653, "length": 4}]}, {"id": "33", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 866, "length": 8}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 878, "length": 4}]}, {"id": "35", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 1182, "length": 8}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1207, "length": 4}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1280, "length": 8}]}], "relations": []}], "relations": [], "pmid": 28608314, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "mutation@c.2677G>T,A", "mutation@rs2032582", "gene@5243", "disease@MESH:D004827"], "journal": "Acta Neurol Belg", "year": 2017, "authors": ["Smolarz B", "Skalski D", "Rysz A", "Marchel A", "Romanowicz H", "Makowska M"]},
{"_id": "27600024|None", "id": "27600024", "infons": {}, "passages": [{"infons": {"journal": "Sci Rep; 2016 09 07; 632708. doi:10.1038/srep32708", "year": "2016", "article-id_pmc": "PMC5013326", "type": "title", "authors": "Zhong X, Liu MY, Sun XH, Wei MJ", "section": "Title"}, "offset": 0, "text": "Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 20, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "Alzheimer's disease", "locations": [{"offset": 59, "length": 19}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 97, "text": "Although several epidemiological studies have investigated the association between ATP-binding cassette subfamily B member 1 (ABCB1) gene polymorphisms and Alzheimer's disease (AD) susceptibility, controversial results exist. Here, we performed a meta-analysis to assess whether ABCB1 polymorphisms 3435C > T (rs1045642), 2677G > T/A (rs2032582), 1236C > T (rs1128503) and haplotypes were associated with AD risk. Nine independent publications were included and analyzed. Crude odds ratio (OR) and 95% confidence interval (CI) were applied to investigate the strength of the association. Sensitivity analysis was conducted to measure the robustness of our analysis. A funnel plot and trim and fill method were used to test and adjust for publication bias. The results showed a significant association between the 3435C > T single nucleotide polymorphism (SNP) and AD susceptibility (CT vs. CC: OR = 1.24, 95% CI = 1.06-1.45, P = 0.01; CT + TT vs. CC: OR = 1.21, 95% CI = 1.04-1.41, P = 0.01) in the total population, as well as in Caucasian subgroup. The 2677G > T/A SNP was related to a decreased AD risk in Caucasian subgroup (TT + TA + AA vs. GT + GA + GG: OR = 0.68, 95% CI = 0.47-0.98, P = 0.04). Moreover, the ABCB1 haplotype analysis showed that the 1236T/2677T/3435C haplotype was associated with a higher risk of AD (OR = 1.99, 95% CI = 1.24-3.18, P = 0.00). Our results suggest that the ABCB1 3435C > T SNP, the 2677G > T/A SNP and 1236T/2677T/3435C haplotype are significantly associated with AD susceptibility.", "sentences": [], "annotations": [{"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ATP-binding cassette subfamily B member 1", "locations": [{"offset": 180, "length": 41}]}, {"id": "27", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 223, "length": 5}]}, {"id": "28", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "Alzheimer's disease", "locations": [{"offset": 253, "length": 19}]}, {"id": "29", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 274, "length": 2}]}, {"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 376, "length": 5}]}, {"id": "31", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "3435C > T", "locations": [{"offset": 396, "length": 9}]}, {"id": "32", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 407, "length": 9}]}, {"id": "33", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T,A;CorrespondingGene:5243", "hgvs": "c.2677G>T,A", "gene_id": 5243}, "text": "2677G > T/A", "locations": [{"offset": 419, "length": 11}]}, {"id": "34", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 432, "length": 9}]}, {"id": "35", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "1236C > T", "locations": [{"offset": 444, "length": 9}]}, {"id": "36", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 455, "length": 9}]}, {"id": "37", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 502, "length": 2}]}, {"id": "38", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "3435C > T", "locations": [{"offset": 910, "length": 9}]}, {"id": "39", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 961, "length": 2}]}, {"id": "40", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T,A;CorrespondingGene:5243", "hgvs": "c.2677G>T,A", "gene_id": 5243}, "text": "2677G > T/A", "locations": [{"offset": 1152, "length": 11}]}, {"id": "41", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 1195, "length": 2}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1313, "length": 5}]}, {"id": "43", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 1419, "length": 2}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1494, "length": 5}]}, {"id": "45", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "3435C > T", "locations": [{"offset": 1500, "length": 9}]}, {"id": "46", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T,A;CorrespondingGene:5243", "hgvs": "c.2677G>T,A", "gene_id": 5243}, "text": "2677G > T/A", "locations": [{"offset": 1519, "length": 11}]}, {"id": "47", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 1601, "length": 2}]}], "relations": []}], "relations": [], "pmid": 27600024, "pmcid": null, "created": {"$date": 1600357501642}, "accessions": ["mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D000544", "mutation@rs2032582", "gene@5243", "mutation@c.2677G>T,A"], "journal": "Sci Rep", "year": 2016, "authors": ["Zhong X", "Liu MY", "Sun XH", "Wei MJ"]},
{"_id": "27296832|None", "id": "27296832", "infons": {}, "passages": [{"infons": {"journal": "BMC Genet.; 2016 06 13; 17(1) 79. doi:10.1186/s12863-016-0390-5", "year": "2016", "article-id_pmc": "PMC4906899", "type": "title", "authors": "Fukunaga K, Nakagawa H, Ishikawa T, Kubo M, Mushiroda T", "section": "Title"}, "offset": 0, "text": "ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "4", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 38, "length": 12}]}, {"id": "5", "infons": {"identifier": "MESH:D056486", "type": "Disease"}, "text": "liver injury", "locations": [{"offset": 59, "length": 12}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 96, "text": "BACKGROUND: To investigate the associations between atorvastatin-induced liver injury (AILI) and polymorphisms in eight genes possibly involved in the hepatic metabolism (CYP2C9, CYP2C19, CYP3A4, CYP3A5 and UGT1A1) and membrane transport (ABCB1, ABCG2 and SLCO1B1) of atorvastatin, we genotyped 30 AILI and 414 non-AILI patients recruited at BioBank Japan for 15 single nucleotide polymorphisms (SNPs). RESULTS: An SNP in ABCB1 (rs2032582: 2677G &gt; T/A) was significantly associated with AILI (P = 0.00068, odds ratio (OR) = 2.59 with 95 % confidence interval (CI) of 1.49-4.50, G allele versus T and A alleles), indicating that the G allele might be a risk factor for AILI. The cytotoxicity test demonstrated that IC50 value of atorvastatin to inhibit the growth and/or viability of Flp-In-293/ABCB1 (2677G) cells was 5.44 +- 0.10 mM, which was significantly lower than those in Flp-In-293/ABCB1 (2677 T) (6.02 +- 0.07 mM) and Flp-In-293/ABCB1 (2677A) cells (5.95 +- 0.08 mM). CONCLUSIONS: These results indicate that ABCB1 rs2032582 may predict the risk of AILI in Japanese population.", "sentences": [], "annotations": [{"id": "27", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 148, "length": 12}]}, {"id": "28", "infons": {"identifier": "MESH:D056486", "type": "Disease"}, "text": "liver injury", "locations": [{"offset": 169, "length": 12}]}, {"id": "29", "infons": {"identifier": "1559", "type": "Gene", "ncbi_homologene": "133566"}, "text": "CYP2C9", "locations": [{"offset": 267, "length": 6}]}, {"id": "30", "infons": {"identifier": "1557", "type": "Gene", "ncbi_homologene": "133565"}, "text": "CYP2C19", "locations": [{"offset": 275, "length": 7}]}, {"id": "31", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 284, "length": 6}]}, {"id": "32", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 292, "length": 6}]}, {"id": "33", "infons": {"identifier": "54658", "type": "Gene", "ncbi_homologene": "128034"}, "text": "UGT1A1", "locations": [{"offset": 303, "length": 6}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 335, "length": 5}]}, {"id": "35", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 342, "length": 5}]}, {"id": "36", "infons": {"identifier": "10599", "type": "Gene", "ncbi_homologene": "74575"}, "text": "SLCO1B1", "locations": [{"offset": 352, "length": 7}]}, {"id": "37", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 364, "length": 12}]}, {"id": "38", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 416, "length": 8}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 518, "length": 5}]}, {"id": "40", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 525, "length": 9}]}, {"id": "41", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "cytotoxicity", "locations": [{"offset": 777, "length": 12}]}, {"id": "42", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 827, "length": 12}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 893, "length": 5}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 989, "length": 5}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1037, "length": 5}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1117, "length": 5}]}, {"id": "47", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1123, "length": 9}]}], "relations": []}], "relations": [], "pmid": 27296832, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@1557", "gene@10599", "disease@MESH:D064420", "disease@MESH:D056486", "gene@1576", "species@9606", "mutation@rs2032582", "gene@5243", "gene@54658", "gene@1577", "gene@1559", "chemical@MESH:D000069059", "gene@9429"], "journal": "BMC Genet.", "year": 2016, "authors": ["Fukunaga K", "Nakagawa H", "Ishikawa T", "Kubo M", "Mushiroda T"]},
{"_id": "26457621|None", "id": "26457621", "infons": {}, "passages": [{"infons": {"journal": "Environ. Res.; 2015 Nov; 143(Pt A) 98-106. doi:10.1016/j.envres.2015.08.022", "year": "2015", "article-id_pmc": "PMC4911423", "type": "title", "authors": "Narayan S, Sinsheimer JS, Paul KC, Liew Z, Cockburn M, Bronstein JM, Ritz B", "section": "Title"}, "offset": 0, "text": "Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 23, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "Parkinson's disease", "locations": [{"offset": 67, "length": 19}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 88, "text": "BACKGROUND: Studies suggested that variants in the ABCB1 gene encoding P-glycoprotein, a xenobiotic transporter, may increase susceptibility to pesticide exposures linked to Parkinson's Disease (PD) risk. OBJECTIVES: To investigate the joint impact of two ABCB1 polymorphisms and pesticide exposures on PD risk. METHODS: In a population-based case control study, we genotyped ABCB1 gene variants at rs1045642 (c.3435C/T) and rs2032582 (c.2677G/T/A) and assessed occupational exposures to organochlorine (OC) and organophosphorus (OP) pesticides based on self-reported occupational use and record-based ambient workplace exposures for 282 PD cases and 514 controls of European ancestry. We identified active ingredients in self-reported occupational use pesticides from a California database and estimated ambient workplace exposures between 1974 and 1999 employing a geographic information system together with records for state pesticide and land use. With unconditional logistic regression, we estimated marginal and joint contributions for occupational pesticide exposures and ABCB1 variants in PD. RESULTS: For occupationally exposed carriers of homozygous ABCB1 variant genotypes, we estimated odds ratios of 1.89 [95% confidence interval (CI): (0.87, 4.07)] to 3.71 [95% CI: (1.96, 7.02)], with the highest odds ratios estimated for occupationally exposed carriers of homozygous ABCB1 variant genotypes at both SNPs; but we found no multiplicative scale interactions. CONCLUSIONS: This study lends support to a previous report that commonly used pesticides, specifically OCs and OPs, and variant ABCB1 genotypes at two polymorphic sites jointly increase risk of PD.", "sentences": [], "annotations": [{"id": "25", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 139, "length": 5}]}, {"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 159, "length": 14}]}, {"id": "27", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "Parkinson's Disease", "locations": [{"offset": 262, "length": 19}]}, {"id": "28", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "PD", "locations": [{"offset": 283, "length": 2}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 344, "length": 5}]}, {"id": "30", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "PD", "locations": [{"offset": 391, "length": 2}]}, {"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 464, "length": 5}]}, {"id": "32", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 487, "length": 9}]}, {"id": "33", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.3435C>T;RS#:1045642", "hgvs": "c.3435C>T", "identifiers": ["rs1045642"]}, "text": "c.3435C/T", "locations": [{"offset": 498, "length": 9}]}, {"id": "34", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 513, "length": 9}]}, {"id": "35", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G,T>A;RS#:2032582", "hgvs": "c.2677G,T>A", "identifiers": ["rs2032582"]}, "text": "c.2677G/T/A", "locations": [{"offset": 524, "length": 11}]}, {"id": "36", "infons": {"identifier": "MESH:D006843", "type": "Chemical"}, "text": "organochlorine", "locations": [{"offset": 576, "length": 14}]}, {"id": "37", "infons": {"identifier": "MESH:D006843", "type": "Chemical"}, "text": "OC", "locations": [{"offset": 592, "length": 2}]}, {"id": "38", "infons": {"identifier": "-", "type": "Chemical"}, "text": "organophosphorus", "locations": [{"offset": 600, "length": 16}]}, {"id": "39", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "PD", "locations": [{"offset": 726, "length": 2}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1168, "length": 5}]}, {"id": "41", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "PD", "locations": [{"offset": 1186, "length": 2}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1249, "length": 5}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1473, "length": 5}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1690, "length": 5}]}, {"id": "45", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "PD", "locations": [{"offset": 1756, "length": 2}]}], "relations": []}], "relations": [], "pmid": 26457621, "pmcid": null, "created": {"$date": 1600357501642}, "accessions": ["chemical@MESH:D006843", "mutation@rs1045642", "mutation@rs2032582", "gene@5243", "disease@MESH:D010300", "chemical@-"], "journal": "Environ. Res.", "year": 2015, "authors": ["Narayan S", "Sinsheimer JS", "Paul KC", "Liew Z", "Cockburn M", "Bronstein JM", "Ritz B"]},
{"_id": "26325438|None", "id": "26325438", "infons": {}, "passages": [{"infons": {"journal": "Biol. Blood Marrow Transplant.; 2016 Feb; 22(2) 268-276. doi:10.1016/j.bbmt.2015.08.027", "year": "2016", "article-id_pmc": "PMC4716887", "type": "title", "authors": "Khaled SK, Palmer JM, Herzog J, Stiller T, Tsai NC, Senitzer D, Liu X, Thomas SH, Shayani S, Weitzel J, Forman SJ, Nakamura R", "section": "Title"}, "offset": 0, "text": "Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "Tacrolimus", "locations": [{"offset": 85, "length": 10}]}, {"id": "3", "infons": {"identifier": "MESH:D020123", "type": "Chemical"}, "text": "Sirolimus", "locations": [{"offset": 96, "length": 9}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 202, "text": "Allelic variants of genes implicated in drug absorption, distribution, metabolism, and excretion (ADME) determine the pharmacokinetic variability of many medications and are increasingly recognized as important factors determining the success or failure of medical treatments. Both tacrolimus and sirolimus have narrow therapeutic ranges maintained by therapeutic drug monitoring (TDM). Using an ADME panel that covers &gt;99% of the PharmaADME working group core list (188 single nucleotide polymorphism [SNP] and 12 copy number variant [CNV] assays in 36 pharmacogenetically relevant genes), we studied 177 patients who underwent allogeneic hematopoietic cell transplantation (HCT) using tacrolimus/sirolimus-based graft-versus-host disease (GVHD) prophylaxis. We tested for possible associations between ADME variants and tacrolimus/sirolimus drug levels, concentration/dose (C/D) ratio, and clinical endpoints, including acute GVHD. A total of 62 SNP and 6 CNV assays were evaluable after removing the variants, which were homozygous in (nearly) all samples. For sirolimus, rs2032582 (ABCB1) T-carriers versus non-T-carriers were associated with higher blood levels (P = .01), with similar results for C/D ratio. Generalized estimating equation analysis supported these findings. For tacrolimus, rs776746 CYP3A5*3/*3 and CYP3A5*3/*1 were associated with higher blood levels than CYP3A5*1/*1 (P = .002). By multivariable analysis, rs776746 CYP3A5*3/*3 and CYP3A5*3/*1 were independently associated with decreased acute GVHD compared with CYP3A5*1/*1, after adjustment for conditioning, donor type, race/ethnicity, and age. We demonstrated association of specific ADME genetic polymorphisms with blood levels of tacrolimus/sirolimus, and incidence of acute GVHD after HCT, in spite of TDM and dose adjustment. A larger ongoing study will determine whether these associations have clinical utility beyond TDM. ", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 484, "length": 10}]}, {"id": "31", "infons": {"identifier": "MESH:D020123", "type": "Chemical"}, "text": "sirolimus", "locations": [{"offset": 499, "length": 9}]}, {"id": "32", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 811, "length": 8}]}, {"id": "33", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 892, "length": 10}]}, {"id": "34", "infons": {"identifier": "MESH:D020123", "type": "Chemical"}, "text": "sirolimus", "locations": [{"offset": 903, "length": 9}]}, {"id": "35", "infons": {"identifier": "MESH:D006086", "type": "Disease"}, "text": "GVHD", "locations": [{"offset": 946, "length": 4}]}, {"id": "36", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1027, "length": 10}]}, {"id": "37", "infons": {"identifier": "MESH:D020123", "type": "Chemical"}, "text": "sirolimus", "locations": [{"offset": 1038, "length": 9}]}, {"id": "38", "infons": {"identifier": "MESH:D006086", "type": "Disease"}, "text": "GVHD", "locations": [{"offset": 1133, "length": 4}]}, {"id": "39", "infons": {"identifier": "MESH:D020123", "type": "Chemical"}, "text": "sirolimus", "locations": [{"offset": 1269, "length": 9}]}, {"id": "40", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1280, "length": 9}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1291, "length": 5}]}, {"id": "42", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1490, "length": 10}]}, {"id": "43", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 1502, "length": 8}]}, {"id": "44", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1511, "length": 6}]}, {"id": "45", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1527, "length": 6}]}, {"id": "46", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1585, "length": 6}]}, {"id": "47", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 1636, "length": 8}]}, {"id": "48", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1645, "length": 6}]}, {"id": "49", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1661, "length": 6}]}, {"id": "50", "infons": {"identifier": "MESH:D006086", "type": "Disease"}, "text": "GVHD", "locations": [{"offset": 1724, "length": 4}]}, {"id": "51", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1743, "length": 6}]}, {"id": "52", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 1791, "length": 5}]}, {"id": "53", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1916, "length": 10}]}, {"id": "54", "infons": {"identifier": "MESH:D020123", "type": "Chemical"}, "text": "sirolimus", "locations": [{"offset": 1927, "length": 9}]}, {"id": "55", "infons": {"identifier": "MESH:D006086", "type": "Disease"}, "text": "GVHD", "locations": [{"offset": 1961, "length": 4}]}], "relations": []}], "relations": [], "pmid": 26325438, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "mutation@rs2032582", "mutation@rs776746", "chemical@MESH:D016559", "gene@5243", "gene@1577", "disease@MESH:D006086", "chemical@MESH:D020123"], "journal": "Biol. Blood Marrow Transplant.", "year": 2016, "authors": ["Khaled SK", "Palmer JM", "Herzog J", "Stiller T", "Tsai NC", "Senitzer D", "Liu X", "Thomas SH", "Shayani S", "Weitzel J", "Forman SJ", "Nakamura R"]},
{"_id": "26189305|None", "id": "26189305", "infons": {}, "passages": [{"infons": {"journal": "Pharmazie; 2015 Jun; 70(6) 416-20", "year": "2015", "type": "title", "authors": "Zhou L, Cao Y, Long H, Long L, Xu L, Liu Z, Zhang Y, Xiao B", "section": "Title"}, "offset": 0, "text": "ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.", "sentences": [], "annotations": [{"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "7", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 7, "length": 5}]}, {"id": "8", "infons": {"identifier": "6323", "type": "Gene", "ncbi_homologene": "21375"}, "text": "SCN1A", "locations": [{"offset": 14, "length": 5}]}, {"id": "9", "infons": {"identifier": "6326", "type": "Gene", "ncbi_homologene": "75001"}, "text": "SCN2A", "locations": [{"offset": 21, "length": 5}]}, {"id": "10", "infons": {"identifier": "2554", "type": "Gene", "ncbi_homologene": "629"}, "text": "GABRA1", "locations": [{"offset": 28, "length": 6}]}, {"id": "11", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 73, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 113, "text": "Drug resistance is common in epilepsy despite multiple available medications. Single nucleotide polymorphisms (SNP) may influence drug efficacy in epilepsy. We therefore aimed to clarify the association between polymorphisms of several controversial SNP loci and drug resistance in Chinese Han epilepsy patients from central China. Among all the 391 recruited subjects, 235 and 156 patients were classified into a drug responsive and resistant group, respectively, according to the definition of drug resistance proposed by the International League Against Epilepsy. The candidate SNP loci, including ATP-binding cassette (ABC) subfamily gene ABCB1 rs2032582 and rs1045642; ABC subfamily gene ABCC2 rs717620 and rs2273697; sodium channel subunit gene SCN1A rs3812718, SCN2A rs2304016; gamma-amino butyric acid type A (GABAA) receptor subunit subtype gene GABRA1 rs2279020 were genotyped following the Illumina protocols. There were no significant differences in allelic or genotypic frequencies between the drug responsive and resistant patients. The polymorphisms of the above SNP loci may not be associated with drug resistance of epilepsy in the Chinese Han population.", "sentences": [], "annotations": [{"id": "32", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 142, "length": 8}]}, {"id": "33", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 260, "length": 8}]}, {"id": "34", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 407, "length": 8}]}, {"id": "35", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 416, "length": 8}]}, {"id": "36", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 495, "length": 8}]}, {"id": "37", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "Epilepsy", "locations": [{"offset": 670, "length": 8}]}, {"id": "38", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 756, "length": 5}]}, {"id": "39", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 762, "length": 9}]}, {"id": "40", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 776, "length": 9}]}, {"id": "41", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 806, "length": 5}]}, {"id": "42", "infons": {"identifier": "rs717620", "type": "Mutation", "subtype": "SNP"}, "text": "rs717620", "locations": [{"offset": 812, "length": 8}]}, {"id": "43", "infons": {"identifier": "rs2273697", "type": "Mutation", "subtype": "SNP"}, "text": "rs2273697", "locations": [{"offset": 825, "length": 9}]}, {"id": "44", "infons": {"identifier": "6323", "type": "Gene", "ncbi_homologene": "21375"}, "text": "SCN1A", "locations": [{"offset": 864, "length": 5}]}, {"id": "45", "infons": {"identifier": "rs3812718", "type": "Mutation", "subtype": "SNP"}, "text": "rs3812718", "locations": [{"offset": 870, "length": 9}]}, {"id": "46", "infons": {"identifier": "6326", "type": "Gene", "ncbi_homologene": "75001"}, "text": "SCN2A", "locations": [{"offset": 881, "length": 5}]}, {"id": "47", "infons": {"identifier": "rs2304016", "type": "Mutation", "subtype": "SNP"}, "text": "rs2304016", "locations": [{"offset": 887, "length": 9}]}, {"id": "48", "infons": {"identifier": "2554", "type": "Gene", "ncbi_homologene": "629"}, "text": "GABRA1", "locations": [{"offset": 968, "length": 6}]}, {"id": "49", "infons": {"identifier": "rs2279020", "type": "Mutation", "subtype": "SNP"}, "text": "rs2279020", "locations": [{"offset": 975, "length": 9}]}, {"id": "50", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1150, "length": 8}]}, {"id": "51", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 1246, "length": 8}]}], "relations": []}], "relations": [], "pmid": 26189305, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@6326", "gene@6323", "mutation@rs2279020", "gene@1244", "species@9606", "mutation@rs2304016", "mutation@rs2032582", "mutation@rs3812718", "gene@2554", "mutation@rs2273697", "gene@5243", "mutation@rs1045642", "disease@MESH:D004827", "mutation@rs717620"], "journal": "Pharmazie", "year": 2015, "authors": ["Zhou L", "Cao Y", "Long H", "Long L", "Xu L", "Liu Z", "Zhang Y", "Xiao B"]},
{"_id": "25520092|None", "id": "25520092", "infons": {}, "passages": [{"infons": {"journal": "Asian Pac. J. Cancer Prev.; 2014; 15(22) 9707-11", "year": "2014", "type": "title", "authors": "Kreile M, Rots D, Piekuse L, Cebura E, Grutupa M, Kovalova Z, Lace B", "section": "Title"}, "offset": 0, "text": "Lack of association between polymorphisms in genes MTHFR and MDR1 with risk of childhood acute lymphoblastic leukemia.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "4524", "type": "Gene", "ncbi_homologene": "4349"}, "text": "MTHFR", "locations": [{"offset": 51, "length": 5}]}, {"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 61, "length": 4}]}, {"id": "5", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "acute lymphoblastic leukemia", "locations": [{"offset": 89, "length": 28}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 119, "text": "BACKGROUND: Acute lymphoblastic leukemia (ALL) is a complex disease caused by interactions between hazardous exogenous or/and endogenous agents and many mild effect inherited susceptibility mutations. Some of them are known, but their functional roles still requireinvestigation. Age is a recognized risk factor; children with disease onset after the age of ten have worse prognosis, presumably also triggered by inherited factors. MATERIALS AND METHODS: The MDR1 gene polymorphisms rs1045642, rs2032582 and MTHFR gene polymorphisms rs1801131 and rs1801133 were genotyped in 68 ALL patients in remission and 102 age and gender matched controls; parental DNA samples were also available for 42 probands. RESULTS: No case control association was found between analyzed polymorphisms and a risk of childhood ALL development. Linkage disequilibrium was not observed in a family-based association study either. Only marginal association was observed between genetic marker rs2032582A and later disease onset (p=0.04). CONCLUSIONS: Our data suggest that late age of ALL onset could be triggered by mild effect common alleles.", "sentences": [], "annotations": [{"id": "15", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "Acute lymphoblastic leukemia", "locations": [{"offset": 131, "length": 28}]}, {"id": "16", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 432, "length": 8}]}, {"id": "17", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 578, "length": 4}]}, {"id": "18", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 602, "length": 9}]}, {"id": "19", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 613, "length": 9}]}, {"id": "20", "infons": {"identifier": "4524", "type": "Gene", "ncbi_homologene": "4349"}, "text": "MTHFR", "locations": [{"offset": 627, "length": 5}]}, {"id": "21", "infons": {"identifier": "rs1801131", "type": "Mutation", "subtype": "SNP"}, "text": "rs1801131", "locations": [{"offset": 652, "length": 9}]}, {"id": "22", "infons": {"identifier": "rs1801133", "type": "Mutation", "subtype": "SNP"}, "text": "rs1801133", "locations": [{"offset": 666, "length": 9}]}, {"id": "23", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 701, "length": 8}]}], "relations": []}], "relations": [], "pmid": 25520092, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs1801131", "species@9606", "mutation@rs2032582", "mutation@rs1801133", "gene@4524", "mutation@rs1045642", "gene@5243", "disease@MESH:D054198"], "journal": "Asian Pac. J. Cancer Prev.", "year": 2014, "authors": ["Kreile M", "Rots D", "Piekuse L", "Cebura E", "Grutupa M", "Kovalova Z", "Lace B"]},
{"_id": "25355168|None", "id": "25355168", "infons": {}, "passages": [{"infons": {"journal": "J. Biomed. Sci.; 2014 Sep 04; 2189. doi:10.1186/s12929-014-0089-8", "year": "2014", "article-id_pmc": "PMC4428509", "type": "title", "authors": "Martinelli M, Scapoli L, Cura F, Rodia MT, Ugolini G, Montroni I, Solmi R", "section": "Title"}, "offset": 0, "text": "Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "Colorectal cancer", "locations": [{"offset": 0, "length": 17}]}, {"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 72, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 98, "text": "BACKGROUND: The ATP-binding cassette transporter B1 (ABCB1) gene codes for a membrane efflux pump localized in epithelial cells. Together with other Permeability-glycoproteins in the small and large intestine, its product represents a barrier against xenobiotics, bacterial toxins, drugs and other substances introduced with diet, including carcinogens. The aim of this investigation was to verify the possible contribution of ABCB1 single nucleotide polymorphisms (SNPs) to the genetic risk of colorectal cancer (CRC). RESULTS: DNA obtained from the peripheral blood of 98 CRC patients and 100 healthy controls was genotyped for the three selected SNPs: 1236C &gt; T (rs1128503), 2677G &gt; T/A (rs2032582), and 3435C &gt; T (rs1045642). Molecular data were analyzed to asses allele and haplotype association with CRC. No evidence of an association between ABCB1 alleles and CRC occurrence as a whole was found. However, ABCB1 showed either association with carcinoma of the sigmoid colon, and appeared able to influence the sex ratio among CRC patients. These two effects seemed to act independently based on multivariate analysis. We showed that ABCB1 polymorphisms were able to influence CRC susceptibility related to tumor localization and patient gender. CONCLUSIONS: We suggest that sensitivity to undetermined risk factors could depend on the genetic background of ABCB1 locus, with a mechanism that also depends on patient gender.", "sentences": [], "annotations": [{"id": "21", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ATP-binding cassette transporter B1", "locations": [{"offset": 114, "length": 35}]}, {"id": "22", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 151, "length": 5}]}, {"id": "23", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 525, "length": 5}]}, {"id": "24", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 593, "length": 17}]}, {"id": "25", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 676, "length": 8}]}, {"id": "26", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 767, "length": 9}]}, {"id": "27", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 795, "length": 9}]}, {"id": "28", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 825, "length": 9}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 956, "length": 5}]}, {"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1020, "length": 5}]}, {"id": "31", "infons": {"identifier": "MESH:D012811", "type": "Disease"}, "text": "carcinoma of the sigmoid colon", "locations": [{"offset": 1057, "length": 30}]}, {"id": "32", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1144, "length": 8}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1247, "length": 5}]}, {"id": "34", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1320, "length": 5}]}, {"id": "35", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 1343, "length": 7}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1471, "length": 5}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 1522, "length": 7}]}], "relations": []}], "relations": [], "pmid": 25355168, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "disease@MESH:D015179", "mutation@rs2032582", "disease@MESH:D012811", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D009369"], "journal": "J. Biomed. Sci.", "year": 2014, "authors": ["Martinelli M", "Scapoli L", "Cura F", "Rodia MT", "Ugolini G", "Montroni I", "Solmi R"]},
{"_id": "24918524|None", "id": "24918524", "infons": {}, "passages": [{"infons": {"journal": "Rev Bras Psiquiatr; 2014 Sep; 36(3) 227-32", "year": "2014", "type": "title", "authors": "Tovilla-Z\u00e1rate CA, Vargas I, Hern\u00e1ndez S, Fres\u00e1n A, Aguilar A, Escamilla R, Saracco R, Palacios J, Camarena B", "section": "Title"}, "offset": 0, "text": "Association study between the MDR1 gene and clinical characteristics in schizophrenia.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 30, "length": 4}]}, {"id": "3", "infons": {"identifier": "MESH:D012559", "type": "Disease"}, "text": "schizophrenia", "locations": [{"offset": 72, "length": 13}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 87, "text": "OBJECTIVE: Schizophrenia is a complex psychiatric disorder, characterized by disturbed patterns of thought and affecting 0.3-2.0% of the world population. Previously, the multidrug resistance 1 (MDR1) gene has been associated with schizophrenia in treatment response studies in psychotic patients. The aim of this study was to determine the association between MDR1 gene polymorphisms and clinical characteristics in patients with schizophrenia. METHODS: Positive and negative symptoms of schizophrenia were assessed with the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) in 158 Mexican patients with schizophrenia. Analyses of MDR1 gene polymorphisms were performed using TaqMan technology. A multivariate ANOVA was performed with MDR1 polymorphisms and gender as independent variables. RESULTS: Males with the G/G genotype of MDR1 rs2032582 presented significantly higher levels of delusions (p = 0.02). When comparing female vs. male groups, the difference was statistically significant (p = 0.0003). Analyses of the MDR1 gene rs1045642 variant showed no significant differences. CONCLUSION: Our findings suggest that male carriers of the G allele of variant rs2032582 exhibit greater severity of delusions; however, these results should be taken as preliminary, and replication studies in other populations of different ethnic origins are required to confirm these findings.", "sentences": [], "annotations": [{"id": "26", "infons": {"identifier": "MESH:D012559", "type": "Disease"}, "text": "Schizophrenia", "locations": [{"offset": 98, "length": 13}]}, {"id": "27", "infons": {"identifier": "MESH:D001523", "type": "Disease"}, "text": "psychiatric disorder", "locations": [{"offset": 125, "length": 20}]}, {"id": "28", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "multidrug resistance 1", "locations": [{"offset": 258, "length": 22}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 282, "length": 4}]}, {"id": "30", "infons": {"identifier": "MESH:D012559", "type": "Disease"}, "text": "schizophrenia", "locations": [{"offset": 318, "length": 13}]}, {"id": "31", "infons": {"identifier": "MESH:D011618", "type": "Disease"}, "text": "psychotic", "locations": [{"offset": 365, "length": 9}]}, {"id": "32", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 375, "length": 8}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 448, "length": 4}]}, {"id": "34", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 504, "length": 8}]}, {"id": "35", "infons": {"identifier": "MESH:D012559", "type": "Disease"}, "text": "schizophrenia", "locations": [{"offset": 518, "length": 13}]}, {"id": "36", "infons": {"identifier": "MESH:D012559", "type": "Disease"}, "text": "schizophrenia", "locations": [{"offset": 576, "length": 13}]}, {"id": "37", "infons": {"identifier": "124590", "type": "Gene", "ncbi_homologene": "56113"}, "text": "SANS", "locations": [{"offset": 660, "length": 4}]}, {"id": "38", "infons": {"identifier": "8935", "type": "Gene", "ncbi_homologene": "2919"}, "text": "SAPS", "locations": [{"offset": 721, "length": 4}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 742, "length": 8}]}, {"id": "40", "infons": {"identifier": "MESH:D012559", "type": "Disease"}, "text": "schizophrenia", "locations": [{"offset": 756, "length": 13}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 783, "length": 4}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 887, "length": 4}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 983, "length": 4}]}, {"id": "44", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 988, "length": 9}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1175, "length": 4}]}, {"id": "46", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1185, "length": 9}]}, {"id": "47", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1317, "length": 9}]}], "relations": []}], "relations": [], "pmid": 24918524, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D011618", "gene@8935", "disease@MESH:D001523", "species@9606", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "disease@MESH:D012559", "gene@124590"], "journal": "Rev Bras Psiquiatr", "year": 2014, "authors": ["Tovilla-Z\u00e1rate CA", "Vargas I", "Hern\u00e1ndez S", "Fres\u00e1n A", "Aguilar A", "Escamilla R", "Saracco R", "Palacios J", "Camarena B"]},
{"_id": "24469730|None", "id": "24469730", "infons": {}, "passages": [{"infons": {"journal": "Mol. Biol. Rep.; 2014 May; 41(5) 3135-46. doi:10.1007/s11033-014-3173-y", "year": "2014", "type": "title", "authors": "Zhang Y, Kong X, Wang R, Li S, Niu Y, Zhu L, Chen W, Lin N", "section": "Title"}, "offset": 0, "text": "Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 47, "length": 5}]}, {"id": "4", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 85, "length": 7}]}, {"id": "5", "infons": {"identifier": "MESH:D005271", "type": "Disease"}, "text": "osteonecrosis of the femoral", "locations": [{"offset": 101, "length": 28}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 158, "text": "Steroid administration, which is commonly performed for the treatment of autoimmune inflammatory diseases, cancers or organ transplantation, has been a leading cause of nontraumatic osteonecrosis of the femoral head (ONFH). Single nucleotide polymorphisms (SNPs) of the adenosine triphosphate-binding cassette B1 (ABCB1) gene have been demonstrated to be related to steroid-induced ONFH in small sample sizes of Japanese kidney failure and Chinese systemic lupus erythematosus patients. However, there are obvious controversial results in the relationship of ABCB1 gene polymorphisms with steroid-induced ONFH. The aim of this study was to validate the genetic association of ABCB1 polymorphisms with the risk for steroid-induced ONFH in a large cohort of Chinese population. A case-control study was conducted, which included 94 and 106 unrelated patients after steroid administration recruited from 14 provinces in China, respectively. Two SNPs (rs1045642 and rs2032582) within ABCB1 were genotyped using Sequenom MassARRAY system. Multivariate analyses based on clinical information were performed to determine the associations between the SNPs and risk of steroid-induced ONFH. rs1045642 SNP was significantly associated with steroid-induced ONFH group in codominant (P=0.02), recessive (P=0.006) and overdominant (P=0.03) models. However, there were no differences found in genotype frequencies of rs2032582 SNP between controls and patients with steroid-induced ONFH (all P&gt;0.05). These findings suggested that rs1045642 SNP of ABCB1 may be associated with the risk of steroid-induced ONFH. Thus, it is useful to analyze this polymorphism for identifying high-risk individuals before the administration of steroids.", "sentences": [], "annotations": [{"id": "35", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "Steroid", "locations": [{"offset": 158, "length": 7}]}, {"id": "36", "infons": {"identifier": "MESH:D001327", "type": "Disease"}, "text": "autoimmune inflammatory diseases", "locations": [{"offset": 231, "length": 32}]}, {"id": "37", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancers", "locations": [{"offset": 265, "length": 7}]}, {"id": "38", "infons": {"identifier": "MESH:D005271", "type": "Disease"}, "text": "nontraumatic osteonecrosis of the femoral", "locations": [{"offset": 327, "length": 41}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "adenosine triphosphate-binding cassette B1", "locations": [{"offset": 428, "length": 42}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 472, "length": 5}]}, {"id": "41", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 524, "length": 7}]}, {"id": "42", "infons": {"identifier": "MESH:D051437", "type": "Disease"}, "text": "kidney failure", "locations": [{"offset": 579, "length": 14}]}, {"id": "43", "infons": {"identifier": "MESH:D008180", "type": "Disease"}, "text": "systemic lupus erythematosus", "locations": [{"offset": 606, "length": 28}]}, {"id": "44", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 635, "length": 8}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 717, "length": 5}]}, {"id": "46", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 747, "length": 7}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 834, "length": 5}]}, {"id": "48", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 872, "length": 7}]}, {"id": "49", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1006, "length": 8}]}, {"id": "50", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1021, "length": 7}]}, {"id": "51", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1106, "length": 9}]}, {"id": "52", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1120, "length": 9}]}, {"id": "53", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1138, "length": 5}]}, {"id": "54", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1318, "length": 7}]}, {"id": "55", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1340, "length": 9}]}, {"id": "56", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1388, "length": 7}]}, {"id": "57", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1561, "length": 9}]}, {"id": "58", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1596, "length": 8}]}, {"id": "59", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1610, "length": 7}]}, {"id": "60", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1678, "length": 9}]}, {"id": "61", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1695, "length": 5}]}, {"id": "62", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1736, "length": 7}]}, {"id": "63", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroids", "locations": [{"offset": 1873, "length": 8}]}], "relations": []}], "relations": [], "pmid": 24469730, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D001327", "species@9606", "mutation@rs2032582", "disease@MESH:D005271", "gene@5243", "mutation@rs1045642", "disease@MESH:D008180", "chemical@MESH:D013256", "disease@MESH:D051437", "disease@MESH:D009369"], "journal": "Mol. Biol. Rep.", "year": 2014, "authors": ["Zhang Y", "Kong X", "Wang R", "Li S", "Niu Y", "Zhu L", "Chen W", "Lin N"]},
{"_id": "23917080|None", "id": "23917080", "infons": {}, "passages": [{"infons": {"journal": "Gynecol. Oncol.; 2013 Oct; 131(1) 8-14. doi:10.1016/j.ygyno.2013.07.107", "year": "2013", "article-id_pmc": "PMC3795832", "type": "title", "authors": "Johnatty SE, Beesley J, Gao B, Chen X, Lu Y, Law MH, Henderson MJ, Russell AJ, Hedditch EL, Emmanuel C, Fereday S, Webb PM, Goode EL, Vierkant RA, Fridley BL, Cunningham JM, Fasching PA, Beckmann MW, Ekici AB, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Brown R, Paul J, Lambrechts S, Despierre E, Vergote I, Lester J, Karlan BY, Heitz F, du Bois A, Harter P, Schwaab I, Bean Y, Pejovic T, Levine DA, Goodman MT, Camey ME, Thompson PJ, Lurie G, Shildkraut J, Berchuck A, Terry KL, Cramer DW, Norris MD, Haber M, MacGregor S, deFazio A, Chenevix-Trench G", "section": "Title"}, "offset": 0, "text": "ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 7, "length": 4}]}, {"id": "7", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "ovarian cancer", "locations": [{"offset": 31, "length": 14}]}, {"id": "8", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "Ovarian Cancer", "locations": [{"offset": 106, "length": 14}]}, {"id": "9", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "Cancer Genome Atlas", "locations": [{"offset": 152, "length": 19}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 173, "text": "OBJECTIVE: ABCB1 encodes the multi-drug efflux pump P-glycoprotein (P-gp) and has been implicated in multi-drug resistance. We comprehensively evaluated this gene and flanking regions for an association with clinical outcome in epithelial ovarian cancer (EOC). METHODS: The best candidates from fine-mapping analysis of 21 ABCB1 SNPs tagging C1236T (rs1128503), G2677T/A (rs2032582), and C3435T (rs1045642) were analysed in 4616 European invasive EOC patients from thirteen Ovarian Cancer Association Consortium (OCAC) studies and The Cancer Genome Atlas (TCGA). Additionally we analysed 1,562 imputed SNPs around ABCB1 in patients receiving cytoreductive surgery and either 'standard' first-line paclitaxel-carboplatin chemotherapy (n=1158) or any first-line chemotherapy regimen (n=2867). We also evaluated ABCB1 expression in primary tumours from 143 EOC patients. RESULT: Fine-mapping revealed that rs1128503, rs2032582, and rs1045642 were the best candidates in optimally debulked patients. However, we observed no significant association between any SNP and either progression-free survival or overall survival in analysis of data from 14 studies. There was a marginal association between rs1128503 and overall survival in patients with nil residual disease (HR 0.88, 95% CI 0.77-1.01; p=0.07). In contrast, ABCB1 expression in the primary tumour may confer worse prognosis in patients with sub-optimally debulked tumours. CONCLUSION: Our study represents the largest analysis of ABCB1 SNPs and EOC progression and survival to date, but has not identified additional signals, or validated reported associations with progression-free survival for rs1128503, rs2032582, and rs1045642. However, we cannot rule out the possibility of a subtle effect of rs1128503, or other SNPs linked to it, on overall survival.", "sentences": [], "annotations": [{"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 184, "length": 5}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 225, "length": 14}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 241, "length": 4}]}, {"id": "44", "infons": {"identifier": "MESH:D000077216", "type": "Disease"}, "text": "epithelial ovarian cancer", "locations": [{"offset": 401, "length": 25}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 496, "length": 5}]}, {"id": "46", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 515, "length": 6}]}, {"id": "47", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 535, "length": 8}]}, {"id": "48", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 545, "length": 9}]}, {"id": "49", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 561, "length": 6}]}, {"id": "50", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 569, "length": 9}]}, {"id": "51", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 624, "length": 8}]}, {"id": "52", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "Cancer", "locations": [{"offset": 655, "length": 6}]}, {"id": "53", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "Cancer Genome Atlas", "locations": [{"offset": 708, "length": 19}]}, {"id": "54", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 787, "length": 5}]}, {"id": "55", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 796, "length": 8}]}, {"id": "56", "infons": {"identifier": "MESH:D017239", "type": "Chemical"}, "text": "paclitaxel", "locations": [{"offset": 870, "length": 10}]}, {"id": "57", "infons": {"identifier": "MESH:D016190", "type": "Chemical"}, "text": "carboplatin", "locations": [{"offset": 881, "length": 11}]}, {"id": "58", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 982, "length": 5}]}, {"id": "59", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumours", "locations": [{"offset": 1010, "length": 7}]}, {"id": "60", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1031, "length": 8}]}, {"id": "61", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1087, "length": 9}]}, {"id": "62", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1102, "length": 9}]}, {"id": "63", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1159, "length": 8}]}, {"id": "64", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1402, "length": 8}]}, {"id": "65", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1487, "length": 5}]}, {"id": "66", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumour", "locations": [{"offset": 1519, "length": 6}]}, {"id": "67", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1556, "length": 8}]}, {"id": "68", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "debulked tumours", "locations": [{"offset": 1584, "length": 16}]}, {"id": "69", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1659, "length": 5}]}, {"id": "70", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1836, "length": 9}]}, {"id": "71", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1851, "length": 9}]}], "relations": []}], "relations": [], "pmid": 23917080, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D010051", "disease@MESH:D000077216", "species@9606", "mutation@c.2677G>T,A", "chemical@MESH:D016190", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "chemical@MESH:D017239", "disease@MESH:D009369"], "journal": "Gynecol. Oncol.", "year": 2013, "authors": ["Johnatty SE", "Beesley J", "Gao B", "Chen X", "Lu Y", "Law MH", "Henderson MJ", "Russell AJ", "Hedditch EL", "Emmanuel C", "Fereday S", "Webb PM", "Goode EL", "Vierkant RA", "Fridley BL", "Cunningham JM", "Fasching PA", "Beckmann MW", "Ekici AB", "Hogdall E", "Kjaer SK", "Jensen A", "Hogdall C", "Brown R", "Paul J", "Lambrechts S", "Despierre E", "Vergote I", "Lester J", "Karlan BY", "Heitz F", "du Bois A", "Harter P", "Schwaab I", "Bean Y", "Pejovic T", "Levine DA", "Goodman MT", "Camey ME", "Thompson PJ", "Lurie G", "Shildkraut J", "Berchuck A", "Terry KL", "Cramer DW", "Norris MD", "Haber M", "MacGregor S", "deFazio A", "Chenevix-Trench G"]},
{"_id": "23733030|None", "id": "23733030", "infons": {}, "passages": [{"infons": {"journal": "Prog. Neuropsychopharmacol. Biol. Psychiatry; 2013 Aug 01; 45183-94. doi:10.1016/j.pnpbp.2013.05.011", "year": "2013", "type": "title", "authors": "Niitsu T, Fabbri C, Bentini F, Serretti A", "section": "Title"}, "offset": 0, "text": "Pharmacogenetics in major depression: a comprehensive meta-analysis.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "major depression", "locations": [{"offset": 20, "length": 16}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 69, "text": "A number of candidate gene studies focused on major depression (MD) and antidepressant (AD) efficacy have been carried out, but results mainly remain inconclusive. We performed a comprehensive meta-analysis of published candidate gene studies focused on AD efficacy in MD to evaluate the cumulative evidence. A random-effect model was applied to study the polymorphisms with genotypic counts available from at least three independent studies. On the base of previous evidence, the analysis was stratified by ethnicity (Caucasian, Asian, and other/mixed), and AD class (SSRIs and mixed/other ADs). Genotypic data were available for 16 polymorphisms in 11 genes. After the exclusion of 5-HTTLPR in SLC6A4 included in another recent meta-analysis, 15 polymorphisms in 11 genes were included in the present meta-analysis (BDNF rs6265, SLC6A4 STin2, HTR1A rs6295, HTR2A rs6311, rs6313 and rs7997012, HTR6 rs1805054, TPH1 rs1800532, SLC6A2 rs5569, COMT rs4680, GNB3 rs5443, FKBP5 rs1360780 and rs3800373, and ABCB1 rs1045642 and rs2032582). Our results suggested that BDNF rs6265 (Val66Met) heterozygous genotype was associated with better SSRIs response compared to the homozygous genotypes, particularly in Asians (OR=1.53, 95%CI 1.12-2.07, p=0.007). SLC6A4 STin2, HTR2A rs6311 and rs7997012, GNB3 rs5443, FKBP5 rs1360780 and rs3800373, and ABCB1 rs2032582 showed associations with AD efficacy, but these results were highly dependent on one or two single studies. In conclusion, our findings suggested the BDNF Val66Met as the best single candidate involved in AD response, with a selective effect on SSRI treatment. Our overall results supported no major effect of any single gene variant on AD efficacy. ", "sentences": [], "annotations": [{"id": "44", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "depression", "locations": [{"offset": 121, "length": 10}]}, {"id": "45", "infons": {"identifier": "6532", "type": "Gene", "ncbi_homologene": "817"}, "text": "5-HTTLPR", "locations": [{"offset": 753, "length": 8}]}, {"id": "46", "infons": {"identifier": "6532", "type": "Gene", "ncbi_homologene": "817"}, "text": "SLC6A4", "locations": [{"offset": 765, "length": 6}]}, {"id": "47", "infons": {"identifier": "627", "type": "Gene", "ncbi_homologene": "7245"}, "text": "BDNF", "locations": [{"offset": 887, "length": 4}]}, {"id": "48", "infons": {"identifier": "rs6265", "type": "Mutation", "subtype": "SNP"}, "text": "rs6265", "locations": [{"offset": 892, "length": 6}]}, {"id": "49", "infons": {"identifier": "6532", "type": "Gene", "ncbi_homologene": "817"}, "text": "SLC6A4", "locations": [{"offset": 900, "length": 6}]}, {"id": "50", "infons": {"identifier": "3350", "type": "Gene", "ncbi_homologene": "20148"}, "text": "HTR1A", "locations": [{"offset": 914, "length": 5}]}, {"id": "51", "infons": {"identifier": "rs6295", "type": "Mutation", "subtype": "SNP"}, "text": "rs6295", "locations": [{"offset": 920, "length": 6}]}, {"id": "52", "infons": {"identifier": "3356", "type": "Gene", "ncbi_homologene": "68073"}, "text": "HTR2A", "locations": [{"offset": 928, "length": 5}]}, {"id": "53", "infons": {"identifier": "rs6311", "type": "Mutation", "subtype": "SNP"}, "text": "rs6311", "locations": [{"offset": 934, "length": 6}]}, {"id": "54", "infons": {"identifier": "rs6313", "type": "Mutation", "subtype": "SNP"}, "text": "rs6313", "locations": [{"offset": 942, "length": 6}]}, {"id": "55", "infons": {"identifier": "rs7997012", "type": "Mutation", "subtype": "SNP"}, "text": "rs7997012", "locations": [{"offset": 953, "length": 9}]}, {"id": "56", "infons": {"identifier": "3362", "type": "Gene", "ncbi_homologene": "673"}, "text": "HTR6", "locations": [{"offset": 964, "length": 4}]}, {"id": "57", "infons": {"identifier": "rs1805054", "type": "Mutation", "subtype": "SNP"}, "text": "rs1805054", "locations": [{"offset": 969, "length": 9}]}, {"id": "58", "infons": {"identifier": "7166", "type": "Gene", "ncbi_homologene": "121565"}, "text": "TPH1", "locations": [{"offset": 980, "length": 4}]}, {"id": "59", "infons": {"identifier": "rs1800532", "type": "Mutation", "subtype": "SNP"}, "text": "rs1800532", "locations": [{"offset": 985, "length": 9}]}, {"id": "60", "infons": {"identifier": "6530", "type": "Gene", "ncbi_homologene": "816"}, "text": "SLC6A2", "locations": [{"offset": 996, "length": 6}]}, {"id": "61", "infons": {"identifier": "rs5569", "type": "Mutation", "subtype": "SNP"}, "text": "rs5569", "locations": [{"offset": 1003, "length": 6}]}, {"id": "62", "infons": {"identifier": "1312", "type": "Gene", "ncbi_homologene": "30982"}, "text": "COMT", "locations": [{"offset": 1011, "length": 4}]}, {"id": "63", "infons": {"identifier": "rs4680", "type": "Mutation", "subtype": "SNP"}, "text": "rs4680", "locations": [{"offset": 1016, "length": 6}]}, {"id": "64", "infons": {"identifier": "2784", "type": "Gene", "ncbi_homologene": "55628"}, "text": "GNB3", "locations": [{"offset": 1024, "length": 4}]}, {"id": "65", "infons": {"identifier": "rs5443", "type": "Mutation", "subtype": "SNP"}, "text": "rs5443", "locations": [{"offset": 1029, "length": 6}]}, {"id": "66", "infons": {"identifier": "2289", "type": "Gene", "ncbi_homologene": "3038"}, "text": "FKBP5", "locations": [{"offset": 1037, "length": 5}]}, {"id": "67", "infons": {"identifier": "rs1360780", "type": "Mutation", "subtype": "SNP"}, "text": "rs1360780", "locations": [{"offset": 1043, "length": 9}]}, {"id": "68", "infons": {"identifier": "rs3800373", "type": "Mutation", "subtype": "SNP"}, "text": "rs3800373", "locations": [{"offset": 1057, "length": 9}]}, {"id": "69", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1072, "length": 5}]}, {"id": "70", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1078, "length": 9}]}, {"id": "71", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1092, "length": 9}]}, {"id": "72", "infons": {"identifier": "627", "type": "Gene", "ncbi_homologene": "7245"}, "text": "BDNF", "locations": [{"offset": 1131, "length": 4}]}, {"id": "73", "infons": {"identifier": "rs6265", "type": "Mutation", "subtype": "SNP"}, "text": "rs6265", "locations": [{"offset": 1136, "length": 6}]}, {"id": "74", "infons": {"identifier": "6532", "type": "Gene", "ncbi_homologene": "817"}, "text": "SLC6A4", "locations": [{"offset": 1316, "length": 6}]}, {"id": "75", "infons": {"identifier": "3356", "type": "Gene", "ncbi_homologene": "68073"}, "text": "HTR2A", "locations": [{"offset": 1330, "length": 5}]}, {"id": "76", "infons": {"identifier": "rs6311", "type": "Mutation", "subtype": "SNP"}, "text": "rs6311", "locations": [{"offset": 1336, "length": 6}]}, {"id": "77", "infons": {"identifier": "rs7997012", "type": "Mutation", "subtype": "SNP"}, "text": "rs7997012", "locations": [{"offset": 1347, "length": 9}]}, {"id": "78", "infons": {"identifier": "2784", "type": "Gene", "ncbi_homologene": "55628"}, "text": "GNB3", "locations": [{"offset": 1358, "length": 4}]}, {"id": "79", "infons": {"identifier": "rs5443", "type": "Mutation", "subtype": "SNP"}, "text": "rs5443", "locations": [{"offset": 1363, "length": 6}]}, {"id": "80", "infons": {"identifier": "2289", "type": "Gene", "ncbi_homologene": "3038"}, "text": "FKBP5", "locations": [{"offset": 1371, "length": 5}]}, {"id": "81", "infons": {"identifier": "rs1360780", "type": "Mutation", "subtype": "SNP"}, "text": "rs1360780", "locations": [{"offset": 1377, "length": 9}]}, {"id": "82", "infons": {"identifier": "rs3800373", "type": "Mutation", "subtype": "SNP"}, "text": "rs3800373", "locations": [{"offset": 1391, "length": 9}]}, {"id": "83", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1406, "length": 5}]}, {"id": "84", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1412, "length": 9}]}, {"id": "85", "infons": {"identifier": "627", "type": "Gene", "ncbi_homologene": "7245"}, "text": "BDNF", "locations": [{"offset": 1572, "length": 4}]}], "relations": []}], "relations": [], "pmid": 23733030, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@7166", "gene@1312", "gene@627", "mutation@rs6313", "gene@6530", "mutation@rs5443", "gene@2289", "mutation@rs3800373", "gene@3350", "mutation@rs6265", "mutation@rs1045642", "mutation@rs1800532", "mutation@rs6295", "mutation@rs6311", "mutation@rs1805054", "gene@3356", "gene@3362", "mutation@rs2032582", "disease@MESH:D003865", "gene@5243", "gene@2784", "gene@6532", "mutation@rs4680", "mutation@rs1360780", "mutation@rs5569", "disease@MESH:D000275", "mutation@rs7997012"], "journal": "Prog. Neuropsychopharmacol. Biol. Psychiatry", "year": 2013, "authors": ["Niitsu T", "Fabbri C", "Bentini F", "Serretti A"]},
{"_id": "23556446|None", "id": "23556446", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenomics; 2013 Apr; 14(5) 485-94. doi:10.2217/pgs.13.18", "year": "2013", "type": "title", "authors": "Cascorbi I, Fl\u00fch C, Remmler C, Haenisch S, Faltraco F, Grumbt M, Peters M, Brenn A, Thal DR, Warzok RW, Vogelgesang S", "section": "Title"}, "offset": 0, "text": "Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "24", "type": "Gene", "ncbi_homologene": "298"}, "text": "ATP-binding cassette transporter", "locations": [{"offset": 15, "length": 32}]}, {"id": "3", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "Alzheimer's disease", "locations": [{"offset": 74, "length": 19}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 95, "text": "AIM: A number of studies have demonstrated that ABCB1 and BCRP (ABCG2) actively transport Abeta. We aimed to investigate the association of genetic variants of selected multidrug transporters with Alzheimer's disease (AD) in histopathologically confirmed AD cases and controls. MATERIALS & METHODS: DNA from brain tissue of 71 AD cases with Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropathological stages B/C and 81 controls was genotyped for selected variants in ABCA1, ABCA7, ABCB1, ABCC2 and ABCG2. In addition, the APOE4 status was analyzed. RESULTS: The novel ABCA7 SNP, rs3752246, tended to be associated with AD in our study. Variants in ABCB1 were significantly less frequent in AD cases older than 65 years of age and among females. This association of ABCB1 2677G>T (rs2032582) was more pronounced in APOE4-negative cases (p = 0.005). However, only ABCC2 3972C>T (rs3740066) was significantly associated with AD risk after logistic regression analysis including all variants. Other transporters showed a lack of association. CONCLUSION: Our results support the hypothesis that ABCB1 and possibly other ABC-transporters are involved in the process of Abeta accumulation in the aging brain and may modulate the risk for AD in an allele-specific manner, and thus might represent a new target for prevention and treatment of AD.", "sentences": [], "annotations": [{"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 143, "length": 5}]}, {"id": "37", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "BCRP", "locations": [{"offset": 153, "length": 4}]}, {"id": "38", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 159, "length": 5}]}, {"id": "39", "infons": {"identifier": "351", "type": "Gene", "ncbi_homologene": "56379"}, "text": "Abeta", "locations": [{"offset": 185, "length": 5}]}, {"id": "40", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "Alzheimer's disease", "locations": [{"offset": 292, "length": 19}]}, {"id": "41", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 313, "length": 2}]}, {"id": "42", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 350, "length": 2}]}, {"id": "43", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 422, "length": 2}]}, {"id": "44", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "Alzheimer's Disease", "locations": [{"offset": 475, "length": 19}]}, {"id": "45", "infons": {"identifier": "19", "type": "Gene", "ncbi_homologene": "21130"}, "text": "ABCA1", "locations": [{"offset": 587, "length": 5}]}, {"id": "46", "infons": {"identifier": "10347", "type": "Gene", "ncbi_homologene": "22783"}, "text": "ABCA7", "locations": [{"offset": 594, "length": 5}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 601, "length": 5}]}, {"id": "48", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 608, "length": 5}]}, {"id": "49", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 618, "length": 5}]}, {"id": "50", "infons": {"identifier": "348", "type": "Gene", "ncbi_homologene": "30951"}, "text": "APOE4", "locations": [{"offset": 642, "length": 5}]}, {"id": "51", "infons": {"identifier": "10347", "type": "Gene", "ncbi_homologene": "22783"}, "text": "ABCA7", "locations": [{"offset": 688, "length": 5}]}, {"id": "52", "infons": {"identifier": "rs3752246", "type": "Mutation", "subtype": "SNP"}, "text": "rs3752246", "locations": [{"offset": 699, "length": 9}]}, {"id": "53", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 739, "length": 2}]}, {"id": "54", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 768, "length": 5}]}, {"id": "55", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 810, "length": 2}]}, {"id": "56", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 885, "length": 5}]}, {"id": "57", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T;RS#:2032582", "hgvs": "c.2677G>T", "identifiers": ["rs2032582"]}, "text": "2677G>T", "locations": [{"offset": 891, "length": 7}]}, {"id": "58", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 900, "length": 9}]}, {"id": "59", "infons": {"identifier": "348", "type": "Gene", "ncbi_homologene": "30951"}, "text": "APOE4", "locations": [{"offset": 934, "length": 5}]}, {"id": "60", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 982, "length": 5}]}, {"id": "61", "infons": {"identifier": "rs3740066", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3972C>T;RS#:3740066", "hgvs": "g.3972C>T", "identifiers": ["rs3740066"]}, "text": "3972C>T", "locations": [{"offset": 988, "length": 7}]}, {"id": "62", "infons": {"identifier": "rs3740066", "type": "Mutation", "subtype": "SNP"}, "text": "rs3740066", "locations": [{"offset": 997, "length": 9}]}, {"id": "63", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 1042, "length": 2}]}, {"id": "64", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1210, "length": 5}]}, {"id": "65", "infons": {"identifier": "351", "type": "Gene", "ncbi_homologene": "56379"}, "text": "Abeta", "locations": [{"offset": 1283, "length": 5}]}, {"id": "66", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 1351, "length": 2}]}, {"id": "67", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "AD", "locations": [{"offset": 1454, "length": 2}]}], "relations": []}], "relations": [], "pmid": 23556446, "pmcid": null, "created": {"$date": 1600357501642}, "accessions": ["mutation@rs3740066", "gene@348", "gene@351", "gene@10347", "mutation@rs3752246", "disease@MESH:D000544", "gene@9429", "gene@19", "gene@1244", "mutation@rs2032582", "gene@5243", "gene@24"], "journal": "Pharmacogenomics", "year": 2013, "authors": ["Cascorbi I", "Fl\u00fch C", "Remmler C", "Haenisch S", "Faltraco F", "Grumbt M", "Peters M", "Brenn A", "Thal DR", "Warzok RW", "Vogelgesang S"]},
{"_id": "23546964|None", "id": "23546964", "infons": {}, "passages": [{"infons": {"journal": "Genet. Mol. Res.; 2013 Mar 13; 12(1) 801-8. doi:10.4238/2013.March.13.9", "year": "2013", "type": "title", "authors": "Khabour OF, Alzoubi KH, Al-Azzam SI, Mhaidat NM", "section": "Title"}, "offset": 0, "text": "Frequency of MDR1 single nucleotide polymorphisms in a Jordanian population, including a novel variant.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 13, "length": 4}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 104, "text": "The multidrug resistance gene (MDR1 or ABCB1) codes for P-glycoprotein, which plays an important role in regulating absorption, distribution, and elimination of drugs. We examined MDR1 gene variants in 100 unrelated subjects from various regions of Jordan. The MDR1 gene was scanned using direct sequencing. Six rare variants in MDR1 were detected, including a new variant, T3075A. This variant did not affect the protein sequence (synonym for threonine). Among the common SNPs, the frequencies of rs1128503 (C1236T) genotypes were: 0.23 (CC), 0.41 (CT) and 0.36 (TT). For the rs2032582 (G2677T) SNP, genotype frequencies were 0.38 for GG, 0.45 for GT, 0.13 for TT, 0.03 for GA, and 0.01 for TA, whereas for rs1045642 (C3435T), genotype frequencies were 0.17 for CC, 0.5 for CT and 0.33 for TT. The observed distribution of the common variants in the Jordanian population was within the range detected in other populations. These data on MDR1 gene variants in the Jordanian population will be useful for investigations on response to P-glycoprotein substrate drugs.", "sentences": [], "annotations": [{"id": "19", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 135, "length": 4}]}, {"id": "20", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 143, "length": 5}]}, {"id": "21", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 160, "length": 14}]}, {"id": "22", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 284, "length": 4}]}, {"id": "23", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 365, "length": 4}]}, {"id": "24", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 433, "length": 4}]}, {"id": "25", "infons": {"identifier": "g.3075T>A", "type": "Mutation", "subtype": "DNAMutation"}, "text": "T3075A", "locations": [{"offset": 478, "length": 6}]}, {"id": "26", "infons": {"identifier": "MESH:D013912", "type": "Chemical"}, "text": "threonine", "locations": [{"offset": 548, "length": 9}]}, {"id": "27", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 602, "length": 9}]}, {"id": "28", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 613, "length": 6}]}, {"id": "29", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 681, "length": 9}]}, {"id": "30", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T;RS#:2032582", "hgvs": "c.2677G>T", "identifiers": ["rs2032582"]}, "text": "G2677T", "locations": [{"offset": 692, "length": 6}]}, {"id": "31", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 812, "length": 9}]}, {"id": "32", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 823, "length": 6}]}, {"id": "33", "infons": {"identifier": "MESH:D002251", "type": "Chemical"}, "text": "CT", "locations": [{"offset": 879, "length": 2}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1042, "length": 4}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 1138, "length": 14}]}], "relations": []}], "relations": [], "pmid": 23546964, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D013912", "mutation@rs2032582", "chemical@MESH:D002251", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "mutation@g.3075T>A"], "journal": "Genet. Mol. Res.", "year": 2013, "authors": ["Khabour OF", "Alzoubi KH", "Al-Azzam SI", "Mhaidat NM"]},
{"_id": "23443032|None", "id": "23443032", "infons": {}, "passages": [{"infons": {"journal": "Eur. J. Hum. Genet.; 2013 Dec; 21(12) 1436-41. doi:10.1038/ejhg.2013.25", "year": "2013", "article-id_pmc": "PMC3831066", "type": "title", "authors": "Omoumi A, Wang Z, Yeow V, Wu-Chou YH, Chen PK, Ruczinski I, Cheng J, Cheah FS, Lee CG, Beaty TH, Chong SS", "section": "Title"}, "offset": 0, "text": "Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 27, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D002972", "type": "Disease"}, "text": "non-syndromic oral cleft malformations", "locations": [{"offset": 94, "length": 38}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 134, "text": "ATP-binding cassette (ABC) proteins in the placenta regulate fetal exposure to xenobiotics. We hypothesized that functional polymorphisms in ABC genes influence risk for non-syndromic oral clefts (NSOC). Both family-based and case-control studies were undertaken to evaluate the association of nine potentially functional single-nucleotide polymorphisms within four ABC genes with risk of NSOC. Peripheral blood DNA from a total of 150 NSOC case-parent trios from Singapore and Taiwan were genotyped, as was cord blood DNA from 189 normal Chinese neonates used as controls. In trios, significant association was observed between the ABCB1 single-nucleotide polymorphisms and NSOC (P&lt;0.05). Only ABCB1 rs1128503 retained significant association after Bonferroni correction (odds ratio (OR)=2.04; 95% confidence interval (CI)=1.42-2.98), while rs2032582 and rs1045642 showed nominal significance. Association with rs1128503 was replicated in a case-control analysis comparing NSOC probands with controls (OR=1.58; 95% CI=1.12-2.23). A comparison between the mothers of probands and controls showed no evidence of association, suggesting NSOC risk is determined by fetal and not maternal ABCB1 genotype. The two studies produced a combined OR of 1.79 (95% CI=1.38-2.30). The T-allele at rs1128503 was associated with higher risk. This study thus provides evidence that potentially functional polymorphisms in fetal ABCB1 modulate risk for NSOC, presumably through suboptimal exclusion of xenobiotics at the fetal-maternal interface. ", "sentences": [], "annotations": [{"id": "14", "infons": {"identifier": "MESH:D002972", "type": "Disease"}, "text": "non-syndromic oral clefts", "locations": [{"offset": 304, "length": 25}]}, {"id": "15", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 767, "length": 5}]}, {"id": "16", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 832, "length": 5}]}, {"id": "17", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 838, "length": 9}]}, {"id": "18", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 979, "length": 9}]}, {"id": "19", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 993, "length": 9}]}, {"id": "20", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1049, "length": 9}]}, {"id": "21", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1322, "length": 5}]}, {"id": "22", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1421, "length": 9}]}, {"id": "23", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1549, "length": 5}]}], "relations": []}], "relations": [], "pmid": 23443032, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs1128503", "mutation@rs2032582", "disease@MESH:D002972", "mutation@rs1045642", "gene@5243"], "journal": "Eur. J. Hum. Genet.", "year": 2013, "authors": ["Omoumi A", "Wang Z", "Yeow V", "Wu-Chou YH", "Chen PK", "Ruczinski I", "Cheng J", "Cheah FS", "Lee CG", "Beaty TH", "Chong SS"]},
{"_id": "23372834|None", "id": "23372834", "infons": {}, "passages": [{"infons": {"journal": "PLoS ONE; 2013; 8(1) 55197. doi:10.1371/journal.pone.0055197", "year": "2013", "article-id_pmc": "PMC3555879", "type": "title", "authors": "Zhu P, Zhu Q, Zhang Y, Ma X, Li Z, Li J, Chen J, Luo L, Ring HZ, Ring BZ, Su L", "section": "Title"}, "offset": 0, "text": "ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohort.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "4", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 42, "length": 4}]}, {"id": "5", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 47, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 94, "text": "HIV/AIDS has the highest mortality among infectious diseases in China. In ongoing efforts to alleviate this crisis, the national government has placed great emphasis on efforts in Henan province where HIV-infected former plasma donors in the 1990s contributed to AIDS becoming a public health crisis. Concomitant with a national initiative focusing the use of pharmacogenetics for the better prediction of treatment response, we studied genetic variants with known pharmacokinetic phenotypes in a set of 298 HAART-treated (highly active antiretroviral therapy) patients infected with HIV from the Henan cohort. We measured the association of response to treatment, assessed as changes in CD4+ T cell counts after antiretroviral therapy, of five polymorphisms in four genes (CYP2B6, ABCB1/MDR1, ABCG2, and ABCC4) in which variation has been suggested to affect the pharmacokinetics of drugs commonly employed to treat HIV/AIDS. We show that genotyping for ABCB1 variations (rs1045642 and rs2032582) may help predict HIV treatment response. We found variations in this gene have a significant association with outcome as measured by CD4+ T cell counts in a discovery subset (N= 197; odds ratio (OR) = 1.58; 95% CI 1.02-2.45), these results were confirmed in a validation subset of the cohort (N = 78; OR= 2.81; 95% CI 1.32-5.96). Exploratory analysis suggests that this effect may be specific to NVP (nevirapine) or 3TC (lamivudine) response. This publication represents the first genetic analysis in a continuing effort to study and assist the patients in a very large, unique, and historically significant HIV-AIDS cohort. Genotyping of AIDS patients for ABCB1 variation may help predict outcome and potentially could help guide treatment strategies.", "sentences": [], "annotations": [{"id": "32", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 94, "length": 3}]}, {"id": "33", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 98, "length": 4}]}, {"id": "34", "infons": {"identifier": "MESH:D003141", "type": "Disease"}, "text": "infectious diseases", "locations": [{"offset": 135, "length": 19}]}, {"id": "35", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected", "locations": [{"offset": 295, "length": 12}]}, {"id": "36", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 357, "length": 4}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 655, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 678, "length": 3}]}, {"id": "39", "infons": {"identifier": "1555", "type": "Gene", "ncbi_homologene": "73894"}, "text": "CYP2B6", "locations": [{"offset": 868, "length": 6}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 876, "length": 5}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 882, "length": 4}]}, {"id": "42", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 888, "length": 5}]}, {"id": "43", "infons": {"identifier": "10257", "type": "Gene", "ncbi_homologene": "74563"}, "text": "ABCC4", "locations": [{"offset": 899, "length": 5}]}, {"id": "44", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 1011, "length": 3}]}, {"id": "45", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 1015, "length": 4}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1049, "length": 5}]}, {"id": "47", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1067, "length": 9}]}, {"id": "48", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1081, "length": 9}]}, {"id": "49", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 1109, "length": 3}]}, {"id": "50", "infons": {"identifier": "MESH:D019829", "type": "Chemical"}, "text": "nevirapine", "locations": [{"offset": 1493, "length": 10}]}, {"id": "51", "infons": {"identifier": "MESH:D019259", "type": "Chemical"}, "text": "3TC", "locations": [{"offset": 1508, "length": 3}]}, {"id": "52", "infons": {"identifier": "MESH:D019259", "type": "Chemical"}, "text": "lamivudine", "locations": [{"offset": 1513, "length": 10}]}, {"id": "53", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1637, "length": 8}]}, {"id": "54", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "HIV-AIDS cohort", "locations": [{"offset": 1700, "length": 15}]}, {"id": "55", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 1731, "length": 4}]}, {"id": "56", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1736, "length": 8}]}, {"id": "57", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1749, "length": 5}]}], "relations": []}], "relations": [], "pmid": 23372834, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D003141", "disease@MESH:D015658", "disease@MESH:D000163", "species@9606", "chemical@MESH:D019829", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "chemical@MESH:D019259", "gene@1555", "gene@10257", "gene@9429"], "journal": "PLoS ONE", "year": 2013, "authors": ["Zhu P", "Zhu Q", "Zhang Y", "Ma X", "Li Z", "Li J", "Chen J", "Luo L", "Ring HZ", "Ring BZ", "Su L"]},
{"_id": "23279665|None", "id": "23279665", "infons": {}, "passages": [{"infons": {"journal": "Colorectal Dis; 2013 Jan; 15(1) 12-8. doi:10.1111/j.1463-1318.2012.02919.x", "year": "2013", "type": "title", "authors": "He T, Mo A, Zhang K, Liu L", "section": "Title"}, "offset": 0, "text": "ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 6, "length": 4}]}, {"id": "5", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 33, "length": 17}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 98, "text": "AIM: ABCB1/MDR1 protein is found in high concentrations on the apical surfaces of colonic epithelial cells. It acts as an efflux pump by transporting toxic endogenous substances, drugs and xenobiotics out of cells. Polymorphisms in the ABCB1/MDR1 gene may either change expression of the ABCB1/MDR1 protein or alter its function, suggesting its possible association with colorectal cancer. Several studies have reported a relationship between ABCB1 gene polymorphisms and colorectal cancer risk, but no consistent conclusion has been reached. We therefore conducted a meta-analysis to identify any association between the ABCB1 gene and CRC risk. METHOD: PubMed, Embase, Google Scholar, Cbmdisc and CNKI were searched for studies on the relationship of ABCB1/MDR1 gene SNPs and the incidence of colorectal cancer. Eligible articles were included for data extraction. The main outcome was the frequency of ABCB1/MDR1 gene SNPs among cases and controls. Comparison of the distribution of SNPs was performed mainly using Review Manager 5.0. RESULTS: Ten, four and two trials were identified that focussed on the ABCB1 gene SNPs rs1045642, rs2032582 and rs3789243, respectively. A total of 3175 cases and 3715 controls were included. The meta-analysis, stratified by ethnicity or population source, indicated no association between the ABCB1 gene rs1045642 polymorphism and colorectal cancer risk. However, when the study by Bae et al. was removed from the analysis, there was some evidence to indicate a higher T-allele frequency in Asian colorectal cancer patients (OR = 1.30, 95% CI: 1.02-1.67, P = 0.03). Neither ABCB1 rs2032582 nor ABCB1 rs3789243 indicated an association with colorectal cancer risk. An increased frequency only of the wild-type combined allele (rs2032582G/rs1045642C) was found in Caucasian patients (OR = 1.22, 95% CI: 1.03-1.44, P = 0.02). CONCLUSION: There is some evidence to indicate an association between ABCB1 rs1045642T and colorectal cancer risk in Asians. Compared with the ABCB1 gene SNPs rs1045642, rs2032582 or rs3789243 alone, combined haplotypes of several SNPs might be a better marker to determine the genetic influence on the susceptibility to colorectal cancer among Caucasians.", "sentences": [], "annotations": [{"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 103, "length": 5}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 109, "length": 4}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 334, "length": 5}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 340, "length": 4}]}, {"id": "50", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 386, "length": 5}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 392, "length": 4}]}, {"id": "52", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 469, "length": 17}]}, {"id": "53", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 541, "length": 5}]}, {"id": "54", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 570, "length": 17}]}, {"id": "55", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 720, "length": 5}]}, {"id": "56", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 851, "length": 5}]}, {"id": "57", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 857, "length": 4}]}, {"id": "58", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 893, "length": 17}]}, {"id": "59", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1003, "length": 5}]}, {"id": "60", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1009, "length": 4}]}, {"id": "61", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1207, "length": 5}]}, {"id": "62", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1223, "length": 9}]}, {"id": "63", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1234, "length": 9}]}, {"id": "64", "infons": {"identifier": "rs3789243", "type": "Mutation", "subtype": "SNP"}, "text": "rs3789243", "locations": [{"offset": 1248, "length": 9}]}, {"id": "65", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1430, "length": 5}]}, {"id": "66", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1441, "length": 9}]}, {"id": "67", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 1468, "length": 17}]}, {"id": "68", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 1634, "length": 17}]}, {"id": "69", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1652, "length": 8}]}, {"id": "70", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1711, "length": 5}]}, {"id": "71", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1717, "length": 9}]}, {"id": "72", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1731, "length": 5}]}, {"id": "73", "infons": {"identifier": "rs3789243", "type": "Mutation", "subtype": "SNP"}, "text": "rs3789243", "locations": [{"offset": 1737, "length": 9}]}, {"id": "74", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 1777, "length": 17}]}, {"id": "75", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1863, "length": 9}]}, {"id": "76", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1874, "length": 9}]}, {"id": "77", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1909, "length": 8}]}, {"id": "78", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2030, "length": 5}]}, {"id": "79", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 2036, "length": 9}]}, {"id": "80", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 2051, "length": 17}]}, {"id": "81", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2103, "length": 5}]}, {"id": "82", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 2119, "length": 9}]}, {"id": "83", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 2130, "length": 9}]}, {"id": "84", "infons": {"identifier": "rs3789243", "type": "Mutation", "subtype": "SNP"}, "text": "rs3789243", "locations": [{"offset": 2143, "length": 9}]}, {"id": "85", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 2281, "length": 17}]}], "relations": []}], "relations": [], "pmid": 23279665, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "disease@MESH:D015179", "mutation@rs2032582", "mutation@rs3789243", "mutation@rs1045642", "gene@5243"], "journal": "Colorectal Dis", "year": 2013, "authors": ["He T", "Mo A", "Zhang K", "Liu L"]},
{"_id": "23188198|None", "id": "23188198", "infons": {}, "passages": [{"infons": {"journal": "Transl Psychiatry; 2012 Nov 27; 2198. doi:10.1038/tp.2012.115", "year": "2012", "article-id_pmc": "PMC3565756", "type": "title", "authors": "Singh AB, Bousman CA, Ng CH, Byron K, Berk M", "section": "Title"}, "offset": 0, "text": "ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "4", "infons": {"identifier": "MESH:D015283", "type": "Chemical"}, "text": "escitalopram", "locations": [{"offset": 28, "length": 12}]}, {"id": "5", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "depression", "locations": [{"offset": 76, "length": 10}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 88, "text": "The ATP-binding cassette family of transporter proteins, subfamily B (MDR/TAP), member 1 (ABCB1) (P-glycoprotein) transporter is a key component of the blood-brain barrier. Many antidepressants are subject to ABCB1 efflux. Functional polymorphisms of ABCB1 may influence central nervous system bioavailability of antidepressants subject to efflux. Single-nucleotide polymorphisms (SNPs) at rs1045642 (C3435T) of ABCB1 have been associated with efflux pump efficiency. This may explain part of the interindividual variation in antidepressant dose needed to remit. Individuals (N=113) with DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) major depressive disorder (MDD) were treated with escitalopram (ESC) or venlafaxine (VEN) over 8 weeks. The17-item Hamilton Depression Rating Scale was assessed serially, blind to genotype. SNP rs1045642 of ABCB1 along with two SNPs previously reported to be in linkage disequilibrium with it (rs2032582 and rs1128503) were genotyped. Demographic features, clinical features, P450 metabolizer status and 5-HTTLPR (serotonin-transporter-linked promoter region) genotype were controlled for. Carriers of rs1045642 TT needed on average 11 mg of ESC to remit, whereas TC and CC carriers required 24 and 19 mg, respectively (P=0.0001). This equates to a 2.0- (95% confidence interval=1.5-3.4; P&lt;0.001) fold greater ESC dose needed to remit for C carriers compared with TT carriers at rs1045642. Of VEN-treated subjects carrying TT genotype at rs1045642, 73.3% remitted compared with 12.5% for CC genotype (odds ratio=6.69; 95% confidence interval=1.72-25.9, P=0.006). These data suggest that antidepressant dose needed to remit can be predicted by an ABCB1 SNP. This has the potential clinical translation implications for dose selection and remission from MDD.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 178, "length": 5}]}, {"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 297, "length": 5}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 339, "length": 5}]}, {"id": "33", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 478, "length": 9}]}, {"id": "34", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 489, "length": 6}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 500, "length": 5}]}, {"id": "36", "infons": {"identifier": "MESH:D001523", "type": "Disease"}, "text": "Mental Disorders", "locations": [{"offset": 721, "length": 16}]}, {"id": "37", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "depressive disorder", "locations": [{"offset": 761, "length": 19}]}, {"id": "38", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "MDD", "locations": [{"offset": 782, "length": 3}]}, {"id": "39", "infons": {"identifier": "MESH:D015283", "type": "Chemical"}, "text": "escitalopram", "locations": [{"offset": 805, "length": 12}]}, {"id": "40", "infons": {"identifier": "MESH:D015283", "type": "Chemical"}, "text": "ESC", "locations": [{"offset": 819, "length": 3}]}, {"id": "41", "infons": {"identifier": "MESH:D000069470", "type": "Chemical"}, "text": "venlafaxine", "locations": [{"offset": 827, "length": 11}]}, {"id": "42", "infons": {"identifier": "MESH:D000069470", "type": "Chemical"}, "text": "VEN", "locations": [{"offset": 840, "length": 3}]}, {"id": "43", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "Hamilton Depression", "locations": [{"offset": 870, "length": 19}]}, {"id": "44", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 949, "length": 9}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 962, "length": 5}]}, {"id": "46", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1049, "length": 9}]}, {"id": "47", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1063, "length": 9}]}, {"id": "48", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1257, "length": 9}]}, {"id": "49", "infons": {"identifier": "MESH:D013667", "type": "Chemical"}, "text": "TC", "locations": [{"offset": 1319, "length": 2}]}, {"id": "50", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1537, "length": 9}]}, {"id": "51", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1596, "length": 9}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1804, "length": 5}]}, {"id": "53", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "MDD", "locations": [{"offset": 1910, "length": 3}]}], "relations": []}], "relations": [], "pmid": 23188198, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs1128503", "disease@MESH:D001523", "chemical@MESH:D013667", "mutation@rs2032582", "disease@MESH:D000275", "disease@MESH:D003865", "chemical@MESH:D000069470", "mutation@rs1045642", "gene@5243", "chemical@MESH:D015283"], "journal": "Transl Psychiatry", "year": 2012, "authors": ["Singh AB", "Bousman CA", "Ng CH", "Byron K", "Berk M"]},
{"_id": "23133441|None", "id": "23133441", "infons": {}, "passages": [{"infons": {"journal": "Front Genet; 2012; 3236. doi:10.3389/fgene.2012.00236", "year": "2012", "article-id_pmc": "PMC3488761", "type": "title", "authors": "Swart M, Ren Y, Smith P, Dandara C", "section": "Title"}, "offset": 0, "text": "ABCB1 4036A&gt;G and 1236C&gt;T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "5", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 94, "length": 3}]}, {"id": "6", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 98, "length": 4}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 103, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 113, "text": "The ABCB1 gene encodes P-glycoprotein, an ATP-dependent drug efflux pump, which is responsible for drug transport across extra- and intra-cellular membranes. The variability in the expression of ABCB1 may contribute to variable plasma efavirenz concentration which results in variability in the levels of suppression of the human immunodeficiency syndrome virus (HIV). The aim of the study was to evaluate the role of polymorphisms in ABCB1 gene on plasma efavirenz levels and treatment response in the form of change in viral load and CD-4 cell count in HIV/AIDS patients receiving efavirenz-containing highly active antiretroviral treatment regimens. Two hundred and eighty-two HIV-infected patients were recruited from Themba Lethu Clinic in Johannesburg and plasma efavirenz drug concentration levels were measured using LC-MS/MS. SNaPshot was used to genotype five known ABCB1 single nucleotide polymorphisms (SNPs). Genotype-phenotype correlations were computed. The ABCB1 4036A/G and 4036G/G genotypes were significantly associated with low plasma efavirenz concentrations (P = 0.0236), while the ABCB1 1236C/T and 1236T/T genotypes were associated with high efavirenz concentrations (P = 0.0282). A haplotype ABCB1 T-G-T-A is reported that is associated with significantly increased plasma efavirenz levels. This is the first report on 61A&gt;G, 2677G&gt;T/A, and 4036A&gt;G SNPs in the South African population. ABCB1 plays a role in determining the plasma concentrations of efavirenz and should be taken into account in future design of assays for genotype-based dosing of efavirenz-containing regimens.", "sentences": [], "annotations": [{"id": "28", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 117, "length": 5}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 136, "length": 14}]}, {"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 308, "length": 5}]}, {"id": "31", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 437, "length": 5}]}, {"id": "32", "infons": {"identifier": "MESH:D007153", "type": "Disease"}, "text": "immunodeficiency syndrome", "locations": [{"offset": 443, "length": 25}]}, {"id": "33", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 476, "length": 3}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 548, "length": 5}]}, {"id": "35", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV", "locations": [{"offset": 668, "length": 3}]}, {"id": "36", "infons": {"identifier": "MESH:D000163", "type": "Disease"}, "text": "AIDS", "locations": [{"offset": 672, "length": 4}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 677, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "efavirenz", "locations": [{"offset": 696, "length": 9}]}, {"id": "39", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected", "locations": [{"offset": 793, "length": 12}]}, {"id": "40", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 806, "length": 8}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 989, "length": 5}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1086, "length": 5}]}, {"id": "43", "infons": {"identifier": "g.4036A>G", "type": "Mutation", "subtype": "DNAMutation"}, "text": "4036A/G", "locations": [{"offset": 1092, "length": 7}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1217, "length": 5}]}, {"id": "45", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "1236C/T", "locations": [{"offset": 1223, "length": 7}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1330, "length": 5}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1534, "length": 5}]}], "relations": []}], "relations": [], "pmid": 23133441, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D015658", "disease@MESH:D007153", "disease@MESH:D000163", "species@9606", "mutation@g.4036A>G", "gene@5243", "mutation@rs1128503", "chemical@MESH:C098320"], "journal": "Front Genet", "year": 2012, "authors": ["Swart M", "Ren Y", "Smith P", "Dandara C"]},
{"_id": "23133420|None", "id": "23133420", "infons": {}, "passages": [{"infons": {"journal": "Front Pharmacol; 2012; 3191. doi:10.3389/fphar.2012.00191", "year": "2012", "article-id_pmc": "PMC3490152", "type": "title", "authors": "Suarez-Kurtz G, Pena SD, Struchiner CJ, Hutz MH", "section": "Title"}, "offset": 0, "text": "Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.", "sentences": [], "annotations": [], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 113, "text": "BY VIRTUE OF BEING THE PRODUCT OF THE GENETIC ADMIXTURE OF THREE ANCESTRAL ROOTS: Europeans, Africans, and Amerindians, the present-day Brazilian population displays very high levels of genomic diversity, which have important pharmacogenetic/-genomic (PGx) implications. Recognition of this fact has prompted the creation of the Brazilian Pharmacogenomics Network (Refargen), a nationwide consortium of research groups, with the mission to provide leadership in PGx research and education in Brazil, with a population heath impact. Here, we present original data and review published results from a Refargen comprehensive study of the distribution of PGx polymorphisms in a representative cohort of the Brazilian people, comprising 1,034 healthy, unrelated adults, self-identified as white, brown, or black, according to the Color categories adopted by the Brazilian Census. Multinomial log-linear regression analysis was applied to infer the statistical association between allele, genotype, and haplotype distributions among Brazilians (response variables) and self-reported Color, geographical region, and biogeographical ancestry (explanatory variables), whereas Wright's F(ST) statistics was used to assess the extent of PGx divergence among different strata of the Brazilian population. Major PGx implications of these findings are: first, extrapolation of data from relatively well-defined ethnic groups is clearly not applicable to the majority of Brazilians; second, the frequency distribution of polymorphisms in several pharmacogenes of clinical relevance (e.g., ABCB1, CYP3A5, CYP2C9, VKORC) varies continuously among Brazilians and is not captured by race/Color self-identification; third, the intrinsic heterogeneity of the Brazilian population must be acknowledged in the design and interpretation of PGx studies in order to avoid spurious conclusions based on improper matching of study cohorts.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "9606", "type": "Species"}, "text": "people", "locations": [{"offset": 826, "length": 6}]}, {"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1687, "length": 5}]}, {"id": "6", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1694, "length": 6}]}, {"id": "7", "infons": {"identifier": "1559", "type": "Gene", "ncbi_homologene": "133566"}, "text": "CYP2C9", "locations": [{"offset": 1702, "length": 6}]}], "relations": []}], "relations": [], "pmid": 23133420, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@1577", "gene@1559", "species@9606", "gene@5243"], "journal": "Front Pharmacol", "year": 2012, "authors": ["Suarez-Kurtz G", "Pena SD", "Struchiner CJ", "Hutz MH"]},
{"_id": "23093106|None", "id": "23093106", "infons": {}, "passages": [{"infons": {"journal": "Clin. Chem. Lab. Med.; 2012 Nov; 50(11) 1999-2007. doi:10.1515/cclm-2012-0103", "year": "2012", "type": "title", "authors": "Vaclavikova R, Ehrlichova M, Hlavata I, Pecha V, Kozevnikovova R, Trnkova M, Adamek J, Edvardsen H, Kristensen VN, Gut I, Soucek P", "section": "Title"}, "offset": 0, "text": "Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 22, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast carcinoma", "locations": [{"offset": 104, "length": 16}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 132, "text": "BACKGROUND: The ABCB1 gene encodes P-glycoprotein implicated in the development of cellular drug resistance. The aim of this study was to develop high-resolution melting (HRM) analysis for determination of ABCB1 polymorphisms and evaluate their associations with clinical data of breast carcinoma patients. METHODS: HRM analysis was designed to assess five single nucleotide polymorphisms (SNPs) in ABCB1 (rs2214102, rs1128503, rs2032582, rs2032583 and rs1045642) in genomic DNA from 103 breast carcinoma patients. Results were confirmed by direct DNA sequencing. RESULTS: HRM analysis revealed distinct patterns of melting curves for the respective genotypes of all followed SNPs. Sensitivity of HRM analysis compared with direct DNA sequencing was superior (97.1% vs. 93.9%). The overall accuracy of HRM was 97.6%. The coefficients of variation in replicate experiments encompassed the range 0.002%-0.038%. On the basis of the examined SNPs, one strong haplotype block containing rs2032582 and rs1128503 SNPs was identified. Significant associations of rs2032582 SNP with tumor size, negative HER-2/neu status, and family history of breast carcinoma were found. Patients carrying the ancestral homozygous genotype (GG) in rs2214102 had significantly worse progression-free survival in comparison with carriers of the non-ancestral allele (A) in the adjuvant set (p=0.005). CONCLUSIONS: A rapid, accurate, low-cost and time-effective method for screening ABCB1 SNPs was developed. Significant associations of ABCB1 rs2032582 and rs2214102 SNPs with prognostic factors and survival of patients were found.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 148, "length": 5}]}, {"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 167, "length": 14}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 338, "length": 5}]}, {"id": "33", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast carcinoma", "locations": [{"offset": 412, "length": 16}]}, {"id": "34", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 429, "length": 8}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 531, "length": 5}]}, {"id": "36", "infons": {"identifier": "rs2214102", "type": "Mutation", "subtype": "SNP"}, "text": "rs2214102", "locations": [{"offset": 538, "length": 9}]}, {"id": "37", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 549, "length": 9}]}, {"id": "38", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 560, "length": 9}]}, {"id": "39", "infons": {"identifier": "rs2032583", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032583", "locations": [{"offset": 571, "length": 9}]}, {"id": "40", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 585, "length": 9}]}, {"id": "41", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast carcinoma", "locations": [{"offset": 620, "length": 16}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 637, "length": 8}]}, {"id": "43", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1114, "length": 9}]}, {"id": "44", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1128, "length": 9}]}, {"id": "45", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1187, "length": 9}]}, {"id": "46", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1206, "length": 5}]}, {"id": "47", "infons": {"identifier": "2064", "type": "Gene", "ncbi_homologene": "3273"}, "text": "HER-2/neu", "locations": [{"offset": 1227, "length": 9}]}, {"id": "48", "infons": {"identifier": "MESH:D001943", "type": "Disease"}, "text": "breast carcinoma", "locations": [{"offset": 1267, "length": 16}]}, {"id": "49", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 1296, "length": 8}]}, {"id": "50", "infons": {"identifier": "rs2214102", "type": "Mutation", "subtype": "SNP"}, "text": "rs2214102", "locations": [{"offset": 1356, "length": 9}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1588, "length": 5}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1642, "length": 5}]}, {"id": "53", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1648, "length": 9}]}, {"id": "54", "infons": {"identifier": "rs2214102", "type": "Mutation", "subtype": "SNP"}, "text": "rs2214102", "locations": [{"offset": 1662, "length": 9}]}, {"id": "55", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1717, "length": 8}]}], "relations": []}], "relations": [], "pmid": 23093106, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs2032583", "gene@2064", "species@9606", "mutation@rs2214102", "mutation@rs2032582", "disease@MESH:D001943", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D009369"], "journal": "Clin. Chem. Lab. Med.", "year": 2012, "authors": ["Vaclavikova R", "Ehrlichova M", "Hlavata I", "Pecha V", "Kozevnikovova R", "Trnkova M", "Adamek J", "Edvardsen H", "Kristensen VN", "Gut I", "Soucek P"]},
{"_id": "22672924|None", "id": "22672924", "infons": {}, "passages": [{"infons": {"journal": "Eur. J. Endocrinol.; 2012 Sep; 167(3) 327-35. doi:10.1530/EJE-12-0198", "year": "2012", "type": "title", "authors": "Athanasoulia AP, Sievers C, Ising M, Brockhaus AC, Yassouridis A, Stalla GK, Uhr M", "section": "Title"}, "offset": 0, "text": "Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 43, "length": 5}]}, {"id": "5", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 88, "length": 11}]}, {"id": "6", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 103, "length": 8}]}, {"id": "7", "infons": {"identifier": "MESH:D000236", "type": "Disease"}, "text": "adenomas", "locations": [{"offset": 121, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 131, "text": "INTRODUCTION: Treatment with dopamine agonists in patients with prolactin (PRL) adenomas and Parkinson's disease is associated with central side effects. Central side effects may depend on a substance's ability to pass the blood-brain barrier, which can be actively controlled by transporter molecules such as the P-glycoprotein (P-gp) encoded by the ABCB1 gene. MATERIALS AND METHODS: We aimed to determine whether cabergoline is transported by the P-gp and whether polymorphisms of its encoding ABCB1 gene predict central side effects of cabergoline therapy in patients with PRL adenomas. i) In an experimental mouse model lacking the homologues of the human ABCB1 gene (Abcb1ab double knockout mouse model), we examined whether cabergoline is a substrate of the P-gp using eight mutant and eight wild-type mice. ii) In a human case-control study including 79 patients with PRL adenomas treated with cabergoline at the Max Planck Institute of Psychiatry in Munich, we investigated the association of four selected ABCB1 gene single nucleotide polymorphisms (SNPs) (rs1045642, rs2032582, rs2032583 and rs2235015), with the occurrence of central side effects under cabergoline therapy. RESULTS: i) In the experimental mouse model, we observed that brain concentrations of cabergoline were tenfold higher in the mutant mice compared with their wild-type littermates, implying that cabergoline is indeed a substrate of the transporter P-gp at the blood-brain barrier level. ii) In the human study, we observed significant negative associations under cabergoline for the C-carriers and heterozygous CT individuals of SNP rs1045642 with two central side effects (frequency of fatigue and sleep disorders) and for the G-carriers of SNP rs2032582 with the enhancement of dizziness. For the SNPs rs2235015 and rs2032583, no associations with central side effects under cabergoline were found. DISCUSSION: This is the first study demonstrating that individual ABCB1 gene polymorphisms, reflecting a different expression and function of the P-gp, could predict the occurrence of central side effects under cabergoline. Our findings can be viewed as a step into personalised therapy in PRL adenoma patients.", "sentences": [], "annotations": [{"id": "58", "infons": {"identifier": "MESH:D004298", "type": "Chemical"}, "text": "dopamine", "locations": [{"offset": 160, "length": 8}]}, {"id": "59", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 181, "length": 8}]}, {"id": "60", "infons": {"identifier": "MESH:D000236", "type": "Disease"}, "text": "adenomas", "locations": [{"offset": 211, "length": 8}]}, {"id": "61", "infons": {"identifier": "MESH:D010300", "type": "Disease"}, "text": "Parkinson's disease", "locations": [{"offset": 224, "length": 19}]}, {"id": "62", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 445, "length": 14}]}, {"id": "63", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 461, "length": 4}]}, {"id": "64", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 482, "length": 5}]}, {"id": "65", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 547, "length": 11}]}, {"id": "66", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 581, "length": 4}]}, {"id": "67", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 628, "length": 5}]}, {"id": "68", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 671, "length": 11}]}, {"id": "69", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 694, "length": 8}]}, {"id": "70", "infons": {"identifier": "MESH:D000236", "type": "Disease"}, "text": "adenomas", "locations": [{"offset": 712, "length": 8}]}, {"id": "71", "infons": {"identifier": "10090", "type": "Species"}, "text": "mouse", "locations": [{"offset": 744, "length": 5}]}, {"id": "72", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 786, "length": 5}]}, {"id": "73", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 792, "length": 5}]}, {"id": "74", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "Abcb1", "locations": [{"offset": 804, "length": 5}]}, {"id": "75", "infons": {"identifier": "10090", "type": "Species"}, "text": "mouse", "locations": [{"offset": 828, "length": 5}]}, {"id": "76", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 862, "length": 11}]}, {"id": "77", "infons": {"identifier": "67078", "type": "Gene", "ncbi_homologene": "5513"}, "text": "P-gp", "locations": [{"offset": 896, "length": 4}]}, {"id": "78", "infons": {"identifier": "10090", "type": "Species"}, "text": "mice", "locations": [{"offset": 940, "length": 4}]}, {"id": "79", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 955, "length": 5}]}, {"id": "80", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 993, "length": 8}]}, {"id": "81", "infons": {"identifier": "MESH:D000236", "type": "Disease"}, "text": "adenomas", "locations": [{"offset": 1011, "length": 8}]}, {"id": "82", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 1033, "length": 11}]}, {"id": "83", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1147, "length": 5}]}, {"id": "84", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1198, "length": 9}]}, {"id": "85", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1209, "length": 9}]}, {"id": "86", "infons": {"identifier": "rs2032583", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032583", "locations": [{"offset": 1220, "length": 9}]}, {"id": "87", "infons": {"identifier": "rs2235015", "type": "Mutation", "subtype": "SNP"}, "text": "rs2235015", "locations": [{"offset": 1234, "length": 9}]}, {"id": "88", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 1296, "length": 11}]}, {"id": "89", "infons": {"identifier": "10090", "type": "Species"}, "text": "mouse", "locations": [{"offset": 1349, "length": 5}]}, {"id": "90", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 1403, "length": 11}]}, {"id": "91", "infons": {"identifier": "10090", "type": "Species"}, "text": "mice", "locations": [{"offset": 1449, "length": 4}]}, {"id": "92", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 1511, "length": 11}]}, {"id": "93", "infons": {"identifier": "67078", "type": "Gene", "ncbi_homologene": "5513"}, "text": "P-gp", "locations": [{"offset": 1564, "length": 4}]}, {"id": "94", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 1614, "length": 5}]}, {"id": "95", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 1679, "length": 11}]}, {"id": "96", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1749, "length": 9}]}, {"id": "97", "infons": {"identifier": "MESH:D005221", "type": "Disease"}, "text": "fatigue and sleep disorders", "locations": [{"offset": 1803, "length": 27}]}, {"id": "98", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1862, "length": 9}]}, {"id": "99", "infons": {"identifier": "MESH:D004244", "type": "Disease"}, "text": "dizziness", "locations": [{"offset": 1896, "length": 9}]}, {"id": "100", "infons": {"identifier": "rs2235015", "type": "Mutation", "subtype": "SNP"}, "text": "rs2235015", "locations": [{"offset": 1920, "length": 9}]}, {"id": "101", "infons": {"identifier": "rs2032583", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032583", "locations": [{"offset": 1934, "length": 9}]}, {"id": "102", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 1993, "length": 11}]}, {"id": "103", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2083, "length": 5}]}, {"id": "104", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 2163, "length": 4}]}, {"id": "105", "infons": {"identifier": "MESH:D000077465", "type": "Chemical"}, "text": "cabergoline", "locations": [{"offset": 2228, "length": 11}]}, {"id": "106", "infons": {"identifier": "MESH:D000236", "type": "Disease"}, "text": "adenoma", "locations": [{"offset": 2311, "length": 7}]}, {"id": "107", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2319, "length": 8}]}], "relations": []}], "relations": [], "pmid": 22672924, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@67078", "chemical@MESH:D000077465", "disease@MESH:D005221", "disease@MESH:D004244", "mutation@rs2032583", "species@9606", "species@10090", "mutation@rs2032582", "chemical@MESH:D004298", "disease@MESH:D000236", "disease@MESH:D010300", "gene@5243", "mutation@rs1045642", "mutation@rs2235015"], "journal": "Eur. J. Endocrinol.", "year": 2012, "authors": ["Athanasoulia AP", "Sievers C", "Ising M", "Brockhaus AC", "Yassouridis A", "Stalla GK", "Uhr M"]},
{"_id": "22306099|None", "id": "22306099", "infons": {}, "passages": [{"infons": {"journal": "J Psychiatr Res; 2012 Apr; 46(4) 555-9. doi:10.1016/j.jpsychires.2012.01.012", "year": "2012", "type": "title", "authors": "Fujii T, Ota M, Hori H, Sasayama D, Hattori K, Teraishi T, Yamamoto N, Hashikura M, Tatsumi M, Higuchi T, Kunugi H", "section": "Title"}, "offset": 0, "text": "Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 49, "length": 6}]}, {"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 78, "length": 14}]}, {"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 94, "length": 5}]}, {"id": "7", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "depressive disorder", "locations": [{"offset": 111, "length": 19}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 159, "text": "Human P-glycoprotein (P-gp), which is encoded by ABCB1 (ATP-binding cassette, sub-family B member 1), is expressed in the blood brain barrier and protects the brain from many kinds of drugs and toxins including glucocorticoids by acting as an efflux pump. We examined whether functional polymorphisms of ABCB1 give susceptibility to major depressive disorder (MDD). The five functional single nucleotide polymorphisms (SNPs), A-41G (rs2188524), T-129C (rs3213619), C1236T (Gly412Gly: rs1128503), G2677A/T (Ala893Ser/Thr: rs2032582), and C3435T (Ile1145Ile: rs1045642) were genotyped in 631 MDD patients and 1100 controls in the Japanese population. A tri-allelic SNP, G2677A/T, was genotyped by pyrosequencing and the remaining SNPs were genotyped by the TaqMan 5'-exonuclease allelic discrimination assay. The minor T3435 allele was significantly increased in MDD patients than in the controls (chi(2) = 4.5, df = 1, p = 0.034, odds ratio [OR] 1.16, 95% confidential interval [CI] 1.01-1.34). Homozygotes for the T3435 allele was significantly more common in patients than in the controls (chi(2) = 7.5, df = 1, p = 0.0062, OR 1.43, 95%CI 1.11-1.85). With respect to the other 4 SNPs, there was no significant difference in genotype or allele distribution. In the haplotype-based analysis, the proportion of individuals with the TT1236-TT3435 haploid genotype was significantly increased in patients than in controls (chi(2) = 8.5, df = 1, p = 0.0037, OR 1.50, 95%CI 1.14-1.98). Our results suggest that the T3435 allele or carrying two copies of this allele confers susceptibility to MDD in the Japanese population.", "sentences": [], "annotations": [{"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "Human", "locations": [{"offset": 159, "length": 5}]}, {"id": "38", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 165, "length": 14}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 181, "length": 4}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 208, "length": 5}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ATP-binding cassette, sub-family B member 1", "locations": [{"offset": 215, "length": 43}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 463, "length": 5}]}, {"id": "43", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "depressive disorder", "locations": [{"offset": 498, "length": 19}]}, {"id": "44", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "MDD", "locations": [{"offset": 519, "length": 3}]}, {"id": "45", "infons": {"identifier": "rs2188524", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.-41A>G;RS#:2188524", "hgvs": "c.-41A>G", "identifiers": ["rs2188524"]}, "text": "A-41G", "locations": [{"offset": 585, "length": 5}]}, {"id": "46", "infons": {"identifier": "rs2188524", "type": "Mutation", "subtype": "SNP"}, "text": "rs2188524", "locations": [{"offset": 592, "length": 9}]}, {"id": "47", "infons": {"identifier": "rs3213619", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.-129T>C;RS#:3213619", "hgvs": "c.-129T>C", "identifiers": ["rs3213619"]}, "text": "T-129C", "locations": [{"offset": 604, "length": 6}]}, {"id": "48", "infons": {"identifier": "rs3213619", "type": "Mutation", "subtype": "SNP"}, "text": "rs3213619", "locations": [{"offset": 612, "length": 9}]}, {"id": "49", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 624, "length": 6}]}, {"id": "50", "infons": {"identifier": "-", "type": "Chemical"}, "text": "Gly412Gly", "locations": [{"offset": 632, "length": 9}]}, {"id": "51", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 643, "length": 9}]}, {"id": "52", "infons": {"identifier": "c.2677G>A,T", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677A/T", "locations": [{"offset": 655, "length": 8}]}, {"id": "53", "infons": {"identifier": "MESH:D013912", "type": "Chemical"}, "text": "Thr", "locations": [{"offset": 675, "length": 3}]}, {"id": "54", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 680, "length": 9}]}, {"id": "55", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 696, "length": 6}]}, {"id": "56", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.I1145I;RS#:1045642", "hgvs": "p.I1145I", "identifiers": ["rs1045642"]}, "text": "Ile1145Ile", "locations": [{"offset": 704, "length": 10}]}, {"id": "57", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 716, "length": 9}]}, {"id": "58", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "MDD", "locations": [{"offset": 749, "length": 3}]}, {"id": "59", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 753, "length": 8}]}, {"id": "60", "infons": {"identifier": "c.2677G>A,T", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677A/T", "locations": [{"offset": 827, "length": 8}]}, {"id": "61", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "MDD", "locations": [{"offset": 1020, "length": 3}]}, {"id": "62", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1024, "length": 8}]}, {"id": "63", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1219, "length": 8}]}, {"id": "64", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1551, "length": 8}]}, {"id": "65", "infons": {"identifier": "MESH:D003865", "type": "Disease"}, "text": "MDD", "locations": [{"offset": 1745, "length": 3}]}], "relations": []}], "relations": [], "pmid": 22306099, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@-", "mutation@rs1128503", "chemical@MESH:D013912", "species@9606", "mutation@c.2677G>A,T", "mutation@rs3213619", "disease@MESH:D003865", "disease@MESH:D000275", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "mutation@rs2188524"], "journal": "J Psychiatr Res", "year": 2012, "authors": ["Fujii T", "Ota M", "Hori H", "Sasayama D", "Hattori K", "Teraishi T", "Yamamoto N", "Hashikura M", "Tatsumi M", "Higuchi T", "Kunugi H"]},
{"_id": "22136368|None", "id": "22136368", "infons": {}, "passages": [{"infons": {"journal": "Basic Clin. Pharmacol. Toxicol.; 2012 May; 110(5) 460-8. doi:10.1111/j.1742-7843.2011.00838.x", "year": "2012", "type": "title", "authors": "Sortica Vde A, Ojopi EB, Genro JP, Callegari-Jacques S, Ribeiro-Dos-Santos A, de Moraes MO, Romano-Silva MA, Pena SD, Suarez-Kurtz G, Hutz MH", "section": "Title"}, "offset": 0, "text": "Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "10599", "type": "Gene", "ncbi_homologene": "74575"}, "text": "SLCO1B1", "locations": [{"offset": 53, "length": 7}]}, {"id": "4", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 62, "length": 7}]}, {"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 74, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 117, "text": "The frequency distribution of SNPs and haplotypes in the ABCB1, SLCO1B1 and SLCO1B3 genes varies largely among continental populations. This variation can lead to biases in pharmacogenetic studies conducted in admixed populations such as those from Brazil and other Latin American countries. The aim of this study was to evaluate the influence of self-reported colour, geographical origin and genomic ancestry on distributions of the ABCB1, SLCO1B1 and SLCO1B3 polymorphisms and derived haplotypes in admixed Brazilian populations. A total of 1039 healthy adults from the north, north-east, south-east and south of Brazil were recruited for this investigation. The c.388A&gt;G (rs2306283), c.463C&gt;A (rs11045819) and c.521T&gt;C (rs4149056) SNPs in the SLCO1B1 gene and c.334T&gt;G (rs4149117) and c.699G&gt;A (rs7311358) SNPs in the SLCO1B3 gene were determined by Taqman 5'-nuclease assays. The ABCB1 c.1236C&gt;T (rs1128503), c.2677G&gt;T/A (rs2032582) and c.3435C&gt;T (rs1045642) polymorphisms were genotyped using a previously described single-base extension/termination method. The results showed that genotype and haplotype distributions are highly variable among populations of the same self-reported colour and geographical region. However, genomic ancestry showed that these associations are better explained by a continuous variable. The influence of ancestry on the distribution of alleles and haplotype frequencies was more evident in variants with large differences in allele frequencies between European and African populations. Design and interpretation of pharmacogenetic studies using these transporter genes should include genomic controls to avoid spurious conclusions based on improper matching of study cohorts from Brazilian populations and other highly admixed populations.", "sentences": [], "annotations": [{"id": "23", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 174, "length": 5}]}, {"id": "24", "infons": {"identifier": "10599", "type": "Gene", "ncbi_homologene": "74575"}, "text": "SLCO1B1", "locations": [{"offset": 181, "length": 7}]}, {"id": "25", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 193, "length": 7}]}, {"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 551, "length": 5}]}, {"id": "27", "infons": {"identifier": "10599", "type": "Gene", "ncbi_homologene": "74575"}, "text": "SLCO1B1", "locations": [{"offset": 558, "length": 7}]}, {"id": "28", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 570, "length": 7}]}, {"id": "29", "infons": {"identifier": "rs2306283", "type": "Mutation", "subtype": "SNP"}, "text": "rs2306283", "locations": [{"offset": 795, "length": 9}]}, {"id": "30", "infons": {"identifier": "rs11045819", "type": "Mutation", "subtype": "SNP"}, "text": "rs11045819", "locations": [{"offset": 820, "length": 10}]}, {"id": "31", "infons": {"identifier": "rs4149056", "type": "Mutation", "subtype": "SNP"}, "text": "rs4149056", "locations": [{"offset": 849, "length": 9}]}, {"id": "32", "infons": {"identifier": "10599", "type": "Gene", "ncbi_homologene": "74575"}, "text": "SLCO1B1", "locations": [{"offset": 872, "length": 7}]}, {"id": "33", "infons": {"identifier": "rs4149117", "type": "Mutation", "subtype": "SNP"}, "text": "rs4149117", "locations": [{"offset": 902, "length": 9}]}, {"id": "34", "infons": {"identifier": "rs7311358", "type": "Mutation", "subtype": "SNP"}, "text": "rs7311358", "locations": [{"offset": 930, "length": 9}]}, {"id": "35", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 953, "length": 7}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1016, "length": 5}]}, {"id": "37", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1036, "length": 9}]}, {"id": "38", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1064, "length": 9}]}, {"id": "39", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1093, "length": 9}]}], "relations": []}], "relations": [], "pmid": 22136368, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@10599", "mutation@rs4149056", "mutation@rs4149117", "mutation@rs2306283", "gene@28234", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "mutation@rs7311358", "mutation@rs11045819"], "journal": "Basic Clin. Pharmacol. Toxicol.", "year": 2012, "authors": ["Sortica Vde A", "Ojopi EB", "Genro JP", "Callegari-Jacques S", "Ribeiro-Dos-Santos A", "de Moraes MO", "Romano-Silva MA", "Pena SD", "Suarez-Kurtz G", "Hutz MH"]},
{"_id": "22134106|None", "id": "22134106", "infons": {}, "passages": [{"infons": {"journal": "Blood Cells Mol. Dis.; 2012 Feb 15; 48(2) 132-6. doi:10.1016/j.bcmd.2011.11.001", "year": "2012", "type": "title", "authors": "Vivona D, Bueno CT, Lima LT, Hirata RD, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM", "section": "Title"}, "offset": 0, "text": "ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "5", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "chronic myeloid leukemia", "locations": [{"offset": 63, "length": 24}]}, {"id": "6", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 88, "length": 8}]}, {"id": "7", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "imatinib", "locations": [{"offset": 127, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 137, "text": "BACKGROUND: Imatinib mesylate (IM) is a selective tyrosine kinase inhibitor used for treating chronic myeloid leukemia (CML). IM has high efficacy, however some individuals develop a resistance due to impaired bioavailability. Polymorphisms in genes encoding membrane transporters such as ABCB1 have been associated with differences in protein expression and function that influence the response to several drugs. AIM: To investigate the relationship of ABCB1 polymorphisms with markers of response to IM in patients with CML. METHODS: One hundred eighteen CML patients initially treated with a standard dose of IM (400mg/day) for 18months were selected at two health centers in Sao Paulo City, Brazil. The response criteria were based on the European LeukemiaNet recommendations. ABCB1 polymorphisms c.1236C&gt;T (rs1128503), c.3435C&gt;T (rs1045642) and c.2677G&gt;T/A (rs2032582) were evaluated by PCR-RFLP. RESULTS: ABCB1 polymorphisms were not related with a risk for CML in this sample population (p&lt;0.05). In the CML group, frequencies of ABCB1 SNPs were similar between responder and non-responder patients (p&gt;0.05). In the responder group, the frequency of ABCB11236CT/2677GT/3435CT haplotype was higher in patients with major molecular response (MMR) (51.7%) than in patients without MMR (8.3%, p=0.010). Furthermore, carriers of this haplotype had increased the probability of reaching the MMR compared with the non-carriers (OR: 11.8; 95% CI: 1.43-97.3, p=0.022). CONCLUSIONS: The ABCB1 1236CT/2677GT/3435CT haplotype is positively associated with the major molecular response to IM in CML patients.", "sentences": [], "annotations": [{"id": "33", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "Imatinib mesylate", "locations": [{"offset": 149, "length": 17}]}, {"id": "34", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "IM", "locations": [{"offset": 168, "length": 2}]}, {"id": "35", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "chronic myeloid leukemia", "locations": [{"offset": 231, "length": 24}]}, {"id": "36", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "CML", "locations": [{"offset": 257, "length": 3}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 426, "length": 5}]}, {"id": "38", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 591, "length": 5}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 645, "length": 8}]}, {"id": "40", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "CML", "locations": [{"offset": 659, "length": 3}]}, {"id": "41", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "CML", "locations": [{"offset": 694, "length": 3}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 698, "length": 8}]}, {"id": "43", "infons": {"type": "Disease", "identifier": null, "db": null}, "text": "LeukemiaNet", "locations": [{"offset": 889, "length": 11}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 918, "length": 5}]}, {"id": "45", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 952, "length": 9}]}, {"id": "46", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 978, "length": 9}]}, {"id": "47", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1009, "length": 9}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1057, "length": 5}]}, {"id": "49", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "CML", "locations": [{"offset": 1110, "length": 3}]}, {"id": "50", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "CML", "locations": [{"offset": 1160, "length": 3}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1186, "length": 5}]}, {"id": "52", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1246, "length": 8}]}, {"id": "53", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1359, "length": 8}]}, {"id": "54", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1420, "length": 8}]}, {"id": "55", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1636, "length": 5}]}, {"id": "56", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "CML", "locations": [{"offset": 1741, "length": 3}]}, {"id": "57", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1745, "length": 8}]}], "relations": []}], "relations": [], "pmid": 22134106, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "chemical@MESH:D000068877", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D015464"], "journal": "Blood Cells Mol. Dis.", "year": 2012, "authors": ["Vivona D", "Bueno CT", "Lima LT", "Hirata RD", "Hirata MH", "Luchessi AD", "Zanichelli MA", "Chiattone CS", "Guerra-Shinohara EM"]},
{"_id": "22120734|None", "id": "22120734", "infons": {}, "passages": [{"infons": {"journal": "Clin. Chim. Acta; 2012 Feb 18; 413(3-4) 495-501. doi:10.1016/j.cca.2011.11.003", "year": "2012", "type": "title", "authors": "Rosales A, Alvear M, Cuevas A, Saavedra N, Zambrano T, Salazar LA", "section": "Title"}, "offset": 0, "text": "Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "MESH:D008055", "type": "Chemical"}, "text": "lipid", "locations": [{"offset": 48, "length": 5}]}, {"id": "4", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 75, "length": 12}]}, {"id": "5", "infons": {"identifier": "MESH:D006937", "type": "Disease"}, "text": "hypercholesterolemia", "locations": [{"offset": 113, "length": 20}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 135, "text": "BACKGROUND: Statins are normally the first-line therapy for hypercholesterolemia (HC); however, the lipid-lowering response shows high interindividual variation. We investigated the effect of four polymorphisms in CYP3A4, CYP3A5 and ABCB1 genes on response to atorvastatin and CYP3A4 activity in Chilean subjects with HC. METHODS: A total of 142 hypercholesterolemic individuals underwent atorvastatin therapy (10mg/day/1month). Serum lipid levels before and after treatment were measured. Genetic variants in CYP3A4 (-290A&gt;G, rs2740574), CYP3A5 (6986A&gt;G, rs776746) and ABCB1 (2677G&gt;A/T, rs2032582 and 3435C&gt;T, rs1045642) were analyzed by PCR-RFLP. CYP3A4 enzyme activity in urine samples was assessed through determination of 6beta-hydroxycortisol/cortisol free ratio (6betaOHC/FC). RESULTS: After 4weeks of therapy, a significant reduction in total cholesterol (TC) and LDL-c was observed (P&lt;0.001). The G allele for -290A&gt;G polymorphism was related to higher percentage of variation in TC and LDL-c (P&lt;0.001). Moreover, same allele was associated with higher HDL-c variation (P=0.017). In addition, CYP3A4 enzyme activity was lower in subjects carrying this polymorphism (P=0.009). No differences were observed for CYP3A5 and ABCB1 variants. CONCLUSION: Our results suggest that presence of G allele for -290A&gt;G polymorphism determines a better response to atorvastatin, being also associated with lower CYP3A4 activity in vivo, causing an increased atorvastatin activity.", "sentences": [], "annotations": [{"id": "39", "infons": {"identifier": "MESH:D006937", "type": "Disease"}, "text": "hypercholesterolemia", "locations": [{"offset": 195, "length": 20}]}, {"id": "40", "infons": {"identifier": "MESH:D008055", "type": "Chemical"}, "text": "lipid", "locations": [{"offset": 235, "length": 5}]}, {"id": "41", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 349, "length": 6}]}, {"id": "42", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 357, "length": 6}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 368, "length": 5}]}, {"id": "44", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 395, "length": 12}]}, {"id": "45", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 412, "length": 6}]}, {"id": "46", "infons": {"identifier": "MESH:D006938", "type": "Disease"}, "text": "hypercholesterolemic", "locations": [{"offset": 481, "length": 20}]}, {"id": "47", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 524, "length": 12}]}, {"id": "48", "infons": {"identifier": "MESH:D008055", "type": "Chemical"}, "text": "lipid", "locations": [{"offset": 570, "length": 5}]}, {"id": "49", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 645, "length": 6}]}, {"id": "50", "infons": {"identifier": "rs2740574", "type": "Mutation", "subtype": "SNP"}, "text": "rs2740574", "locations": [{"offset": 665, "length": 9}]}, {"id": "51", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 677, "length": 6}]}, {"id": "52", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 697, "length": 8}]}, {"id": "53", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 711, "length": 5}]}, {"id": "54", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 732, "length": 9}]}, {"id": "55", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 758, "length": 9}]}, {"id": "56", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 796, "length": 6}]}, {"id": "57", "infons": {"identifier": "MESH:C001380", "type": "Chemical"}, "text": "6beta-hydroxycortisol", "locations": [{"offset": 874, "length": 21}]}, {"id": "58", "infons": {"identifier": "MESH:D006854", "type": "Chemical"}, "text": "cortisol", "locations": [{"offset": 896, "length": 8}]}, {"id": "59", "infons": {"identifier": "-", "type": "Chemical"}, "text": "6betaOHC", "locations": [{"offset": 917, "length": 8}]}, {"id": "60", "infons": {"identifier": "-", "type": "Chemical"}, "text": "FC", "locations": [{"offset": 926, "length": 2}]}, {"id": "61", "infons": {"identifier": "MESH:D002784", "type": "Chemical"}, "text": "cholesterol", "locations": [{"offset": 998, "length": 11}]}, {"id": "62", "infons": {"identifier": "-", "type": "Chemical"}, "text": "TC", "locations": [{"offset": 1011, "length": 2}]}, {"id": "63", "infons": {"identifier": "22796", "type": "Gene", "ncbi_homologene": "7206"}, "text": "LDL-c", "locations": [{"offset": 1019, "length": 5}]}, {"id": "64", "infons": {"identifier": "-", "type": "Chemical"}, "text": "TC", "locations": [{"offset": 1142, "length": 2}]}, {"id": "65", "infons": {"identifier": "22796", "type": "Gene", "ncbi_homologene": "7206"}, "text": "LDL-c", "locations": [{"offset": 1149, "length": 5}]}, {"id": "66", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1258, "length": 6}]}, {"id": "67", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1374, "length": 6}]}, {"id": "68", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1385, "length": 5}]}, {"id": "69", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 1519, "length": 12}]}, {"id": "70", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1566, "length": 6}]}, {"id": "71", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 1612, "length": 12}]}], "relations": []}], "relations": [], "pmid": 22120734, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D008055", "disease@MESH:D006937", "gene@1576", "chemical@-", "chemical@MESH:D006854", "mutation@rs2032582", "mutation@rs776746", "gene@22796", "mutation@rs2740574", "gene@5243", "mutation@rs1045642", "gene@1577", "disease@MESH:D006938", "chemical@MESH:D000069059", "chemical@MESH:C001380", "chemical@MESH:D002784"], "journal": "Clin. Chim. Acta", "year": 2012, "authors": ["Rosales A", "Alvear M", "Cuevas A", "Saavedra N", "Zambrano T", "Salazar LA"]},
{"_id": "22112610|None", "id": "22112610", "infons": {}, "passages": [{"infons": {"journal": "Gynecol. Oncol.; 2012 Mar; 124(3) 575-81. doi:10.1016/j.ygyno.2011.11.022", "year": "2012", "article-id_pmc": "PMC3278512", "type": "title", "authors": "Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA", "section": "Title"}, "offset": 0, "text": "Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.", "sentences": [], "annotations": [{"id": "7", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 19, "length": 5}]}, {"id": "8", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 26, "length": 5}]}, {"id": "9", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 36, "length": 5}]}, {"id": "10", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 76, "length": 5}]}, {"id": "11", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "advanced stage ovarian cancer", "locations": [{"offset": 87, "length": 29}]}, {"id": "12", "infons": {"identifier": "MESH:D010984", "type": "Chemical"}, "text": "platinum", "locations": [{"offset": 130, "length": 8}]}, {"id": "13", "infons": {"identifier": "MESH:C080625", "type": "Chemical"}, "text": "taxane", "locations": [{"offset": 143, "length": 6}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 206, "text": "PURPOSE: Efflux transporters of the ATP-binding cassette (ABC) family are major determinants of chemoresistance in tumor cells. This study examined associations between functional variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes in patients with epithelial ovarian/primary peritoneal cancer (EOC/PPC) following platinum and taxane-based chemotherapy. METHODS: Sequenom iPLEXTMGOLD Assay and MALDI-TOF platform were used to genotype the non-synonymous G2677T/A (rs2032582; encoding Ala893Ser/Thr) and synonymous C3435T (rs1045642; encoding Ile1145Ile) variants in ABCB1, the non-synonymous G1249A variant in ABCC2 (rs2273697; encoding Val417Ile), and the non-synonymous C421A variant in ABCG2 (rs2231142; encoding Q141K, Gln141Lys) in normal DNA from up to 511 women in Gynecologic Oncology Group (GOG) phase III trials, GOG-172 or GOG-182. Progression-free survival (PFS) and overall survival (OS) were analyzed in relation to genetic polymorphisms using Kaplan-Meier and Cox proportional hazards model. RESULTS: The C421A variant (CA+AA versus CC) in ABCG2 was associated with a 6-month longer median PFS (22.7 versus 16.8 months, p=0.041). In multivariate analysis, patients with variant genotypes were at a reduced risk of disease progression (hazard ratio [HR]=0.75, 95% confidence interval [CI]=0.59-0.96, p=0.022). The association between C421A and OS was not statistically significant (HR=0.88, 95% CI=0.67-1.15, p=0.356). None of the other variants measured in either ABCB1 or ABCC2 was associated with PFS or OS. CONCLUSION: The C421A variant in ABCG2, previously shown to be associated with enhanced protein degradation and drug sensitivity, was associated with longer PFS in advanced stage EOC/PPC patents treated with platinum+taxane-based chemotherapy. This finding requires further validation.", "sentences": [], "annotations": [{"id": "50", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 321, "length": 5}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 398, "length": 5}]}, {"id": "52", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 405, "length": 5}]}, {"id": "53", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 415, "length": 5}]}, {"id": "54", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 452, "length": 8}]}, {"id": "55", "infons": {"identifier": "MESH:D000077216", "type": "Disease"}, "text": "epithelial ovarian/primary peritoneal cancer", "locations": [{"offset": 466, "length": 44}]}, {"id": "56", "infons": {"identifier": "MESH:D010984", "type": "Chemical"}, "text": "platinum", "locations": [{"offset": 531, "length": 8}]}, {"id": "57", "infons": {"identifier": "MESH:C080625", "type": "Chemical"}, "text": "taxane", "locations": [{"offset": 544, "length": 6}]}, {"id": "58", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 671, "length": 8}]}, {"id": "59", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 681, "length": 9}]}, {"id": "60", "infons": {"identifier": "rs1289543302", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.A893S,T;RS#:1289543302", "hgvs": "p.A893S,T", "identifiers": ["rs1289543302"]}, "text": "Ala893Ser/T", "locations": [{"offset": 701, "length": 11}]}, {"id": "61", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 731, "length": 6}]}, {"id": "62", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 739, "length": 9}]}, {"id": "63", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.I1145I;RS#:1045642", "hgvs": "p.I1145I", "identifiers": ["rs1045642"]}, "text": "Ile1145Ile", "locations": [{"offset": 759, "length": 10}]}, {"id": "64", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 783, "length": 5}]}, {"id": "65", "infons": {"identifier": "rs2273697", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1249G>A;RS#:2273697", "hgvs": "c.1249G>A", "identifiers": ["rs2273697"]}, "text": "G1249A", "locations": [{"offset": 809, "length": 6}]}, {"id": "66", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 827, "length": 5}]}, {"id": "67", "infons": {"identifier": "rs2273697", "type": "Mutation", "subtype": "SNP"}, "text": "rs2273697", "locations": [{"offset": 834, "length": 9}]}, {"id": "68", "infons": {"identifier": "rs2273697", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.V417I;RS#:2273697", "hgvs": "p.V417I", "identifiers": ["rs2273697"]}, "text": "Val417Ile", "locations": [{"offset": 854, "length": 9}]}, {"id": "69", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.421C>A;RS#:2231142", "hgvs": "c.421C>A", "identifiers": ["rs2231142"]}, "text": "C421A", "locations": [{"offset": 889, "length": 5}]}, {"id": "70", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 906, "length": 5}]}, {"id": "71", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "SNP"}, "text": "rs2231142", "locations": [{"offset": 913, "length": 9}]}, {"id": "72", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.Q141K;RS#:2231142", "hgvs": "p.Q141K", "identifiers": ["rs2231142"]}, "text": "Q141K", "locations": [{"offset": 933, "length": 5}]}, {"id": "73", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.Q141K;RS#:2231142", "hgvs": "p.Q141K", "identifiers": ["rs2231142"]}, "text": "Gln141Lys", "locations": [{"offset": 940, "length": 9}]}, {"id": "74", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 980, "length": 5}]}, {"id": "75", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.421C>A;RS#:2231142", "hgvs": "c.421C>A", "identifiers": ["rs2231142"]}, "text": "C421A", "locations": [{"offset": 1237, "length": 5}]}, {"id": "76", "infons": {"identifier": "-", "type": "Chemical"}, "text": "CA+AA", "locations": [{"offset": 1252, "length": 5}]}, {"id": "77", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 1272, "length": 5}]}, {"id": "78", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1388, "length": 8}]}, {"id": "79", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.421C>A;RS#:2231142", "hgvs": "c.421C>A", "identifiers": ["rs2231142"]}, "text": "C421A", "locations": [{"offset": 1565, "length": 5}]}, {"id": "80", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1696, "length": 5}]}, {"id": "81", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 1705, "length": 5}]}, {"id": "82", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.421C>A;RS#:2231142", "hgvs": "c.421C>A", "identifiers": ["rs2231142"]}, "text": "C421A", "locations": [{"offset": 1758, "length": 5}]}, {"id": "83", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 1775, "length": 5}]}, {"id": "84", "infons": {"identifier": "MESH:D010984", "type": "Chemical"}, "text": "platinum", "locations": [{"offset": 1950, "length": 8}]}, {"id": "85", "infons": {"identifier": "MESH:C080625", "type": "Chemical"}, "text": "taxane", "locations": [{"offset": 1959, "length": 6}]}], "relations": []}], "relations": [], "pmid": 22112610, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs1289543302", "chemical@-", "disease@MESH:D010051", "gene@1244", "species@9606", "disease@MESH:D000077216", "mutation@c.2677G>T,A", "mutation@rs2032582", "mutation@rs2273697", "gene@5243", "chemical@MESH:D010984", "mutation@rs1045642", "mutation@rs2231142", "chemical@MESH:C080625", "gene@9429", "disease@MESH:D009369"], "journal": "Gynecol. Oncol.", "year": 2012, "authors": ["Tian C", "Ambrosone CB", "Darcy KM", "Krivak TC", "Armstrong DK", "Bookman MA", "Davis W", "Zhao H", "Moysich K", "Gallion H", "DeLoia JA"]},
{"_id": "22110582|None", "id": "22110582", "infons": {}, "passages": [{"infons": {"journal": "PLoS ONE; 2011; 6(11) 25933. doi:10.1371/journal.pone.0025933", "year": "2011", "article-id_pmc": "PMC3215699", "type": "title", "authors": "Yu X, Xie H, Wei B, Zhang M, Wang W, Wu J, Yan S, Zheng S, Zhou L", "section": "Title"}, "offset": 0, "text": "Association of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 15, "length": 4}]}, {"id": "3", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 54, "length": 10}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 127, "text": "BACKGROUND: This work seeks to evaluate the association between the C/D ratios (plasma concentration of tacrolimus divided by daily dose of tacrolimus per body weight) of tacrolimus and the haplotypes of MDR1 gene combined by C1236T (rs1128503), G2677A/T (rs2032582) and C3435T (rs1045642), and to further determine the functional significance of haplotypes in the clinical pharmacokinetics of oral tacrolimus in Han Chinese liver transplant recipients. METHODOLOGY/PRINCIPAL FINDINGS: The tacrolimus blood concentrations were continuously recorded for one month after initial administration, and the peripheral blood DNA from a total of 62 liver transplant recipients was extracted. Genotyping of C1236T, G2677A/T and C3435T was performed, and SNP frequency, Hardy-Weinberg equilibrium, linkage disequilibrium, haplotypes analysis and multiple testing were achieved by software PLINK. C/D ratios of different SNP groups or haplotype groups were compared, with a p value&lt;0.05 considered statistically significant. Linkage studies revealed that C1236T, G2677A/T and C3435T are genetically associated with each other. Patients carrying T-T haplotype combined by C1236T and G2677A/T, and an additional T/T homozygote at either position would require higher dose of tacrolimus. Tacrolimus C/D ratios of liver transplant recipients varied significantly among different haplotype groups of MDR1 gene. CONCLUSIONS: Our studies suggest that the genetic polymorphism could be used as a valuable molecular marker for the prediction of tacrolimus C/D ratios of liver transplant recipients.", "sentences": [], "annotations": [{"id": "25", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 331, "length": 4}]}, {"id": "26", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 353, "length": 6}]}, {"id": "27", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 361, "length": 9}]}, {"id": "28", "infons": {"identifier": "c.2677G>A,T", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677A/T", "locations": [{"offset": 373, "length": 8}]}, {"id": "29", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 383, "length": 9}]}, {"id": "30", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 398, "length": 6}]}, {"id": "31", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 406, "length": 9}]}, {"id": "32", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 617, "length": 10}]}, {"id": "33", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 825, "length": 6}]}, {"id": "34", "infons": {"identifier": "c.2677G>A,T", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677A/T", "locations": [{"offset": 833, "length": 8}]}, {"id": "35", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 846, "length": 6}]}, {"id": "36", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 1174, "length": 6}]}, {"id": "37", "infons": {"identifier": "c.2677G>A,T", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677A/T", "locations": [{"offset": 1182, "length": 8}]}, {"id": "38", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 1195, "length": 6}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 1246, "length": 8}]}, {"id": "40", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 1290, "length": 6}]}, {"id": "41", "infons": {"identifier": "c.2677G>A,T", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677A/T", "locations": [{"offset": 1301, "length": 8}]}, {"id": "42", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1392, "length": 10}]}, {"id": "43", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "Tacrolimus", "locations": [{"offset": 1404, "length": 10}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1514, "length": 4}]}, {"id": "45", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1655, "length": 10}]}], "relations": []}], "relations": [], "pmid": 22110582, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs1128503", "species@9606", "mutation@rs2032582", "chemical@MESH:D016559", "mutation@c.2677G>A,T", "gene@5243", "mutation@rs1045642"], "journal": "PLoS ONE", "year": 2011, "authors": ["Yu X", "Xie H", "Wei B", "Zhang M", "Wang W", "Wu J", "Yan S", "Zheng S", "Zhou L"]},
{"_id": "22015057|None", "id": "22015057", "infons": {}, "passages": [{"infons": {"journal": "Lancet Oncol.; 2011 Nov; 12(12) 1143-50. doi:10.1016/S1470-2045(11)70266-2", "year": "2011", "type": "title", "authors": "Garcia-Donas J, Esteban E, Leandro-Garc\u00eda LJ, Castellano DE, del Alba AG, Climent MA, Arranz JA, Gallardo E, Puente J, Bellmunt J, Mellado B, Mart\u00ednez E, Moreno F, Font A, Robledo M, Rodr\u00edguez-Antona C", "section": "Title"}, "offset": 0, "text": "Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 79, "length": 8}]}, {"id": "4", "infons": {"identifier": "MESH:C538614", "type": "Disease"}, "text": "renal-cell carcinoma", "locations": [{"offset": 102, "length": 20}]}, {"id": "5", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "sunitinib", "locations": [{"offset": 147, "length": 9}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 207, "text": "BACKGROUND: Sunitinib is a tyrosine kinase inhibitor with proven efficacy in renal-cell carcinoma, but some patients do not respond or need dose reductions due to toxicity. Because there are no validated molecular predictors of response or toxicity to sunitinib, we aimed to identify genetic markers predictive of outcome and toxic effects. METHODS: In our observational, prospective study we enrolled previously untreated adults (&gt;= 18 years) with clear-cell renal-cell carcinoma at 15 institutions in the Spanish Oncology Genitourinary Group in Spain. Patients received sunitinib according to local practice guidelines. We assessed RECIST response, progression-free survival (PFS), overall survival, and toxicity of sunitinib with 16 key polymorphisms in nine genes: VEGFR2 (rs2305948 and rs1870377), VEGFR3 (rs307826, rs448012, and rs307821), PDGFR-alpha (rs35597368), VEGF-A (rs2010963, rs699947, and rs1570360), IL8 (rs1126647), CYP3A4 (rs2740574), CYP3A5 (rs776746), ABCB1 (rs1045642, rs1128503, and rs2032582), and ABCB2 (rs2231142). We assessed associations with efficacy and toxicity by use of univariable and multivariable analyses (with clinical factors associated with outcomes as covariates). We adjusted for multiplicity using the Bonferroni method; p values of less than 0 0031 before adjustment were deemed to still be significant after adjustment. FINDINGS: We enrolled 101 patients between Oct 10, 2007, and Dec 13, 2010. 95 of these patients were included in toxicity analyses and 89 in the efficacy analyses. Two VEGFR3 missense polymorphisms were associated with reduced PFS with sunitinib on multivariable analysis: rs307826 (hazard ratio [HR] per allele 3 57, 1 75-7 30; p(unadjusted)=0 00049, p(adjusted)=0 0079) and rs307821 (3 31, 1 64-6 68; p(unadjusted)=0 00085, p(adjusted)=0 014). The CYP3A5*1 (rs776746) high metabolising allele was associated in a multivariable analysis with an increased risk of dose reductions due to toxicity (HR per allele 3 75, 1 67-8 41; p(unadjusted)=0 0014, p(adjusted)=0 022). No other SNPs were associated with sunitinib response or toxicity. INTERPRETATION: Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability. If confirmed, these results should promote interventional studies testing alternative therapeutic approaches for patients with such variants. FUNDING: Pfizer.", "sentences": [], "annotations": [{"id": "60", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "Sunitinib", "locations": [{"offset": 219, "length": 9}]}, {"id": "61", "infons": {"identifier": "MESH:C538614", "type": "Disease"}, "text": "renal-cell carcinoma", "locations": [{"offset": 284, "length": 20}]}, {"id": "62", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 315, "length": 8}]}, {"id": "63", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 370, "length": 8}]}, {"id": "64", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 447, "length": 8}]}, {"id": "65", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "sunitinib", "locations": [{"offset": 459, "length": 9}]}, {"id": "66", "infons": {"identifier": "MESH:C538614", "type": "Disease"}, "text": "clear-cell renal-cell carcinoma", "locations": [{"offset": 659, "length": 31}]}, {"id": "67", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 764, "length": 8}]}, {"id": "68", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "sunitinib", "locations": [{"offset": 782, "length": 9}]}, {"id": "69", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 916, "length": 8}]}, {"id": "70", "infons": {"identifier": "3791", "type": "Gene", "ncbi_homologene": "55639"}, "text": "VEGFR2", "locations": [{"offset": 979, "length": 6}]}, {"id": "71", "infons": {"identifier": "rs2305948", "type": "Mutation", "subtype": "SNP"}, "text": "rs2305948", "locations": [{"offset": 987, "length": 9}]}, {"id": "72", "infons": {"identifier": "rs1870377", "type": "Mutation", "subtype": "SNP"}, "text": "rs1870377", "locations": [{"offset": 1001, "length": 9}]}, {"id": "73", "infons": {"identifier": "2324", "type": "Gene", "ncbi_homologene": "7321"}, "text": "VEGFR3", "locations": [{"offset": 1013, "length": 6}]}, {"id": "74", "infons": {"identifier": "rs307826", "type": "Mutation", "subtype": "SNP"}, "text": "rs307826", "locations": [{"offset": 1021, "length": 8}]}, {"id": "75", "infons": {"identifier": "rs448012", "type": "Mutation", "subtype": "SNP"}, "text": "rs448012", "locations": [{"offset": 1031, "length": 8}]}, {"id": "76", "infons": {"identifier": "rs307821", "type": "Mutation", "subtype": "SNP"}, "text": "rs307821", "locations": [{"offset": 1045, "length": 8}]}, {"id": "77", "infons": {"identifier": "5156", "type": "Gene", "ncbi_homologene": "31361"}, "text": "PDGFR-alpha", "locations": [{"offset": 1056, "length": 11}]}, {"id": "78", "infons": {"identifier": "rs35597368", "type": "Mutation", "subtype": "SNP"}, "text": "rs35597368", "locations": [{"offset": 1069, "length": 10}]}, {"id": "79", "infons": {"identifier": "7422", "type": "Gene", "ncbi_homologene": "2534"}, "text": "VEGF-A", "locations": [{"offset": 1082, "length": 6}]}, {"id": "80", "infons": {"identifier": "rs2010963", "type": "Mutation", "subtype": "SNP"}, "text": "rs2010963", "locations": [{"offset": 1090, "length": 9}]}, {"id": "81", "infons": {"identifier": "rs699947", "type": "Mutation", "subtype": "SNP"}, "text": "rs699947", "locations": [{"offset": 1101, "length": 8}]}, {"id": "82", "infons": {"identifier": "rs1570360", "type": "Mutation", "subtype": "SNP"}, "text": "rs1570360", "locations": [{"offset": 1115, "length": 9}]}, {"id": "83", "infons": {"identifier": "3576", "type": "Gene", "ncbi_homologene": "47937"}, "text": "IL8", "locations": [{"offset": 1127, "length": 3}]}, {"id": "84", "infons": {"identifier": "rs1126647", "type": "Mutation", "subtype": "SNP"}, "text": "rs1126647", "locations": [{"offset": 1132, "length": 9}]}, {"id": "85", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1144, "length": 6}]}, {"id": "86", "infons": {"identifier": "rs2740574", "type": "Mutation", "subtype": "SNP"}, "text": "rs2740574", "locations": [{"offset": 1152, "length": 9}]}, {"id": "87", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1164, "length": 6}]}, {"id": "88", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 1172, "length": 8}]}, {"id": "89", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1183, "length": 5}]}, {"id": "90", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1190, "length": 9}]}, {"id": "91", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1201, "length": 9}]}, {"id": "92", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1216, "length": 9}]}, {"id": "93", "infons": {"identifier": "6890", "type": "Gene", "ncbi_homologene": "495"}, "text": "ABCB2", "locations": [{"offset": 1232, "length": 5}]}, {"id": "94", "infons": {"identifier": "rs2231142", "type": "Mutation", "subtype": "SNP"}, "text": "rs2231142", "locations": [{"offset": 1239, "length": 9}]}, {"id": "95", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 1294, "length": 8}]}, {"id": "96", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1601, "length": 8}]}, {"id": "97", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1662, "length": 8}]}, {"id": "98", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 1688, "length": 8}]}, {"id": "99", "infons": {"identifier": "2324", "type": "Gene", "ncbi_homologene": "7321"}, "text": "VEGFR3", "locations": [{"offset": 1743, "length": 6}]}, {"id": "100", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "sunitinib", "locations": [{"offset": 1811, "length": 9}]}, {"id": "101", "infons": {"identifier": "rs307826", "type": "Mutation", "subtype": "SNP"}, "text": "rs307826", "locations": [{"offset": 1848, "length": 8}]}, {"id": "102", "infons": {"identifier": "rs307821", "type": "Mutation", "subtype": "SNP"}, "text": "rs307821", "locations": [{"offset": 1951, "length": 8}]}, {"id": "103", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 2025, "length": 6}]}, {"id": "104", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 2035, "length": 8}]}, {"id": "105", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 2162, "length": 8}]}, {"id": "106", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "sunitinib", "locations": [{"offset": 2280, "length": 9}]}, {"id": "107", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicity", "locations": [{"offset": 2302, "length": 8}]}, {"id": "108", "infons": {"identifier": "2324", "type": "Gene", "ncbi_homologene": "7321"}, "text": "VEGFR3", "locations": [{"offset": 2345, "length": 6}]}, {"id": "109", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 2356, "length": 6}]}, {"id": "110", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2401, "length": 8}]}, {"id": "111", "infons": {"identifier": "MESH:C538614", "type": "Disease"}, "text": "renal-cell carcinoma", "locations": [{"offset": 2415, "length": 20}]}, {"id": "112", "infons": {"identifier": "MESH:D000077210", "type": "Chemical"}, "text": "sunitinib", "locations": [{"offset": 2451, "length": 9}]}, {"id": "113", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2601, "length": 8}]}], "relations": []}], "relations": [], "pmid": 22015057, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@5156", "gene@7422", "mutation@rs1870377", "gene@2324", "mutation@rs307821", "gene@1576", "mutation@rs1045642", "mutation@rs2305948", "disease@MESH:C538614", "mutation@rs307826", "disease@MESH:D064420", "mutation@rs699947", "mutation@rs2010963", "species@9606", "mutation@rs2032582", "mutation@rs776746", "chemical@MESH:D000077210", "gene@5243", "mutation@rs1128503", "gene@1577", "mutation@rs448012", "mutation@rs2231142", "mutation@rs1126647", "mutation@rs35597368", "gene@6890", "gene@3576", "mutation@rs1570360", "mutation@rs2740574", "gene@3791"], "journal": "Lancet Oncol.", "year": 2011, "authors": ["Garcia-Donas J", "Esteban E", "Leandro-Garc\u00eda LJ", "Castellano DE", "del Alba AG", "Climent MA", "Arranz JA", "Gallardo E", "Puente J", "Bellmunt J", "Mellado B", "Mart\u00ednez E", "Moreno F", "Font A", "Robledo M", "Rodr\u00edguez-Antona C"]},
{"_id": "21902503|None", "id": "21902503", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenomics; 2011 Oct; 12(10) 1493-501. doi:10.2217/pgs.11.91", "year": "2011", "type": "title", "authors": "L Huillier AG, Ing Lorenzini K, Crisinel PA, Rebsamen MC, Fluss J, Korff CM, Barbe RP, Siegrist CA, Dayer P, Posfay-Barbe KM, Desmeules JA", "section": "Title"}, "offset": 0, "text": "ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "6", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 59, "length": 11}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 79, "length": 8}]}, {"id": "8", "infons": {"identifier": "114727", "type": "Species"}, "text": "H1N1", "locations": [{"offset": 105, "length": 4}]}, {"id": "9", "infons": {"type": "Disease", "identifier": null, "db": null}, "text": "pandemia", "locations": [{"offset": 113, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 123, "text": "AIMS: To examine the safety profile of oseltamivir in children and evaluate the impact of P-glycoprotein polymorphisms on the incidence of neuropsychiatric adverse events (NPAE) in oseltamivir-treated children. SUBJECTS &amp; METHODS: This prospective cohort study was conducted in our tertiary care pediatric hospital (University Hospitals of Geneva, Switzerland) during the H1N1 pandemia, between 1 October 2009 and 31 January 2010. All newborn to 18 year-old patients presenting at the emergency department with a flu-like illness were eligible for inclusion. Adverse events were systematically recorded by pediatricians and/or by parents at home using a diary card, with a 30-day follow-up period. The causality assessment of oseltamivir in NPAE was performed by two clinical pharmacologists. After informed consent, enrolled patients were also genotyped for ABCB1 3435C&gt;T (rs1045642) and 2677G&gt;T/A (rs2032582) polymorphisms. RESULTS: Among the 42 H1N1-infected, oseltamivir-treated children who were genotyped for ABCB1 3435C&gt;T and 2677G&gt;T/A variants, 36% presented NPAE. When examining the association between the diplotype and the development of NPAE, we observed that the frequency of NPAE displayed a 'genotype-trend effect' with the variant and the wild-type subgroups at the two far ends. A total of 11% of the 2677GG-3435CC individuals (wild-type homozygous) presented NPAE, compared with 39% of the individuals being heterozygous for at least one variant allele and 67% of the 2677TT-3435TT individuals (homozygous variants) (p = 0.149, nonsignificant). CONCLUSION: These observations suggest a potential influence of ABCB1 polymorphisms in oseltamivir-related NPAE, maybe as a result of an enhanced permeability of the blood-brain barrier to oseltamivir", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 162, "length": 11}]}, {"id": "31", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 177, "length": 8}]}, {"id": "32", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 304, "length": 11}]}, {"id": "33", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 324, "length": 8}]}, {"id": "34", "infons": {"identifier": "MESH:D000249", "type": "Chemical"}, "text": "amp", "locations": [{"offset": 344, "length": 3}]}, {"id": "35", "infons": {"identifier": "114727", "type": "Species"}, "text": "H1N1", "locations": [{"offset": 499, "length": 4}]}, {"id": "36", "infons": {"type": "Disease", "identifier": null, "db": null}, "text": "pandemia", "locations": [{"offset": 504, "length": 8}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 585, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 853, "length": 11}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 953, "length": 8}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 986, "length": 5}]}, {"id": "41", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1004, "length": 9}]}, {"id": "42", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1033, "length": 9}]}, {"id": "43", "infons": {"identifier": "MESH:D007239", "type": "Disease"}, "text": "H1N1-infected", "locations": [{"offset": 1081, "length": 13}]}, {"id": "44", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 1096, "length": 11}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 1116, "length": 8}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1148, "length": 5}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1766, "length": 5}]}, {"id": "48", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 1789, "length": 11}]}, {"id": "49", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 1891, "length": 11}]}], "relations": []}], "relations": [], "pmid": 21902503, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D007239", "chemical@MESH:D053139", "species@9606", "species@114727", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "chemical@MESH:D000249"], "journal": "Pharmacogenomics", "year": 2011, "authors": ["L Huillier AG", "Ing Lorenzini K", "Crisinel PA", "Rebsamen MC", "Fluss J", "Korff CM", "Barbe RP", "Siegrist CA", "Dayer P", "Posfay-Barbe KM", "Desmeules JA"]},
{"_id": "21896346|None", "id": "21896346", "infons": {}, "passages": [{"infons": {"journal": "Biol. Blood Marrow Transplant.; 2012 Jan; 18(1) 37-43. doi:10.1016/j.bbmt.2011.08.019", "year": "2012", "type": "title", "authors": "Koh Y, Kim I, Shin DY, Bae JY, Kim HK, Yoon SS, Park SS, Lee DS, Park S, Kim BK", "section": "Title"}, "offset": 0, "text": "Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 37, "length": 12}]}, {"id": "4", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 68, "length": 12}]}, {"id": "5", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 119, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 192, "text": "In patients who received allogeneic hematopoietic stem cell transplantation (HSCT), we investigated the correlations between single nucleotide polymorphisms (SNPs) in genes that regulate cyclosporine metabolism and clinical outcomes. All patients received sibling-matched HSCT. DNA samples of patients and donors were analyzed for 4 SNPs: MDR1 +1236C&gt;T (rs1128503), +2677G&gt;T&gt;A (rs2032582), +3435C&gt;T (rs1045642), and CYP3A5 +6986G&gt;A (rs776746). A total of 156 patients (median age 40 years) were analyzed. Nineteen patients received HSCT for nonmalignant disease. The CYP3A5 +6986AA genotype was associated with a high cyclosporine blood level after transplantation. However, this genotype was not related to any particular clinical outcome. In contrast, the MDR1 +1236C&gt;T SNP was correlated with specific clinical outcomes. When neither the donor nor the recipient had the CC genotype of MDR1 +1236, patients had lower creatinine levels (P &lt; .001) and less transplantation-related mortality (TRM) (P = .012). These patients also showed longer overall survival (OS) in both univariate (P = .003) and multivariate (P = .003) analyses. Although the CYP3A5 +6986AA genotype was correlated with a high blood cyclosporine concentration, lack of the MDR1 +1236CC genotype in both the donor and recipient was correlated with less TRM and a longer OS in patients who received allogeneic HSCT.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 195, "length": 8}]}, {"id": "32", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 379, "length": 12}]}, {"id": "33", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 430, "length": 8}]}, {"id": "34", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 485, "length": 8}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 531, "length": 4}]}, {"id": "36", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 549, "length": 9}]}, {"id": "37", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 579, "length": 9}]}, {"id": "38", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 604, "length": 9}]}, {"id": "39", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 620, "length": 6}]}, {"id": "40", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 640, "length": 8}]}, {"id": "41", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 666, "length": 8}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 721, "length": 8}]}, {"id": "43", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 774, "length": 6}]}, {"id": "44", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 825, "length": 12}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 965, "length": 4}]}, {"id": "46", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 1051, "length": 5}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1098, "length": 4}]}, {"id": "48", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1110, "length": 8}]}, {"id": "49", "infons": {"identifier": "MESH:D003404", "type": "Chemical"}, "text": "creatinine", "locations": [{"offset": 1129, "length": 10}]}, {"id": "50", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1228, "length": 8}]}, {"id": "51", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1359, "length": 6}]}, {"id": "52", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 1416, "length": 12}]}, {"id": "53", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1456, "length": 4}]}, {"id": "54", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 1490, "length": 5}]}, {"id": "55", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1558, "length": 8}]}], "relations": []}], "relations": [], "pmid": 21896346, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@1577", "chemical@MESH:D016572", "species@9606", "mutation@rs2032582", "mutation@rs776746", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "chemical@MESH:D003404"], "journal": "Biol. Blood Marrow Transplant.", "year": 2012, "authors": ["Koh Y", "Kim I", "Shin DY", "Bae JY", "Kim HK", "Yoon SS", "Park SS", "Lee DS", "Park S", "Kim BK"]},
{"_id": "21840870|None", "id": "21840870", "infons": {}, "passages": [{"infons": {"journal": "Jpn. J. Clin. Oncol.; 2011 Oct; 41(10) 1168-76. doi:10.1093/jjco/hyr117", "year": "2011", "type": "title", "authors": "Perwitasari DA, Wessels JA, van der Straaten RJ, Baak-Pablo RF, Mustofa M, Hakimi M, Nortier JW, Gelderblom H, Guchelaar HJ", "section": "Title"}, "offset": 0, "text": "Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.", "sentences": [], "annotations": [{"id": "7", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 15, "length": 5}]}, {"id": "8", "infons": {"identifier": "9177", "type": "Gene", "ncbi_homologene": "38131"}, "text": "5-HT3B", "locations": [{"offset": 22, "length": 6}]}, {"id": "9", "infons": {"identifier": "1565", "type": "Gene", "ncbi_homologene": "133550"}, "text": "CYP2D6", "locations": [{"offset": 42, "length": 6}]}, {"id": "10", "infons": {"identifier": "MESH:D017294", "type": "Chemical"}, "text": "ondansetron", "locations": [{"offset": 76, "length": 11}]}, {"id": "11", "infons": {"identifier": "MESH:D008787", "type": "Chemical"}, "text": "metoclopramide", "locations": [{"offset": 92, "length": 14}]}, {"id": "12", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 141, "length": 6}]}, {"id": "13", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 148, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 202, "text": "OBJECTIVE: Suboptimal treatment of chemotherapy-induced nausea and vomiting and unsatisfactory response to antiemetic drugs cause impairment of cancer patient's daily functioning. This study was aimed to investigate the association of selected germline polymorphisms with ondansetron and metoclopramide response in Indonesian cancer patients treated with highly emetogenic chemotherapy. METHODS: We enrolled 202 chemotherapy naive patients treated with cisplatin at a dosage of &gt;=50 mg/m(2) as monotherapy or as combined chemotherapy. Ondansetron 8 mg and dexamethasone 8 mg intravenously were the standard antiemetic therapy for prevention of acute chemotherapy-induced nausea and vomiting. Metoclopramide 10 mg orally, three times per day as fixed prescription, was given until 5 days after chemotherapy to prevent delayed chemotherapy-induced nausea and vomiting. Primary and secondary outcomes were the occurrence of chemotherapy-induced nausea and vomiting in the acute and delayed phase. The following single-nucleotide polymorphisms were determined in ABCB1: rs1045642, rs2032582 and rs1128503; in 5-HT3B-R: rs45460698, rs4938058 and rs7943062; and in CYP2D6: rs16947 (CYP2D6 2), rs3892097 (CYP2D6 4) and rs1065852 (CYP2D6 10) using Taqman assays. RESULTS: During the acute phase, 21.8 and 30.2% patients experienced Grade 3 and 4 nausea and vomiting, respectively, whereas 38.6% patients experienced nausea and/or vomiting in the delayed phase. Carriers of the CTG haplotype of the ABCB1 gene experienced Grade 3 and 4 chemotherapy-induced nausea and vomiting more often than other haplotypes in the delayed phase (P&lt; 0.05). No associations were found with the 5-HT3B receptor haplotypes and CYP2D6-predicted phenotypes. CONCLUSIONS: Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and vomiting.", "sentences": [], "annotations": [{"id": "65", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 258, "length": 6}]}, {"id": "66", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 269, "length": 8}]}, {"id": "67", "infons": {"identifier": "MESH:D009422", "type": "Disease"}, "text": "impairment of cancer", "locations": [{"offset": 332, "length": 20}]}, {"id": "68", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 353, "length": 7}]}, {"id": "69", "infons": {"identifier": "MESH:D017294", "type": "Chemical"}, "text": "ondansetron", "locations": [{"offset": 474, "length": 11}]}, {"id": "70", "infons": {"identifier": "MESH:D008787", "type": "Chemical"}, "text": "metoclopramide", "locations": [{"offset": 490, "length": 14}]}, {"id": "71", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 528, "length": 6}]}, {"id": "72", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 535, "length": 8}]}, {"id": "73", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 633, "length": 8}]}, {"id": "74", "infons": {"identifier": "MESH:D002945", "type": "Chemical"}, "text": "cisplatin", "locations": [{"offset": 655, "length": 9}]}, {"id": "75", "infons": {"identifier": "MESH:D017294", "type": "Chemical"}, "text": "Ondansetron", "locations": [{"offset": 740, "length": 11}]}, {"id": "76", "infons": {"identifier": "MESH:D003907", "type": "Chemical"}, "text": "dexamethasone", "locations": [{"offset": 761, "length": 13}]}, {"id": "77", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 876, "length": 6}]}, {"id": "78", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 887, "length": 8}]}, {"id": "79", "infons": {"identifier": "MESH:D008787", "type": "Chemical"}, "text": "Metoclopramide", "locations": [{"offset": 897, "length": 14}]}, {"id": "80", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 1051, "length": 6}]}, {"id": "81", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 1062, "length": 8}]}, {"id": "82", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 1147, "length": 6}]}, {"id": "83", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 1158, "length": 8}]}, {"id": "84", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1264, "length": 5}]}, {"id": "85", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1271, "length": 9}]}, {"id": "86", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1282, "length": 9}]}, {"id": "87", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1296, "length": 9}]}, {"id": "88", "infons": {"identifier": "9177", "type": "Gene", "ncbi_homologene": "38131"}, "text": "5-HT3B", "locations": [{"offset": 1310, "length": 6}]}, {"id": "89", "infons": {"identifier": "rs45460698", "type": "Mutation", "subtype": "SNP"}, "text": "rs45460698", "locations": [{"offset": 1320, "length": 10}]}, {"id": "90", "infons": {"identifier": "rs4938058", "type": "Mutation", "subtype": "SNP"}, "text": "rs4938058", "locations": [{"offset": 1332, "length": 9}]}, {"id": "91", "infons": {"identifier": "rs7943062", "type": "Mutation", "subtype": "SNP"}, "text": "rs7943062", "locations": [{"offset": 1346, "length": 9}]}, {"id": "92", "infons": {"identifier": "1565", "type": "Gene", "ncbi_homologene": "133550"}, "text": "CYP2D6", "locations": [{"offset": 1364, "length": 6}]}, {"id": "93", "infons": {"identifier": "rs16947", "type": "Mutation", "subtype": "SNP"}, "text": "rs16947", "locations": [{"offset": 1372, "length": 7}]}, {"id": "94", "infons": {"identifier": "1565", "type": "Gene", "ncbi_homologene": "133550"}, "text": "CYP2D6", "locations": [{"offset": 1381, "length": 6}]}, {"id": "95", "infons": {"identifier": "rs3892097", "type": "Mutation", "subtype": "SNP"}, "text": "rs3892097", "locations": [{"offset": 1392, "length": 9}]}, {"id": "96", "infons": {"identifier": "1565", "type": "Gene", "ncbi_homologene": "133550"}, "text": "CYP2D6", "locations": [{"offset": 1403, "length": 6}]}, {"id": "97", "infons": {"identifier": "rs1065852", "type": "Mutation", "subtype": "SNP"}, "text": "rs1065852", "locations": [{"offset": 1417, "length": 9}]}, {"id": "98", "infons": {"identifier": "1565", "type": "Gene", "ncbi_homologene": "133550"}, "text": "CYP2D6", "locations": [{"offset": 1428, "length": 6}]}, {"id": "99", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1508, "length": 8}]}, {"id": "100", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 1543, "length": 6}]}, {"id": "101", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 1554, "length": 8}]}, {"id": "102", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1592, "length": 8}]}, {"id": "103", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 1613, "length": 6}]}, {"id": "104", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 1627, "length": 8}]}, {"id": "105", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1695, "length": 5}]}, {"id": "106", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 1753, "length": 6}]}, {"id": "107", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 1764, "length": 8}]}, {"id": "108", "infons": {"identifier": "9177", "type": "Gene", "ncbi_homologene": "38131"}, "text": "5-HT3B", "locations": [{"offset": 1877, "length": 6}]}, {"id": "109", "infons": {"identifier": "1565", "type": "Gene", "ncbi_homologene": "133550"}, "text": "CYP2D6", "locations": [{"offset": 1908, "length": 6}]}, {"id": "110", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 1985, "length": 6}]}, {"id": "111", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1992, "length": 8}]}, {"id": "112", "infons": {"identifier": "-", "type": "Chemical"}, "text": "CTG", "locations": [{"offset": 2063, "length": 3}]}, {"id": "113", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2084, "length": 5}]}, {"id": "114", "infons": {"identifier": "MESH:D009325", "type": "Disease"}, "text": "nausea", "locations": [{"offset": 2159, "length": 6}]}, {"id": "115", "infons": {"identifier": "MESH:D014839", "type": "Disease"}, "text": "vomiting", "locations": [{"offset": 2170, "length": 8}]}], "relations": []}], "relations": [], "pmid": 21840870, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D014839", "gene@1565", "disease@MESH:D009369", "chemical@MESH:D002945", "chemical@-", "disease@MESH:D009422", "mutation@rs1045642", "disease@MESH:D009325", "chemical@MESH:D003907", "species@9606", "mutation@rs3892097", "mutation@rs2032582", "chemical@MESH:D017294", "mutation@rs1128503", "gene@5243", "chemical@MESH:D008787", "mutation@rs45460698", "mutation@rs1065852", "mutation@rs7943062", "mutation@rs4938058", "gene@9177", "mutation@rs16947"], "journal": "Jpn. J. Clin. Oncol.", "year": 2011, "authors": ["Perwitasari DA", "Wessels JA", "van der Straaten RJ", "Baak-Pablo RF", "Mustofa M", "Hakimi M", "Nortier JW", "Gelderblom H", "Guchelaar HJ"]},
{"_id": "21827404|None", "id": "21827404", "infons": {}, "passages": [{"infons": {"journal": "Curr. Pharm. Des.; 2011; 17(26) 2843-51", "year": "2011", "type": "title", "authors": "Rosenhagen MC, Uhr M", "section": "Title"}, "offset": 0, "text": "The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 23, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D001523", "type": "Disease"}, "text": "psychiatric diseases", "locations": [{"offset": 63, "length": 20}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 85, "text": "Polymorphisms in the drug transporter gene ABCB1 account for differences in the clinically efficacy of the most drugs, most likely by influencing their access to the brain. The majority proportion of depressed patients, given a regular dose, do not respond properly or experience severe side effects. One explanation may be the polymorphisms in the drug transporter gene ABCB1, which account for differences in the clinical efficacy of antidepressants, neuroleptics or mood stabilizers most likely by influencing their access to the brain. If patients are treated with a substrate of P-gp, functionally relevant genetic variants in the ABCB1 transporter could influence intracerebral drug concentrations and, thereby, clinical response. The review shows recently investigated clinical impact of ABCB1 variants including the three most important SNPs rs1045642, rs2032582, and rs2032583. In the paper, with respect not to go beyond the scope of this review, we will focus on these three SNPs. The final goal of pharmacogenetics is to help clinicians to choose the best treatment for each individual patient. &gt;From the evidence reviewed in this publication, it is likely that combination of metabolizing and drug target polymorphisms will produce the best prediction for the selection of the optimal dose and optimal drug as a function of the individual` s genetic profile.", "sentences": [], "annotations": [{"id": "16", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 128, "length": 5}]}, {"id": "17", "infons": {"identifier": "MESH:D000275", "type": "Disease"}, "text": "depressed", "locations": [{"offset": 285, "length": 9}]}, {"id": "18", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 295, "length": 8}]}, {"id": "19", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 456, "length": 5}]}, {"id": "20", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 628, "length": 8}]}, {"id": "21", "infons": {"identifier": "283871", "type": "Gene", "ncbi_homologene": "5513"}, "text": "P-gp", "locations": [{"offset": 669, "length": 4}]}, {"id": "22", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 721, "length": 5}]}, {"id": "23", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 880, "length": 5}]}, {"id": "24", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 935, "length": 9}]}, {"id": "25", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 946, "length": 9}]}, {"id": "26", "infons": {"identifier": "rs2032583", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032583", "locations": [{"offset": 961, "length": 9}]}, {"id": "27", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 1183, "length": 7}]}], "relations": []}], "relations": [], "pmid": 21827404, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs2032583", "disease@MESH:D001523", "species@9606", "mutation@rs2032582", "disease@MESH:D000275", "gene@5243", "mutation@rs1045642", "gene@283871"], "journal": "Curr. Pharm. Des.", "year": 2011, "authors": ["Rosenhagen MC", "Uhr M"]},
{"_id": "21806386|None", "id": "21806386", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenomics; 2011 Sep; 12(9) 1293-303. doi:10.2217/pgs.11.70", "year": "2011", "type": "title", "authors": "Santoro A, Felipe CR, Tedesco-Silva H, Medina-Pestana JO, Struchiner CJ, Ojopi EB, Suarez-Kurtz G", "section": "Title"}, "offset": 0, "text": "Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 73, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 83, "text": "AIM: Polymorphisms in the CYP3A5 and ABCB1 genes have been investigated as modulators of the pharmacokinetics and clinical effects of cyclosporine (CSA) and tacrolimus (TAC) in European, North American and Asian populations, with controversial results. The extensive variation in worldwide frequency distribution of CYP3A5 and ABCB1 polymorphisms is a caveat against the extrapolation of these data to the heterogeneous and admixed Brazilian population. We investigated the effect of CYP3A5 and ABCB1 polymorphisms on CSA and TAC dose-adjusted trough concentration (C0/dose) in Brazilian renal transplant recipients, during the first 3 months post-transplantation. MATERIALS &amp; METHODS: Patients receiving CSA (n = 150) or TAC (n = 151) were genotyped for CYP3A5*3 (rs776746, 6986A&gt;G), *6 (rs10264272, 14690G&gt;A) and *7 (rs41303343, 27131-27132insT) and for ABCB1 1236C&gt;T (rs1128503), 2677G&gt;T/A (rs2032582) and 3435C&gt;T (rs1045642) polymorphisms. We explored the effects of CYP3A5 and ABCB1 polymorphisms, clinical and demographical characteristics on CSA and TAC C0/dose under a two-step data analysis strategy by fitting a longitudinal mixed-effects model to the data; first to select the important covariates under a univariate setting and then to fit the final multivariate model. RESULTS: C0/dose of TAC was associated with the number of CYP3A5-defective alleles, in a gene-dose manner, throughout the observation period, whereas C0/dose of CSA was associated with body surface area and prednisone dosing. No other significant associations were detected. CONCLUSION: Individual adjustment of the initial TAC dose according to the CYP3A5 haplotypes comprising the CYP3A5*3, *6 and *7 defective alleles might prove beneficial to Brazilian renal transplant recipients and should be further investigated in prospective trials.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 109, "length": 6}]}, {"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 120, "length": 5}]}, {"id": "32", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 217, "length": 12}]}, {"id": "33", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "CSA", "locations": [{"offset": 231, "length": 3}]}, {"id": "34", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 240, "length": 10}]}, {"id": "35", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "TAC", "locations": [{"offset": 252, "length": 3}]}, {"id": "36", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 399, "length": 6}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 410, "length": 5}]}, {"id": "38", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 567, "length": 6}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 578, "length": 5}]}, {"id": "40", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "CSA", "locations": [{"offset": 601, "length": 3}]}, {"id": "41", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 773, "length": 8}]}, {"id": "42", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 842, "length": 6}]}, {"id": "43", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 852, "length": 8}]}, {"id": "44", "infons": {"identifier": "rs10264272", "type": "Mutation", "subtype": "SNP"}, "text": "rs10264272", "locations": [{"offset": 879, "length": 10}]}, {"id": "45", "infons": {"identifier": "rs41303343", "type": "Mutation", "subtype": "SNP"}, "text": "rs41303343", "locations": [{"offset": 912, "length": 10}]}, {"id": "46", "infons": {"identifier": "rs41303343", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "c.27131_27132insT;RS#:41303343", "hgvs": "c.27131_27132insT", "identifiers": ["rs41303343"]}, "text": "27131-27132insT", "locations": [{"offset": 924, "length": 15}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 949, "length": 5}]}, {"id": "48", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 967, "length": 9}]}, {"id": "49", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 993, "length": 9}]}, {"id": "50", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1020, "length": 9}]}, {"id": "51", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1073, "length": 6}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1084, "length": 5}]}, {"id": "53", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1442, "length": 6}]}, {"id": "54", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "CSA", "locations": [{"offset": 1545, "length": 3}]}, {"id": "55", "infons": {"identifier": "MESH:D011241", "type": "Chemical"}, "text": "prednisone", "locations": [{"offset": 1591, "length": 10}]}, {"id": "56", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1734, "length": 6}]}, {"id": "57", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1767, "length": 6}]}], "relations": []}], "relations": [], "pmid": 21806386, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D016572", "mutation@rs1128503", "species@9606", "chemical@MESH:D011241", "mutation@rs2032582", "mutation@rs776746", "mutation@rs41303343", "chemical@MESH:D016559", "gene@5243", "gene@1577", "mutation@rs1045642", "mutation@rs10264272"], "journal": "Pharmacogenomics", "year": 2011, "authors": ["Santoro A", "Felipe CR", "Tedesco-Silva H", "Medina-Pestana JO", "Struchiner CJ", "Ojopi EB", "Suarez-Kurtz G"]},
{"_id": "21705081|None", "id": "21705081", "infons": {}, "passages": [{"infons": {"journal": "Leuk. Res.; 2011 Nov; 35(11) 1457-63. doi:10.1016/j.leukres.2011.05.033", "year": "2011", "type": "title", "authors": "Drain S, Flannely L, Drake MB, Kettle P, Orr N, Bjourson AJ, Catherwood MA, Alexander HD", "section": "Title"}, "offset": 0, "text": "Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 41, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D009101", "type": "Disease"}, "text": "myeloma", "locations": [{"offset": 67, "length": 7}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 76, "text": "Multi-drug resistance (MDR) leads to impaired treatment efficacy in all forms of malignancy. The main forms of MDR are thought to be mediated by the substrate transporting actions of certain adenosine triphosphate binding cassette (ABC) transport proteins. The genes ABCB1, ABCB4, ABCC1, ABCG2 and LRP1 have been identified as the most prominent contributors to clinically significant MDR. To date, no study has investigated the expression of these genes in plasma cell myeloma (PCM), or attempted to relate their expression to the incidence of relapse and/or stage at presentation. Here, we show that ABCB4 may be a prominent mediator of tumour cell MDR within PCM. Additionally, there are three SNPs (rs1045642, rs2032582 and rs1128503) within the most widely studied of these genes, ABCB1, which have been suggested to have a potential impact on OS in PCM and which may form a haplotype in ABCB1. rs1045642 in ABCB1 appears to be the only SNP affecting OS within the PCM patients studied, with minimal linkage disequilibrium demonstrated between it and rs2032582 and rs1128503.", "sentences": [], "annotations": [{"id": "23", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "malignancy", "locations": [{"offset": 157, "length": 10}]}, {"id": "24", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 343, "length": 5}]}, {"id": "25", "infons": {"identifier": "5244", "type": "Gene", "ncbi_homologene": "136368"}, "text": "ABCB4", "locations": [{"offset": 350, "length": 5}]}, {"id": "26", "infons": {"identifier": "4363", "type": "Gene", "ncbi_homologene": "133779"}, "text": "ABCC1", "locations": [{"offset": 357, "length": 5}]}, {"id": "27", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 364, "length": 5}]}, {"id": "28", "infons": {"identifier": "4035", "type": "Gene", "ncbi_homologene": "1744"}, "text": "LRP1", "locations": [{"offset": 374, "length": 4}]}, {"id": "29", "infons": {"identifier": "MESH:D009101", "type": "Disease"}, "text": "myeloma", "locations": [{"offset": 546, "length": 7}]}, {"id": "30", "infons": {"identifier": "5244", "type": "Gene", "ncbi_homologene": "136368"}, "text": "ABCB4", "locations": [{"offset": 678, "length": 5}]}, {"id": "31", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumour", "locations": [{"offset": 715, "length": 6}]}, {"id": "32", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 779, "length": 9}]}, {"id": "33", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 790, "length": 9}]}, {"id": "34", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 804, "length": 9}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 862, "length": 5}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 969, "length": 5}]}, {"id": "37", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 976, "length": 9}]}, {"id": "38", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 989, "length": 5}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1050, "length": 8}]}, {"id": "40", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1132, "length": 9}]}, {"id": "41", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1146, "length": 9}]}], "relations": []}], "relations": [], "pmid": 21705081, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@4035", "disease@MESH:D009101", "gene@5244", "mutation@rs1128503", "gene@9429", "species@9606", "gene@4363", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "disease@MESH:D009369"], "journal": "Leuk. Res.", "year": 2011, "authors": ["Drain S", "Flannely L", "Drake MB", "Kettle P", "Orr N", "Bjourson AJ", "Catherwood MA", "Alexander HD"]},
{"_id": "21553324|None", "id": "21553324", "infons": {}, "passages": [{"infons": {"journal": "Pediatr. Nephrol.; 2011 Nov; 26(11) 1981-8. doi:10.1007/s00467-011-1903-0", "year": "2011", "type": "title", "authors": "Choi HJ, Cho HY, Ro H, Lee SH, Han KH, Lee H, Kang HG, Ha IS, Choi Y, Cheong HI", "section": "Title"}, "offset": 0, "text": "Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 21, "length": 4}]}, {"id": "5", "infons": {"identifier": "4282", "type": "Gene", "ncbi_homologene": "55655"}, "text": "MIF", "locations": [{"offset": 30, "length": 3}]}, {"id": "6", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 43, "length": 8}]}, {"id": "7", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "nephrotic syndrome", "locations": [{"offset": 57, "length": 18}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 77, "text": "Oral steroid treatment is the first line of therapy for childhood nephrotic syndrome (NS). Nonetheless, some patients are resistant to this treatment. Many efforts have been made to explain the differences in the response to steroid treatment in patients with NS based on the genetic background. We have investigated single nucleotide polymorphisms of the MDR1 [C1236T (rs1128503), G2677T/A (rs2032582), and C3435T (rs1045642)] and MIF (G-173C, rs755622) genes in 170 children with NS. Of these children, 69 (40.6%) were initial steroid non-responders, and 23 (13.5% of total) developed chronic kidney disease. Renal biopsy findings, which were available for 101 patients, showed that 35 patients had minimal change lesion and 66 had focal segmental glomerulosclerosis. The frequencies of the MDR1 1236 CC (18.8 vs 7.2%) or TC (53.5 vs 43.5%) genotype and C allele (45.5 vs 29.0%) were significantly higher in the initial steroid responders than in the non-responders. Analysis of MDR1 three-marker haplotypes revealed that the frequency of the TGC haplotype was significantly lower in the initial steroid responders than in the non-responders (15.8 vs 29.0%). There was no association between the MIF G-173C polymorphism and clinical parameters, renal histological findings, and steroid responsiveness. These data suggest that the initial steroid response in children with NS may be influenced by genetic variations in the MDR1 gene.", "sentences": [], "annotations": [{"id": "45", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 82, "length": 7}]}, {"id": "46", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "nephrotic syndrome", "locations": [{"offset": 143, "length": 18}]}, {"id": "47", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 163, "length": 2}]}, {"id": "48", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 186, "length": 8}]}, {"id": "49", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 302, "length": 7}]}, {"id": "50", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 323, "length": 8}]}, {"id": "51", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 337, "length": 2}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 433, "length": 4}]}, {"id": "53", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 439, "length": 6}]}, {"id": "54", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 447, "length": 9}]}, {"id": "55", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 459, "length": 8}]}, {"id": "56", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 469, "length": 9}]}, {"id": "57", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 485, "length": 6}]}, {"id": "58", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 493, "length": 9}]}, {"id": "59", "infons": {"identifier": "4282", "type": "Gene", "ncbi_homologene": "55655"}, "text": "MIF", "locations": [{"offset": 509, "length": 3}]}, {"id": "60", "infons": {"identifier": "rs755622", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.-173G>C;RS#:755622", "hgvs": "c.-173G>C", "identifiers": ["rs755622"]}, "text": "G-173C", "locations": [{"offset": 514, "length": 6}]}, {"id": "61", "infons": {"identifier": "rs755622", "type": "Mutation", "subtype": "SNP"}, "text": "rs755622", "locations": [{"offset": 522, "length": 8}]}, {"id": "62", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 545, "length": 8}]}, {"id": "63", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 559, "length": 2}]}, {"id": "64", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 572, "length": 8}]}, {"id": "65", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 606, "length": 7}]}, {"id": "66", "infons": {"identifier": "MESH:D051436", "type": "Disease"}, "text": "chronic kidney disease", "locations": [{"offset": 664, "length": 22}]}, {"id": "67", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 740, "length": 8}]}, {"id": "68", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 765, "length": 8}]}, {"id": "69", "infons": {"identifier": "MESH:D005921", "type": "Disease"}, "text": "glomerulosclerosis", "locations": [{"offset": 827, "length": 18}]}, {"id": "70", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 870, "length": 4}]}, {"id": "71", "infons": {"identifier": "MESH:D013667", "type": "Chemical"}, "text": "TC", "locations": [{"offset": 901, "length": 2}]}, {"id": "72", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 999, "length": 7}]}, {"id": "73", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1058, "length": 4}]}, {"id": "74", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1175, "length": 7}]}, {"id": "75", "infons": {"identifier": "4282", "type": "Gene", "ncbi_homologene": "55655"}, "text": "MIF", "locations": [{"offset": 1275, "length": 3}]}, {"id": "76", "infons": {"identifier": "rs755622", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.-173G>C;RS#:755622", "hgvs": "c.-173G>C", "identifiers": ["rs755622"]}, "text": "G-173C", "locations": [{"offset": 1279, "length": 6}]}, {"id": "77", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1357, "length": 7}]}, {"id": "78", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1417, "length": 7}]}, {"id": "79", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 1437, "length": 8}]}, {"id": "80", "infons": {"identifier": "MESH:D009404", "type": "Disease"}, "text": "NS", "locations": [{"offset": 1451, "length": 2}]}, {"id": "81", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1501, "length": 4}]}], "relations": []}], "relations": [], "pmid": 21553324, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D005921", "disease@MESH:D009404", "mutation@rs755622", "species@9606", "mutation@c.2677G>T,A", "chemical@MESH:D013667", "disease@MESH:D051436", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "gene@4282", "chemical@MESH:D013256"], "journal": "Pediatr. Nephrol.", "year": 2011, "authors": ["Choi HJ", "Cho HY", "Ro H", "Lee SH", "Han KH", "Lee H", "Kang HG", "Ha IS", "Choi Y", "Cheong HI"]},
{"_id": "21544031|None", "id": "21544031", "infons": {}, "passages": [{"infons": {"journal": "Transplantation; 2011 May 27; 91(10) 1098-102. doi:10.1097/TP.0b013e3182177502", "year": "2011", "type": "title", "authors": "Metalidis C, Lerut E, Naesens M, Kuypers DR", "section": "Title"}, "offset": 0, "text": "Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 14, "length": 6}]}, {"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 25, "length": 14}]}, {"id": "6", "infons": {"identifier": "23523", "type": "Gene", "ncbi_homologene": "49307"}, "text": "calcineurin inhibitor", "locations": [{"offset": 87, "length": 21}]}, {"id": "7", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 109, "length": 14}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 125, "text": "BACKGROUND: Susceptibility to calcineurin inhibitor nephrotoxicity (CNIT) after solid organ transplantation could be related to an interindividual variability in renal expression and function of the metabolizing cytochrome P450 3A5 (CYP3A5) isoenzyme and of the multidrug efflux transporter P-glycoprotein (P-gp, ABCB1). METHODS: We compared renal expression of CYP3A5 and P-gp, measured by immunohistochemistry, in 32 renal allograft biopsies with de novo arteriolar hyalinosis as a sign of CNIT with a control group, consisting of normal protocol allograft biopsies (n=50) and protocol biopsies demonstrating alloimmune injury (n=21). In addition, we studied the association between renal expression and donor and recipient single-nucleotide polymorphisms CYP3A5 A6986G (rs776746), ABCB1 C3435T (rs1045642), and G2677T (rs2032582). RESULTS: CYP3A5 positivity at the brushborder of the proximal tubules was present in 47% of CNIT and 14% of control biopsies (P&lt;0.01). In contrast, brushborder staining for CYP3A5 in distal tubules was present in 10% of CNIT and 39% of control biopsies (P&lt;0.01). No significant association between tubular cell P-gp expression and CNIT was detected. The presence of genetic polymorphisms CYP3A5 A6986G and ABCB1 C3435T and G2677T in donors and recipients was not predictive of the renal expression profile of these molecules. CONCLUSIONS: Based on retrospectively collected data of 103 renal transplant recipients receiving tacrolimus in combination with mycophenolate mofetil and corticosteroids, we found that renal expression and localization of CYP3A5 but not P-gp is associated with the occurrence of CNIT. Common genetic polymorphisms in these proteins did not influence their expression profile as measured by immunohistochemistry.", "sentences": [], "annotations": [{"id": "40", "infons": {"identifier": "23523", "type": "Gene", "ncbi_homologene": "49307"}, "text": "calcineurin inhibitor", "locations": [{"offset": 155, "length": 21}]}, {"id": "41", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 177, "length": 14}]}, {"id": "42", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "cytochrome P450 3A5", "locations": [{"offset": 337, "length": 19}]}, {"id": "43", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 358, "length": 6}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 416, "length": 14}]}, {"id": "45", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 432, "length": 4}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 438, "length": 5}]}, {"id": "47", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 487, "length": 6}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 498, "length": 4}]}, {"id": "49", "infons": {"identifier": "MESH:D057770", "type": "Disease"}, "text": "hyalinosis", "locations": [{"offset": 593, "length": 10}]}, {"id": "50", "infons": {"identifier": "MESH:C536394", "type": "Disease"}, "text": "alloimmune injury", "locations": [{"offset": 736, "length": 17}]}, {"id": "51", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 831, "length": 5}]}, {"id": "52", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 883, "length": 6}]}, {"id": "53", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.6986A>G;RS#:776746", "hgvs": "g.6986A>G", "identifiers": ["rs776746"]}, "text": "A6986G", "locations": [{"offset": 890, "length": 6}]}, {"id": "54", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 898, "length": 8}]}, {"id": "55", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 909, "length": 5}]}, {"id": "56", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 915, "length": 6}]}, {"id": "57", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 923, "length": 9}]}, {"id": "58", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T;RS#:2032582", "hgvs": "c.2677G>T", "identifiers": ["rs2032582"]}, "text": "G2677T", "locations": [{"offset": 939, "length": 6}]}, {"id": "59", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 947, "length": 9}]}, {"id": "60", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 968, "length": 6}]}, {"id": "61", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1135, "length": 6}]}, {"id": "62", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 1276, "length": 4}]}, {"id": "63", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1353, "length": 6}]}, {"id": "64", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.6986A>G;RS#:776746", "hgvs": "g.6986A>G", "identifiers": ["rs776746"]}, "text": "A6986G", "locations": [{"offset": 1360, "length": 6}]}, {"id": "65", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1371, "length": 5}]}, {"id": "66", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 1377, "length": 6}]}, {"id": "67", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T;RS#:2032582", "hgvs": "c.2677G>T", "identifiers": ["rs2032582"]}, "text": "G2677T", "locations": [{"offset": 1388, "length": 6}]}, {"id": "68", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1589, "length": 10}]}, {"id": "69", "infons": {"identifier": "MESH:D009173", "type": "Chemical"}, "text": "mycophenolate mofetil", "locations": [{"offset": 1620, "length": 21}]}, {"id": "70", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1714, "length": 6}]}, {"id": "71", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 1729, "length": 4}]}], "relations": []}], "relations": [], "pmid": 21544031, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@23523", "species@9606", "disease@MESH:C536394", "disease@MESH:D057770", "mutation@rs2032582", "mutation@rs776746", "chemical@MESH:D009173", "gene@5243", "disease@MESH:D007674", "gene@1577", "mutation@rs1045642", "chemical@MESH:D016559"], "journal": "Transplantation", "year": 2011, "authors": ["Metalidis C", "Lerut E", "Naesens M", "Kuypers DR"]},
{"_id": "21468756|None", "id": "21468756", "infons": {}, "passages": [{"infons": {"journal": "Cancer Chemother. Pharmacol.; 2011 Jun; 67(6) 1471-8. doi:10.1007/s00280-011-1625-9", "year": "2011", "type": "title", "authors": "Chew SC, Singh O, Chen X, Ramasamy RD, Kulkarni T, Lee EJ, Tan EH, Lim WT, Chowbay B", "section": "Title"}, "offset": 0, "text": "The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.", "sentences": [], "annotations": [{"id": "9", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 15, "length": 6}]}, {"id": "10", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 23, "length": 6}]}, {"id": "11", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 31, "length": 5}]}, {"id": "12", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 38, "length": 5}]}, {"id": "13", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 45, "length": 5}]}, {"id": "14", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 55, "length": 7}]}, {"id": "15", "infons": {"identifier": "MESH:D000077143", "type": "Chemical"}, "text": "docetaxel", "locations": [{"offset": 143, "length": 9}]}, {"id": "16", "infons": {"identifier": "MESH:D000077274", "type": "Disease"}, "text": "nasopharyngeal carcinoma", "locations": [{"offset": 156, "length": 24}]}, {"id": "17", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 181, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 191, "text": "PURPOSE: This exploratory study aimed to explain the interindividual variabilities of docetaxel pharmacokinetics and pharmacodynamics in Asian nasopharyngeal carcinoma patients (n = 54) through the genotyping of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 genes. METHODS: Docetaxel was administered over 1 h on days 1, 8, and 15 every 28 days at 30 mg/m(2)/dose. Genomic DNA was isolated from peripheral blood and genotyped for the selected polymorphisms in the candidate genes. Docetaxel pharmacokinetic parameters were estimated by non-compartmental modelling. RESULTS: Patients homozygous for the variant allele (GG) of SLCO1B3 rs11045585 (IVS12-5676A &gt; G) had significantly higher area under the plasma concentration-time curve of docetaxel (P = 0.026) and lower clearance (P = 0.036) compared to patients with AA/AG genotypes. Patients harbouring the heterozygous genotype (GA + GT + TA) for ABCB1 rs2032582 (2677G &gt; T/A) had the highest percentage decrease in nadir haemoglobin from cycle 1 baseline compared to those with GG/TT genotypes (P = 0.006). Similar trend was observed for ABCB1 rs1045642 (3435C &gt; T) with heterozygotes (CT) having the highest percentage decrease in nadir haemoglobin from cycle 1 baseline compared to those with CC/TT genotypes (P = 0.066). CONCLUSIONS: This study suggests that the cooperative influence of functional polymorphisms in SLCO1B3 and ABCB1 genes may be responsible for the interindividual variability in docetaxel disposition in Asian nasopharyngeal cancer patients.", "sentences": [], "annotations": [{"id": "44", "infons": {"identifier": "MESH:D000077143", "type": "Chemical"}, "text": "docetaxel", "locations": [{"offset": 277, "length": 9}]}, {"id": "45", "infons": {"identifier": "MESH:D000077274", "type": "Disease"}, "text": "nasopharyngeal carcinoma", "locations": [{"offset": 334, "length": 24}]}, {"id": "46", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 359, "length": 8}]}, {"id": "47", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 403, "length": 6}]}, {"id": "48", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 411, "length": 6}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 419, "length": 5}]}, {"id": "50", "infons": {"identifier": "1244", "type": "Gene", "ncbi_homologene": "68052"}, "text": "ABCC2", "locations": [{"offset": 426, "length": 5}]}, {"id": "51", "infons": {"identifier": "9429", "type": "Gene", "ncbi_homologene": "55852"}, "text": "ABCG2", "locations": [{"offset": 433, "length": 5}]}, {"id": "52", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 443, "length": 7}]}, {"id": "53", "infons": {"identifier": "MESH:D000077143", "type": "Chemical"}, "text": "Docetaxel", "locations": [{"offset": 467, "length": 9}]}, {"id": "54", "infons": {"identifier": "MESH:D000077143", "type": "Chemical"}, "text": "Docetaxel", "locations": [{"offset": 674, "length": 9}]}, {"id": "55", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 767, "length": 8}]}, {"id": "56", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 818, "length": 7}]}, {"id": "57", "infons": {"identifier": "rs11045585", "type": "Mutation", "subtype": "SNP"}, "text": "rs11045585", "locations": [{"offset": 826, "length": 10}]}, {"id": "58", "infons": {"identifier": "MESH:D000077143", "type": "Chemical"}, "text": "docetaxel", "locations": [{"offset": 933, "length": 9}]}, {"id": "59", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 999, "length": 8}]}, {"id": "60", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 1030, "length": 8}]}, {"id": "61", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1095, "length": 5}]}, {"id": "62", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1101, "length": 9}]}, {"id": "63", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1290, "length": 5}]}, {"id": "64", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1296, "length": 9}]}, {"id": "65", "infons": {"identifier": "28234", "type": "Gene", "ncbi_homologene": "75119"}, "text": "SLCO1B3", "locations": [{"offset": 1574, "length": 7}]}, {"id": "66", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1586, "length": 5}]}, {"id": "67", "infons": {"identifier": "MESH:D000077143", "type": "Chemical"}, "text": "docetaxel", "locations": [{"offset": 1656, "length": 9}]}, {"id": "68", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 1702, "length": 6}]}, {"id": "69", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1709, "length": 8}]}], "relations": []}], "relations": [], "pmid": 21468756, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs11045585", "disease@MESH:D000077274", "gene@1576", "gene@1244", "gene@28234", "species@9606", "disease@MESH:D009369", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "gene@1577", "gene@9429", "chemical@MESH:D000077143"], "journal": "Cancer Chemother. Pharmacol.", "year": 2011, "authors": ["Chew SC", "Singh O", "Chen X", "Ramasamy RD", "Kulkarni T", "Lee EJ", "Tan EH", "Lim WT", "Chowbay B"]},
{"_id": "21287651|None", "id": "21287651", "infons": {}, "passages": [{"infons": {"journal": "Phytother Res; 2011 Aug; 25(8) 1141-7. doi:10.1002/ptr.3405", "year": "2011", "type": "title", "authors": "Kim JH, Kim SR, Song IS, Shin HJ, Kim HS, Lee JH, Ko SG, Shin YC", "section": "Title"}, "offset": 0, "text": "Different transport activity of human triallelic MDR1 893Ala/Ser/Thr variant and its association with herb extracts.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 32, "length": 5}]}, {"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 49, "length": 4}]}, {"id": "6", "infons": {"identifier": "MESH:D012694", "type": "Chemical"}, "text": "Ser", "locations": [{"offset": 61, "length": 3}]}, {"id": "7", "infons": {"identifier": "MESH:D013912", "type": "Chemical"}, "text": "Thr", "locations": [{"offset": 65, "length": 3}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 117, "text": "Individual pharmacokinetic differences for herb-drug interaction have been associated with genetic variations of the multidrug resistance (MDR) gene. A high level expression of MDR protein increases cellular efflux and might decrease drug sensitivity. This study investigated the drug efflux activity difference of human MDR1 triallelic variant 2677G/T/A (rs2032582), as a nonsynonymous 893Ala/Ser/Thr, using Xenopus laevis oocytes and MDR1 overexpressing LLC-PK1 cells. Two MDR1 variants (2667T/893Ser and 2667A/893Thr) were generated using human MDR1 cDNA (2677G/893Ala). No significant difference in the expression of MDR1 893Ala/Ser/Thr was found in X. laevis oocytes. However, the MDR1 2667A/893Thr variant interestingly showed a significant decrease of efflux activity for both digoxin and daunorubicin compared with those of 893Ala and 893Ser variants. In further investigation assessing the inhibitory effects of three herbal extracts on MDR1, 893Ala and 893Ser showed significant decreases of efflux activities in treatments with P. cocos (p = 0.005 for 893Ser) and D. dasycarpus (p = 0.0009 for 893Ala; p = 0.002 for 893Ser) in X. laevis oocytes. The results in this study suggest that herbal medicines could interact with other drugs and change the therapeutic effects depending on the genetic polymorphisms of individuals.", "sentences": [], "annotations": [{"id": "29", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 432, "length": 5}]}, {"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 438, "length": 4}]}, {"id": "31", "infons": {"identifier": "c.2677G,T>A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "2677G/T/A", "locations": [{"offset": 462, "length": 9}]}, {"id": "32", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 473, "length": 9}]}, {"id": "33", "infons": {"identifier": "MESH:D012694", "type": "Chemical"}, "text": "Ser", "locations": [{"offset": 511, "length": 3}]}, {"id": "34", "infons": {"identifier": "MESH:D013912", "type": "Chemical"}, "text": "Thr", "locations": [{"offset": 515, "length": 3}]}, {"id": "35", "infons": {"identifier": "8355", "type": "Species"}, "text": "Xenopus laevis", "locations": [{"offset": 526, "length": 14}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 553, "length": 4}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 592, "length": 4}]}, {"id": "38", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 659, "length": 5}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 665, "length": 4}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 738, "length": 4}]}, {"id": "41", "infons": {"identifier": "MESH:D012694", "type": "Chemical"}, "text": "Ser", "locations": [{"offset": 750, "length": 3}]}, {"id": "42", "infons": {"identifier": "MESH:D013912", "type": "Chemical"}, "text": "Thr", "locations": [{"offset": 754, "length": 3}]}, {"id": "43", "infons": {"identifier": "8355", "type": "Species"}, "text": "X. laevis", "locations": [{"offset": 771, "length": 9}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 803, "length": 4}]}, {"id": "45", "infons": {"identifier": "MESH:D004077", "type": "Chemical"}, "text": "digoxin", "locations": [{"offset": 901, "length": 7}]}, {"id": "46", "infons": {"identifier": "MESH:D003630", "type": "Chemical"}, "text": "daunorubicin", "locations": [{"offset": 913, "length": 12}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1063, "length": 4}]}, {"id": "48", "infons": {"identifier": "714465", "type": "Species"}, "text": "D. dasycarpus", "locations": [{"offset": 1192, "length": 13}]}, {"id": "49", "infons": {"identifier": "8355", "type": "Species"}, "text": "X. laevis", "locations": [{"offset": 1255, "length": 9}]}], "relations": []}], "relations": [], "pmid": 21287651, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@8355", "species@714465", "chemical@MESH:D004077", "chemical@MESH:D013912", "species@9606", "chemical@MESH:D003630", "mutation@c.2677G,T>A", "mutation@rs2032582", "gene@5243", "chemical@MESH:D012694"], "journal": "Phytother Res", "year": 2011, "authors": ["Kim JH", "Kim SR", "Song IS", "Shin HJ", "Kim HS", "Lee JH", "Ko SG", "Shin YC"]},
{"_id": "21185600|None", "id": "21185600", "infons": {}, "passages": [{"infons": {"journal": "Leuk. Res.; 2011 Aug; 35(8) 1014-9. doi:10.1016/j.leukres.2010.12.004", "year": "2011", "type": "title", "authors": "Maffioli M, Cam\u00f3s M, Gaya A, Hern\u00e1ndez-Boluda JC, Alvarez-Larr\u00e1n A, Domingo A, Granell M, Guillem V, Vallansot R, Costa D, Bellosillo B, Colomer D, Cervantes F", "section": "Title"}, "offset": 0, "text": "Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "6580", "type": "Gene", "ncbi_homologene": "20665"}, "text": "hOCT1", "locations": [{"offset": 49, "length": 5}]}, {"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 59, "length": 4}]}, {"id": "7", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "imatinib", "locations": [{"offset": 90, "length": 8}]}, {"id": "8", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 102, "length": 8}]}, {"id": "9", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "chronic myeloid leukemia", "locations": [{"offset": 146, "length": 24}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 172, "text": "The association between seven polymorphisms in the genes hOCT1 and MDR1, encoding for imatinib transporter proteins, and the response to imatinib 400mg/daily was investigated in 65 patients newly diagnosed with chronic-phase chronic myeloid leukemia. The AA genotype at the rs6935207 hOCT1 polymorphic locus was not detected in patients with inadequate response to imatinib. The CC genotype at the rs1045642 (C3435T) MDR1 locus was associated with primary failure, whereas a T allele at the rs2032582 (G2677T/A) MDR1 locus seemed to protect from primary failure. Beside, the MDR1 haplotype 1236T-2677G-3435C was more frequently found in patients primarily resistant to imatinib.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "6580", "type": "Gene", "ncbi_homologene": "20665"}, "text": "hOCT1", "locations": [{"offset": 229, "length": 5}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 239, "length": 4}]}, {"id": "33", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "imatinib", "locations": [{"offset": 258, "length": 8}]}, {"id": "34", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "imatinib", "locations": [{"offset": 309, "length": 8}]}, {"id": "35", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 353, "length": 8}]}, {"id": "36", "infons": {"identifier": "MESH:D015464", "type": "Disease"}, "text": "chronic myeloid leukemia", "locations": [{"offset": 397, "length": 24}]}, {"id": "37", "infons": {"identifier": "rs6935207", "type": "Mutation", "subtype": "SNP"}, "text": "rs6935207", "locations": [{"offset": 446, "length": 9}]}, {"id": "38", "infons": {"identifier": "6580", "type": "Gene", "ncbi_homologene": "20665"}, "text": "hOCT1", "locations": [{"offset": 456, "length": 5}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 500, "length": 8}]}, {"id": "40", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "imatinib", "locations": [{"offset": 537, "length": 8}]}, {"id": "41", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 570, "length": 9}]}, {"id": "42", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 581, "length": 6}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 589, "length": 4}]}, {"id": "44", "infons": {"identifier": "MESH:D017093", "type": "Disease"}, "text": "primary failure", "locations": [{"offset": 620, "length": 15}]}, {"id": "45", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 663, "length": 9}]}, {"id": "46", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 674, "length": 8}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 684, "length": 4}]}, {"id": "48", "infons": {"identifier": "MESH:D017093", "type": "Disease"}, "text": "primary failure", "locations": [{"offset": 718, "length": 15}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 747, "length": 4}]}, {"id": "50", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 809, "length": 8}]}, {"id": "51", "infons": {"identifier": "MESH:D000068877", "type": "Chemical"}, "text": "imatinib", "locations": [{"offset": 841, "length": 8}]}], "relations": []}], "relations": [], "pmid": 21185600, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@6580", "species@9606", "mutation@c.2677G>T,A", "chemical@MESH:D000068877", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "mutation@rs6935207", "disease@MESH:D017093", "disease@MESH:D015464"], "journal": "Leuk. Res.", "year": 2011, "authors": ["Maffioli M", "Cam\u00f3s M", "Gaya A", "Hern\u00e1ndez-Boluda JC", "Alvarez-Larr\u00e1n A", "Domingo A", "Granell M", "Guillem V", "Vallansot R", "Costa D", "Bellosillo B", "Colomer D", "Cervantes F"]},
{"_id": "21172166|None", "id": "21172166", "infons": {}, "passages": [{"infons": {"journal": "J Psychiatry Neurosci; 2011 Mar; 36(2) 87-113. doi:10.1503/jpn.100059", "year": "2011", "article-id_pmc": "PMC3044192", "type": "title", "authors": "Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A", "section": "Title"}, "offset": 0, "text": "Pharmacogenetics of antidepressant response.", "sentences": [], "annotations": [], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 45, "text": "Personalized medicine - the adaptation of therapies based on an individual's genetic and molecular profile - is one of the most promising aspects of modern medicine. The identification of the relation between genotype and drug response, including both the therapeutic effect and side effect profile, is expected to deeply affect medical practice. In this paper, we review the current knowledge about the genes related to antidepressant treatment response and provide methodologic proposals for future studies. We have mainly focused on genes associated with pharmacodynamics, for which a list of promising genes has been identified despite some inconsistency across studies. We have also synthesized the main results for pharmacokinetic genes, although so far they seem less relevant than those for pharmaco dynamic genes. We discuss possible reasons for these inconsistent findings and propose new study designs.", "sentences": [], "annotations": [], "relations": []}], "relations": [], "pmid": 21172166, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": [], "journal": "J Psychiatry Neurosci", "year": 2011, "authors": ["Porcelli S", "Drago A", "Fabbri C", "Gibiino S", "Calati R", "Serretti A"]},
{"_id": "21102498|None", "id": "21102498", "infons": {}, "passages": [{"infons": {"journal": "Bone Marrow Transplant.; 2011 Aug; 46(8) 1113-7. doi:10.1038/bmt.2010.273", "year": "2011", "type": "title", "authors": "Onizuka M, Kunii N, Toyosaki M, Machida S, Ohgiya D, Ogawa Y, Kawada H, Inoko H, Ando K", "section": "Title"}, "offset": 0, "text": "Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "4051", "type": "Gene", "ncbi_homologene": "73902"}, "text": "Cytochrome P450", "locations": [{"offset": 0, "length": 15}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 142, "text": "Calcineurin inhibitors are necessary as immunosuppressants during hematopoietic SCT (HSCT) to prevent alloreactivity, but have unfortunate toxicities. So, we investigated the association of gene polymorphisms with the initial calcineurin inhibitor concentration and the subsequent drug dose from day 1 to day 28 among patients who underwent HSCT at a single institution. We analyzed 58 serial cases of Japanese patients receiving GVHD prophylaxis with CsA (21 cases) or tacrolimus (37 cases). We investigated eight single-nucleotide polymorphisms: rs4244285 (CYP2C19), rs15524, rs4646450, rs3800959, rs776746 (CYP3A5), rs1128503, rs2032582 and rs1045642 (MDR1). The CsA concentration was significantly higher when the genotype of CYP3A5 rs15524 was T/T (P=0.044) or rs776746 was G/G (P=0.027). The CYP3A5 rs776746 and rs4646450 genotypes were also associated with tacrolimus concentration (P=0.013 and P=0.0058, respectively). The dosage of tacrolimus was remarkably reduced from day -1 to day 28 when the patient had the CYP3A5 rs4646450 C/C and/or rs776746 G/G genotype (P=0.0010 and P=0.0021, respectively). In this study, we show that genetic variation has a predictable effect on the pharmacological responses to calcineurin inhibitors in HSCT patients.", "sentences": [], "annotations": [{"id": "34", "infons": {"identifier": "MESH:D064420", "type": "Disease"}, "text": "toxicities", "locations": [{"offset": 281, "length": 10}]}, {"id": "35", "infons": {"identifier": "23523", "type": "Gene", "ncbi_homologene": "49307"}, "text": "calcineurin inhibitor", "locations": [{"offset": 368, "length": 21}]}, {"id": "36", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 460, "length": 8}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 553, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:D006086", "type": "Disease"}, "text": "GVHD", "locations": [{"offset": 572, "length": 4}]}, {"id": "39", "infons": {"identifier": "-", "type": "Chemical"}, "text": "CsA", "locations": [{"offset": 594, "length": 3}]}, {"id": "40", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 612, "length": 10}]}, {"id": "41", "infons": {"identifier": "rs4244285", "type": "Mutation", "subtype": "SNP"}, "text": "rs4244285", "locations": [{"offset": 690, "length": 9}]}, {"id": "42", "infons": {"identifier": "1557", "type": "Gene", "ncbi_homologene": "133565"}, "text": "CYP2C19", "locations": [{"offset": 701, "length": 7}]}, {"id": "43", "infons": {"identifier": "rs15524", "type": "Mutation", "subtype": "SNP"}, "text": "rs15524", "locations": [{"offset": 711, "length": 7}]}, {"id": "44", "infons": {"identifier": "rs4646450", "type": "Mutation", "subtype": "SNP"}, "text": "rs4646450", "locations": [{"offset": 720, "length": 9}]}, {"id": "45", "infons": {"identifier": "rs3800959", "type": "Mutation", "subtype": "SNP"}, "text": "rs3800959", "locations": [{"offset": 731, "length": 9}]}, {"id": "46", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 742, "length": 8}]}, {"id": "47", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 752, "length": 6}]}, {"id": "48", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 761, "length": 9}]}, {"id": "49", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 772, "length": 9}]}, {"id": "50", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 786, "length": 9}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 797, "length": 4}]}, {"id": "52", "infons": {"identifier": "-", "type": "Chemical"}, "text": "CsA", "locations": [{"offset": 808, "length": 3}]}, {"id": "53", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 872, "length": 6}]}, {"id": "54", "infons": {"identifier": "rs15524", "type": "Mutation", "subtype": "SNP"}, "text": "rs15524", "locations": [{"offset": 879, "length": 7}]}, {"id": "55", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 908, "length": 8}]}, {"id": "56", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 940, "length": 6}]}, {"id": "57", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 947, "length": 8}]}, {"id": "58", "infons": {"identifier": "rs4646450", "type": "Mutation", "subtype": "SNP"}, "text": "rs4646450", "locations": [{"offset": 960, "length": 9}]}, {"id": "59", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1006, "length": 10}]}, {"id": "60", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1083, "length": 10}]}, {"id": "61", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 1148, "length": 7}]}, {"id": "62", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1164, "length": 6}]}, {"id": "63", "infons": {"identifier": "rs4646450", "type": "Mutation", "subtype": "SNP"}, "text": "rs4646450", "locations": [{"offset": 1171, "length": 9}]}, {"id": "64", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 1192, "length": 8}]}, {"id": "65", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1391, "length": 8}]}], "relations": []}], "relations": [], "pmid": 21102498, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@1557", "disease@MESH:D064420", "gene@23523", "chemical@-", "mutation@rs1128503", "mutation@rs15524", "species@9606", "gene@4051", "mutation@rs2032582", "mutation@rs776746", "chemical@MESH:D016559", "mutation@rs3800959", "gene@1577", "mutation@rs1045642", "gene@5243", "disease@MESH:D006086", "mutation@rs4244285", "mutation@rs4646450"], "journal": "Bone Marrow Transplant.", "year": 2011, "authors": ["Onizuka M", "Kunii N", "Toyosaki M", "Machida S", "Ohgiya D", "Ogawa Y", "Kawada H", "Inoko H", "Ando K"]},
{"_id": "20944127|None", "id": "20944127", "infons": {}, "passages": [{"infons": {"journal": "Anticancer Res.; 2010 Sep; 30(9) 3487-91", "year": "2010", "type": "title", "authors": "Grimm C, Polterauer S, Zeillinger R, Tong D, Heinze G, Wolf A, Natter C, Reinthaller A, Hefler LA", "section": "Title"}, "offset": 0, "text": "Two multidrug-resistance (ABCB1) gene polymorphisms as prognostic parameters in women with ovarian cancer.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 26, "length": 5}]}, {"id": "4", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 80, "length": 5}]}, {"id": "5", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "ovarian cancer", "locations": [{"offset": 91, "length": 14}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 107, "text": "BACKGROUND: The transport protein P-glycoprotein, which is encoded by the multidrug-resistance ABCB1 gene, is crucially involved in the export of taxanes and other cytotoxic substances out of the cell. Treatment response to paclitaxel has been shown to correlate with ABCB1 gene polymorphisms. Data regarding the prognostic value of ABCB1 gene polymorphisms in ovarian cancer patients is conflicting. MATERIALS AND METHODS: The present study evaluates the association of two common ABCB1 gene polymorphisms, namely G2677T/A in exon 21 (rs2032582) and C3435T in exon 26 (rs1045642), and survival in 106 Caucasian women with ovarian cancer. RESULTS: The two ABCB1 gene polymorphisms (G2677T/A and C3435T) were associated neither with disease-free (p=0.8 and p=0.9, respectively) nor with overall survival (p=0.9 and p=0.9, respectively). Tumor stage (p=0.01; p=0.01) and residual tumor mass (p=0.005; p=0.01), but not tumor grade and age at diagnosis were associated with disease-free and overall survival, respectively, in a multivariate analysis. Haplotype analysis did not reveal any association between the combined effect of the two gene polymorphisms and survival. CONCLUSION: In the present study, ABCB1 G2677T/A and ABCB1 C3435T gene polymorphisms were not found to be associated with prognosis in Caucasian women with ovarian cancer.", "sentences": [], "annotations": [{"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 141, "length": 14}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 202, "length": 5}]}, {"id": "34", "infons": {"identifier": "MESH:D043823", "type": "Chemical"}, "text": "taxanes", "locations": [{"offset": 253, "length": 7}]}, {"id": "35", "infons": {"identifier": "MESH:D017239", "type": "Chemical"}, "text": "paclitaxel", "locations": [{"offset": 331, "length": 10}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 375, "length": 5}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 440, "length": 5}]}, {"id": "38", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "ovarian cancer", "locations": [{"offset": 468, "length": 14}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 483, "length": 8}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 589, "length": 5}]}, {"id": "41", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation"}, "text": "G2677T/A", "locations": [{"offset": 622, "length": 8}]}, {"id": "42", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 643, "length": 9}]}, {"id": "43", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 658, "length": 6}]}, {"id": "44", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 677, "length": 9}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 719, "length": 5}]}, {"id": "46", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "ovarian cancer", "locations": [{"offset": 730, "length": 14}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 763, "length": 5}]}, {"id": "48", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation"}, "text": "G2677T/A", "locations": [{"offset": 789, "length": 8}]}, {"id": "49", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 802, "length": 6}]}, {"id": "50", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 985, "length": 5}]}, {"id": "51", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1023, "length": 5}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1310, "length": 5}]}, {"id": "53", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation"}, "text": "G2677T/A", "locations": [{"offset": 1316, "length": 8}]}, {"id": "54", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1329, "length": 5}]}, {"id": "55", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 1335, "length": 6}]}, {"id": "56", "infons": {"identifier": "9606", "type": "Species"}, "text": "women", "locations": [{"offset": 1421, "length": 5}]}, {"id": "57", "infons": {"identifier": "MESH:D010051", "type": "Disease"}, "text": "ovarian cancer", "locations": [{"offset": 1432, "length": 14}]}], "relations": []}], "relations": [], "pmid": 20944127, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D043823", "disease@MESH:D010051", "species@9606", "mutation@c.2677G>T,A", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "chemical@MESH:D017239", "disease@MESH:D009369"], "journal": "Anticancer Res.", "year": 2010, "authors": ["Grimm C", "Polterauer S", "Zeillinger R", "Tong D", "Heinze G", "Wolf A", "Natter C", "Reinthaller A", "Hefler LA"]},
{"_id": "20533057|None", "id": "20533057", "infons": {}, "passages": [{"infons": {"journal": "Int J Colorectal Dis; 2010 Oct; 25(10) 1167-76. doi:10.1007/s00384-010-0961-2", "year": "2010", "article-id_pmc": "PMC2928441", "type": "title", "authors": "Balcerczak E, Panczyk M, Piaskowski S, Pasz-Walczak G, Sa\u0142agacka A, Mirowski M", "section": "Title"}, "offset": 0, "text": "ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 6, "length": 4}]}, {"id": "5", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 56, "length": 17}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 75, "text": "OBJECTIVE: To analyse the single-nucleotide polymorphisms (SNPs): ABCB1(1236C&gt;T), ABCB1(2677G&gt;T/A), ABCB1(3435C&gt;T) and haplotypes in the ABCB1/MDR1 gene, which could contribute to genetic risk of colorectal cancer (CRC). Disease association between the ABCB1/MDR1 genotype, allele, haplotype frequencies and histological features, such as TNM classification, localization of primary carcinoma, grade of malignancy, histological type of tumour, lymphoid infiltration and vessel invasion were estimated. In this study, the potential role of SNPs of the ABCB1/MDR1 gene as a prognostic marker for CRC was analysed. MATERIALS AND METHODS: Tumour specimens of 95 patients with CRC were studied. Using automated sequencing or PCR-RFLP method, DNA for three common SNPs of ABCB1/MDR1 was extracted and analysed. The results of genotyping and haplotype analysis with histopathological features, grading and clinical staging of neoplasms were correlated. RESULTS: A statistically significant higher frequency of T(1236) allele in T1/T2 (89.7%), M0 groups (81.6%) and I/II clinical staging (82.7%) in comparison with T3/T4 (68.2%), M1 groups (47.4%) and III/IV clinical staging (65.1%) was detected. Furthermore, multivariate analysis according to Cox's proportional hazard model indicated that the T(1236) allele is a good, independent prognostic factor and the presence of this allele decreases the risk of death in comparison with a group without this allele (HR = 0.26; p = 0.0424). In addition, a statistically significant higher frequency of C(3435) allele and significant differences in the C(3435) allele distribution in N1/N2 group (91.7% and 62.5%, respectively) than N0 group (71.2% and 44.9%, respectively) was found. Each of the eight possible haplotypes was noted in M0 or I/II group and only seven in M1 or III/IV group. Haplotype T(1236)-G(2677)-C(3435) only in less advanced CRC subjects (9.6% in I/II and 9.2% in M0 group) was detected. In addition, significant differences in haplotype distributions between M0 or I/II and M1 or III/IV group were found (p = 0.01 and p = 0.05, respectively). CONCLUSIONS: These results suggest association between T(1236) allele and T(1236)-G(2677)-C(3435) haplotype and less advanced CRC, so these genetic markers may play a role as potentially good prognostic factors. Differences in haplotype distributions and degree of clinical staging may suggest that some other potential SNPs, especially in regulatory region of ABCB1/MDR1 gene, may influence P-glycoprotein function and CRC progression.", "sentences": [], "annotations": [{"id": "28", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 141, "length": 5}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 160, "length": 5}]}, {"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 181, "length": 5}]}, {"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 221, "length": 5}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 227, "length": 4}]}, {"id": "33", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 280, "length": 17}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 337, "length": 5}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 343, "length": 4}]}, {"id": "36", "infons": {"identifier": "MESH:D002277", "type": "Disease"}, "text": "carcinoma", "locations": [{"offset": 467, "length": 9}]}, {"id": "37", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "malignancy", "locations": [{"offset": 487, "length": 10}]}, {"id": "38", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumour", "locations": [{"offset": 520, "length": 6}]}, {"id": "39", "infons": {"identifier": "MESH:D017254", "type": "Disease"}, "text": "lymphoid infiltration", "locations": [{"offset": 528, "length": 21}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 635, "length": 5}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 641, "length": 4}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 742, "length": 8}]}, {"id": "43", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 850, "length": 5}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 856, "length": 4}]}, {"id": "45", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "neoplasms", "locations": [{"offset": 1003, "length": 9}]}, {"id": "46", "infons": {"identifier": "MESH:D003643", "type": "Disease"}, "text": "death", "locations": [{"offset": 1483, "length": 5}]}, {"id": "47", "infons": {"identifier": "100507027", "type": "Gene"}, "text": "I/II and M1 or III", "locations": [{"offset": 2107, "length": 18}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2546, "length": 5}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 2552, "length": 4}]}], "relations": []}], "relations": [], "pmid": 20533057, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D003643", "species@9606", "disease@MESH:D002277", "disease@MESH:D015179", "gene@100507027", "gene@5243", "disease@MESH:D017254", "disease@MESH:D009369"], "journal": "Int J Colorectal Dis", "year": 2010, "authors": ["Balcerczak E", "Panczyk M", "Piaskowski S", "Pasz-Walczak G", "Sa\u0142agacka A", "Mirowski M"]},
{"_id": "20389299|None", "id": "20389299", "infons": {}, "passages": [{"infons": {"journal": "Br. J. Cancer; 2010 Apr 27; 102(9) 1371-7. doi:10.1038/sj.bjc.6605653", "year": "2010", "article-id_pmc": "PMC2865761", "type": "title", "authors": "Xu CF, Reck BH, Xue Z, Huang L, Baker KL, Chen M, Chen EP, Ellens HE, Mooser VE, Cardon LR, Spraggs CF, Pandite L", "section": "Title"}, "offset": 0, "text": "Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "Pazopanib", "locations": [{"offset": 0, "length": 9}]}, {"id": "5", "infons": {"identifier": "MESH:D006932", "type": "Disease"}, "text": "hyperbilirubinemia", "locations": [{"offset": 18, "length": 18}]}, {"id": "6", "infons": {"identifier": "MESH:D005878", "type": "Disease"}, "text": "Gilbert's syndrome", "locations": [{"offset": 56, "length": 18}]}, {"id": "7", "infons": {"identifier": "54658", "type": "Gene", "ncbi_homologene": "128034"}, "text": "UGT1A1", "locations": [{"offset": 75, "length": 6}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 96, "text": "BACKGROUND: Pazopanib has shown clinical activity against multiple tumour types and is generally well tolerated. However, isolated elevations in transaminases and bilirubin have been observed. This study examined polymorphisms in molecules involved in pharmacokinetic and pharmacodynamic pathways of pazopanib and their association with hepatic dysfunction. METHODS: Twenty-eight polymorphisms in 11 genes were evaluated in pazopanib-treated renal cell carcinoma patients. An exploratory analysis was conducted in 116 patients from a phase II study; a replication study was conducted in 130 patients from a phase III study. RESULTS: No polymorphisms were associated with alanine aminotransferase elevation. The Gilbert's uridine-diphosphoglucuronate glucuronosyltransferase 1A1 (UGT1A1) TA-repeat polymorphism was significantly associated with pazopanib-induced hyperbilirubinemia in the phase II study. This association was replicated in the phase III study (P&lt;0.01). Patients with TA6/TA6, TA6/TA7, and TA7/TA7 genotypes experienced median bilirubin increases of 0.31, 0.37, and 0.71 x upper limit of the normal range (ULN), respectively. Of the 38 patients with hyperbilirubinemia (&gt; or = 1.5 x ULN), 32 (84%) were either TA7 homozygotes (n=18) or TA7 heterozygotes (n=14). For TA7 homozygotes, the odds ratio (95% CI) for developing hyperbilirubinemia was 13.1 (5.3-32.2) compared with other genotypes. CONCLUSIONS: The UGT1A1 polymorphism is frequently associated with pazopanib-induced hyperbilirubinemia. These data suggest that some instances of isolated hyperbilirubinemia in pazopanib-treated patients are benign manifestations of Gilbert's syndrome, thus supporting continuation of pazopanib monotherapy in this setting.", "sentences": [], "annotations": [{"id": "35", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "Pazopanib", "locations": [{"offset": 108, "length": 9}]}, {"id": "36", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumour", "locations": [{"offset": 163, "length": 6}]}, {"id": "37", "infons": {"identifier": "MESH:D001663", "type": "Chemical"}, "text": "bilirubin", "locations": [{"offset": 259, "length": 9}]}, {"id": "38", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "pazopanib", "locations": [{"offset": 396, "length": 9}]}, {"id": "39", "infons": {"identifier": "MESH:D008107", "type": "Disease"}, "text": "hepatic dysfunction", "locations": [{"offset": 433, "length": 19}]}, {"id": "40", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "pazopanib", "locations": [{"offset": 520, "length": 9}]}, {"id": "41", "infons": {"identifier": "MESH:C538614", "type": "Disease"}, "text": "renal cell carcinoma", "locations": [{"offset": 538, "length": 20}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 559, "length": 8}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 614, "length": 8}]}, {"id": "44", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 687, "length": 8}]}, {"id": "45", "infons": {"identifier": "54658", "type": "Gene", "ncbi_homologene": "128034"}, "text": "uridine-diphosphoglucuronate glucuronosyltransferase 1A1", "locations": [{"offset": 817, "length": 56}]}, {"id": "46", "infons": {"identifier": "54658", "type": "Gene", "ncbi_homologene": "128034"}, "text": "UGT1A1", "locations": [{"offset": 875, "length": 6}]}, {"id": "47", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "pazopanib", "locations": [{"offset": 940, "length": 9}]}, {"id": "48", "infons": {"identifier": "MESH:D006932", "type": "Disease"}, "text": "hyperbilirubinemia", "locations": [{"offset": 958, "length": 18}]}, {"id": "49", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 1068, "length": 8}]}, {"id": "50", "infons": {"identifier": "MESH:D001663", "type": "Chemical"}, "text": "bilirubin", "locations": [{"offset": 1141, "length": 9}]}, {"id": "51", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1250, "length": 8}]}, {"id": "52", "infons": {"identifier": "MESH:D006932", "type": "Disease"}, "text": "hyperbilirubinemia", "locations": [{"offset": 1264, "length": 18}]}, {"id": "53", "infons": {"identifier": "MESH:D006932", "type": "Disease"}, "text": "hyperbilirubinemia", "locations": [{"offset": 1439, "length": 18}]}, {"id": "54", "infons": {"identifier": "54658", "type": "Gene", "ncbi_homologene": "128034"}, "text": "UGT1A1", "locations": [{"offset": 1526, "length": 6}]}, {"id": "55", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "pazopanib", "locations": [{"offset": 1576, "length": 9}]}, {"id": "56", "infons": {"identifier": "MESH:D006932", "type": "Disease"}, "text": "hyperbilirubinemia", "locations": [{"offset": 1594, "length": 18}]}, {"id": "57", "infons": {"identifier": "MESH:D006932", "type": "Disease"}, "text": "hyperbilirubinemia", "locations": [{"offset": 1665, "length": 18}]}, {"id": "58", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "pazopanib", "locations": [{"offset": 1687, "length": 9}]}, {"id": "59", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1705, "length": 8}]}, {"id": "60", "infons": {"identifier": "MESH:D005878", "type": "Disease"}, "text": "Gilbert's syndrome", "locations": [{"offset": 1743, "length": 18}]}, {"id": "61", "infons": {"identifier": "MESH:C516667", "type": "Chemical"}, "text": "pazopanib", "locations": [{"offset": 1795, "length": 9}]}], "relations": []}], "relations": [], "pmid": 20389299, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D006932", "disease@MESH:D005878", "disease@MESH:C538614", "species@9606", "chemical@MESH:C516667", "disease@MESH:D008107", "gene@54658", "disease@MESH:D009369", "chemical@MESH:D001663"], "journal": "Br. J. Cancer", "year": 2010, "authors": ["Xu CF", "Reck BH", "Xue Z", "Huang L", "Baker KL", "Chen M", "Chen EP", "Ellens HE", "Mooser VE", "Cardon LR", "Spraggs CF", "Pandite L"]},
{"_id": "20354687|None", "id": "20354687", "infons": {}, "passages": [{"infons": {"journal": "Eur. J. Clin. Pharmacol.; 2010 Jun; 66(6) 579-90. doi:10.1007/s00228-010-0810-9", "year": "2010", "article-id_pmc": "PMC2868991", "type": "title", "authors": "Press RR, Ploeger BA, den Hartigh J, van der Straaten T, van Pelt H, Danhof M, de Fijter H, Guchelaar HJ", "section": "Title"}, "offset": 0, "text": "Explaining variability in ciclosporin exposure in adult kidney transplant recipients.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 26, "length": 11}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 86, "text": "PURPOSE: Optimal ciclosporin A (CsA) exposure in kidney transplant recipients is difficult to attain because of variability in CsA pharmacokinetics. A better understanding of the variability in CsA exposure could be a good means of individualizing therapy. Specifically, genetic variability in genes involved in CsA metabolism could explain exposure differences. Therefore, this study is aimed at identifying a relationship between genetic polymorphisms and the variability in CsA exposure, while accounting for non-genetic sources of variability. METHODS: De novo kidney transplant patients (n = 33) were treated with CsA for 1 year and extensive blood sampling was performed on multiple occasions throughout the year. The effects of the non-genetic covariates hematocrit, serum albumin concentration, cholesterol, demographics (i.e., body weight), CsA dose interval, prednisolone dose and genetic polymorphisms in genes encoding ABCB1, CYP3A4, CYP3A5, and PXR on CsA pharmacokinetics were studied using non-linear mixed effect modeling. RESULTS: The pharmacokinetics of CsA were described by a two-compartment disposition model with delayed absorption. Body weight was identified as the most important covariate and explained 35% of the random inter-individual variability in CsA clearance. Moreover, concurrent prednisolone use at a dosage of 20 mg/day or higher was associated with a 22% higher clearance of CsA, hence lower CsA exposure. In contrast, no considerable genotype effects (i.e., greater than 30-50%) on CsA clearance were found for the selected genes. CONCLUSIONS: It appears that the selected genetic markers explain variability in CsA exposure insufficiently to be of clinical relevance. Therefore, therapeutic drug monitoring is still required to optimize CsA exposure after administration of individualized doses based on body weight and, as this study suggests, co-administration of prednisolone.", "sentences": [], "annotations": [{"id": "28", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "ciclosporin A", "locations": [{"offset": 103, "length": 13}]}, {"id": "29", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 118, "length": 3}]}, {"id": "30", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 213, "length": 3}]}, {"id": "31", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 280, "length": 3}]}, {"id": "32", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 398, "length": 3}]}, {"id": "33", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 563, "length": 3}]}, {"id": "34", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 669, "length": 8}]}, {"id": "35", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 705, "length": 3}]}, {"id": "36", "infons": {"identifier": "MESH:D002784", "type": "Chemical"}, "text": "cholesterol", "locations": [{"offset": 889, "length": 11}]}, {"id": "37", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 936, "length": 3}]}, {"id": "38", "infons": {"identifier": "MESH:D011239", "type": "Chemical"}, "text": "prednisolone", "locations": [{"offset": 955, "length": 12}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1017, "length": 5}]}, {"id": "40", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1024, "length": 6}]}, {"id": "41", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1032, "length": 6}]}, {"id": "42", "infons": {"identifier": "8856", "type": "Gene", "ncbi_homologene": "40757"}, "text": "PXR", "locations": [{"offset": 1044, "length": 3}]}, {"id": "43", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1051, "length": 3}]}, {"id": "44", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1158, "length": 3}]}, {"id": "45", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1364, "length": 3}]}, {"id": "46", "infons": {"identifier": "MESH:D011239", "type": "Chemical"}, "text": "prednisolone", "locations": [{"offset": 1400, "length": 12}]}, {"id": "47", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1498, "length": 3}]}, {"id": "48", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1515, "length": 3}]}, {"id": "49", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1606, "length": 3}]}, {"id": "50", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1736, "length": 3}]}, {"id": "51", "infons": {"identifier": "MESH:D000309", "type": "Disease"}, "text": "insufficiently", "locations": [{"offset": 1749, "length": 14}]}, {"id": "52", "infons": {"identifier": "1161", "type": "Gene", "ncbi_homologene": "62"}, "text": "CsA", "locations": [{"offset": 1862, "length": 3}]}, {"id": "53", "infons": {"identifier": "MESH:D011239", "type": "Chemical"}, "text": "prednisolone", "locations": [{"offset": 1991, "length": 12}]}], "relations": []}], "relations": [], "pmid": 20354687, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D016572", "gene@1576", "chemical@MESH:D011239", "species@9606", "gene@5243", "gene@1161", "gene@1577", "gene@8856", "chemical@MESH:D002784", "disease@MESH:D000309"], "journal": "Eur. J. Clin. Pharmacol.", "year": 2010, "authors": ["Press RR", "Ploeger BA", "den Hartigh J", "van der Straaten T", "van Pelt H", "Danhof M", "de Fijter H", "Guchelaar HJ"]},
{"_id": "20214406|None", "id": "20214406", "infons": {}, "passages": [{"infons": {"journal": "Clin Pharmacokinet; 2010 Apr; 49(4) 207-21. doi:10.2165/11317550-000000000-00000", "year": "2010", "type": "title", "authors": "Staatz CE, Goodman LK, Tett SE", "section": "Title"}, "offset": 0, "text": "Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A", "locations": [{"offset": 10, "length": 5}]}, {"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 20, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 139, "text": "The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant drugs used for the prevention of organ rejection following transplantation. Both agents are metabolic substrates for cytochrome P450 (CYP) 3A enzymes - in particular, CYP3A4 and CYP3A5 - and are transported out of cells via P-glycoprotein (ABCB1). Several single nucleotide polymorphisms (SNPs) have been identified in the genes encoding for CYP3A4, CYP3A5 and P-glycoprotein, including CYP3A4 -392A&gt;G (rs2740574), CYP3A5 6986A&gt;G (rs776746), ABCB1 3435C&gt;T (rs1045642), ABCB1 1236C&gt;T (rs1128503) and ABCB1 2677G&gt;T/A (rs2032582). The aim of this review is to provide the clinician with an extensive overview of the recent literature on the known effects of these SNPs on the pharmacodynamics of ciclosporin and tacrolimus in solid-organ transplant recipients. Literature searches were performed and all relevant primary research articles were critiqued and summarized. There is no evidence that the CYP3A4 -392A&gt;G SNP has an effect on the pharmacodynamics of either ciclosporin or tacrolimus; however, studies have been limited. For patients prescribed ciclosporin, the CYP3A5 6986A&gt;G SNP may influence long-term survival, possibly because of a different metabolite pattern over time. This SNP has no clear association with acute rejection during ciclosporin therapy. Despite a strong association between the CYP3A5 6986A&gt;G SNP and tacrolimus pharmacokinetics, there is no consistent evidence of organ rejection as a result of genotype-related under-immunosuppression. This is likely to be explained by the practice of performing tacrolimus dose adjustments in the early phase after transplantation. The effect of the CYP3A5 6986A&gt;G SNP on ciclosporin- and tacrolimus-related nephrotoxicity and development of hypertension is unclear. Similarly, the ABCB1 SNPs exert no clear influence on either ciclosporin or tacrolimus pharmacodynamics, with studies showing conflicting results in regard to the main parameters of acute rejection and nephrotoxicity. In kidney transplant patients, consideration of the donor kidney genotype rather than the recipient genotype may be more important when assessing development of nephrotoxicity. Studies with low patient numbers may account for many inconsistent results to date. The majority of studies have only evaluated the effects of individual SNPs; however, multiple polymorphisms may interact to produce a combined effect. Further haplotype analyses are likely to be useful, particularly ones that consider both donor and recipient genotype. The effects of polymorphisms associated with the pregnane X receptor, organic anion transporting polypeptides, calcineurin inhibitor target sites and immune response pathways need to be further investigated. A large standardized clinical trial is now required to evaluate the relationship between the pharmacokinetics and pharmacodynamics of CYP3A5-mediated tacrolimus metabolism, particularly in regard to the outcomes of acute rejection and nephrotoxicity. It is not yet clear whether pharmacogenetic profiling of calcineurin inhibitors will be a useful clinical tool for personalizing immunosuppressant therapy.", "sentences": [], "annotations": [{"id": "53", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 166, "length": 11}]}, {"id": "54", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 179, "length": 12}]}, {"id": "55", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 197, "length": 10}]}, {"id": "56", "infons": {"identifier": "13112", "type": "Gene", "ncbi_homologene": "133568"}, "text": "cytochrome P450 (CYP) 3A", "locations": [{"offset": 347, "length": 24}]}, {"id": "57", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 397, "length": 6}]}, {"id": "58", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 408, "length": 6}]}, {"id": "59", "infons": {"identifier": "18669", "type": "Gene", "ncbi_homologene": "69084"}, "text": "ABCB1", "locations": [{"offset": 470, "length": 5}]}, {"id": "60", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 572, "length": 6}]}, {"id": "61", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 580, "length": 6}]}, {"id": "62", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 617, "length": 6}]}, {"id": "63", "infons": {"identifier": "rs2740574", "type": "Mutation", "subtype": "SNP"}, "text": "rs2740574", "locations": [{"offset": 636, "length": 9}]}, {"id": "64", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 648, "length": 6}]}, {"id": "65", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 667, "length": 8}]}, {"id": "66", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 678, "length": 5}]}, {"id": "67", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 696, "length": 9}]}, {"id": "68", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 708, "length": 5}]}, {"id": "69", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 726, "length": 9}]}, {"id": "70", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 741, "length": 5}]}, {"id": "71", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 761, "length": 9}]}, {"id": "72", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 938, "length": 11}]}, {"id": "73", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 954, "length": 10}]}, {"id": "74", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1142, "length": 6}]}, {"id": "75", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1212, "length": 11}]}, {"id": "76", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1227, "length": 10}]}, {"id": "77", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1279, "length": 8}]}, {"id": "78", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1299, "length": 11}]}, {"id": "79", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1316, "length": 6}]}, {"id": "80", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1496, "length": 11}]}, {"id": "81", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1558, "length": 6}]}, {"id": "82", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1584, "length": 10}]}, {"id": "83", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1782, "length": 10}]}, {"id": "84", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1870, "length": 6}]}, {"id": "85", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1895, "length": 11}]}, {"id": "86", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1912, "length": 10}]}, {"id": "87", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 1931, "length": 14}]}, {"id": "88", "infons": {"identifier": "MESH:D006973", "type": "Disease"}, "text": "hypertension", "locations": [{"offset": 1965, "length": 12}]}, {"id": "89", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2005, "length": 5}]}, {"id": "90", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 2051, "length": 11}]}, {"id": "91", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 2066, "length": 10}]}, {"id": "92", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 2192, "length": 14}]}, {"id": "93", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2229, "length": 8}]}, {"id": "94", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 2260, "length": 5}]}, {"id": "95", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 2369, "length": 14}]}, {"id": "96", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 2402, "length": 7}]}, {"id": "97", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 2709, "length": 5}]}, {"id": "98", "infons": {"identifier": "23523", "type": "Gene", "ncbi_homologene": "49307"}, "text": "calcineurin inhibitor", "locations": [{"offset": 2850, "length": 21}]}, {"id": "99", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 3081, "length": 6}]}, {"id": "100", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 3097, "length": 10}]}, {"id": "101", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 3182, "length": 14}]}], "relations": []}], "relations": [], "pmid": 20214406, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@1577", "chemical@MESH:D016572", "gene@1576", "gene@23523", "mutation@rs1128503", "species@9606", "disease@MESH:D007674", "mutation@rs2032582", "mutation@rs776746", "disease@MESH:D006973", "gene@18669", "mutation@rs2740574", "chemical@MESH:D016559", "gene@5243", "gene@13112", "mutation@rs1045642"], "journal": "Clin Pharmacokinet", "year": 2010, "authors": ["Staatz CE", "Goodman LK", "Tett SE"]},
{"_id": "20170205|None", "id": "20170205", "infons": {}, "passages": [{"infons": {"journal": "Clin Pharmacokinet; 2010 Mar; 49(3) 141-75. doi:10.2165/11317350-000000000-00000", "year": "2010", "type": "title", "authors": "Staatz CE, Goodman LK, Tett SE", "section": "Title"}, "offset": 0, "text": "Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A", "locations": [{"offset": 10, "length": 5}]}, {"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 20, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 138, "text": "The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant drugs used for the prevention of organ rejection following transplantation. Both agents are metabolic substrates for cytochrome P450 (CYP) 3A enzymes--in particular, CYP3A4 and CYP3A5--and are transported out of cells via P-glycoprotein (ABCB1). Several single nucleotide polymorphisms (SNPs) have been identified in the genes encoding for CYP3A4, CYP3A5 and P-glycoprotein, including CYP3A4 -392A&gt;G (rs2740574), CYP3A5 6986A&gt;G (rs776746), ABCB1 3435C&gt;T (rs1045642), ABCB1 1236C&gt;T (rs1128503) and ABCB1 2677G&gt;T/A (rs2032582). The aim of this review is to provide the clinician with an extensive overview of the recent literature on the known effects of these SNPs on the pharmacokinetics of ciclosporin and tacrolimus in solid-organ transplant recipients. Literature searches were performed, and all relevant primary research articles were critiqued and summarized. Influence of the CYP3A4 -392A&gt;G SNP on the pharmacokinetics of either ciclosporin or tacrolimus appears limited. Variability in CYP3A4 expression due to environmental factors is likely to be more important than patient genotype. Influence of the CYP3A5 6986A&gt;G SNP on the pharmacokinetics of ciclosporin is also uncertain and likely to be small. CYP3A4 may play a more dominant role than CYP3A5 in the metabolism of ciclosporin. The CYP3A5 6986A&gt;G SNP has a well established influence on the pharmacokinetics of tacrolimus. Several studies in kidney, heart and liver transplant recipients have reported an approximate halving of tacrolimus dose-adjusted trough concentrations and doubling of tacrolimus dose requirements in heterozygous or homozygous carriers of a CYP3A5*1 wild-type allele compared with homozygous carriers of a CYP3A5*3 variant allele. Carriers of a CYP3A5*1 allele take a longer time to reach target blood tacrolimus concentrations. Influence of ABCB1 3435C&gt;T, 1236C&gt;T and 2677G&gt;T/A SNPs on the pharmacokinetics of ciclosporin and tacrolimus remains uncertain, with inconsistent results. Genetic linkage between the three variant genotypes suggests that the pharmacokinetic effects are complex and not related to any one ABCB1 SNP. It is likely that these polymorphisms exert a small but combined effect, which is additive to the effects of the CYP3A5 6986A&gt;G SNP. In liver transplant patients, recipient and donor liver genotypes may act together in determining overall drug disposition, hence the importance of assessing both. Studies with low patient numbers may account for many inconsistent results to date. Meta-analyses of the current data should help resolve some discrepancies. The majority of studies have only evaluated the effects of individual SNPs; however, multiple polymorphisms may interact to produce a combined effect. Further haplotype analyses are likely to be useful. It is not yet clear whether pharmacogenetic profiling of calcineurin inhibitors will be a useful clinical tool for personalizing immunosuppressant therapy.", "sentences": [], "annotations": [{"id": "53", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 165, "length": 11}]}, {"id": "54", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "cyclosporine", "locations": [{"offset": 178, "length": 12}]}, {"id": "55", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 196, "length": 10}]}, {"id": "56", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "cytochrome P450 (CYP) 3A", "locations": [{"offset": 346, "length": 24}]}, {"id": "57", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 395, "length": 6}]}, {"id": "58", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 406, "length": 6}]}, {"id": "59", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 451, "length": 14}]}, {"id": "60", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 467, "length": 5}]}, {"id": "61", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 569, "length": 6}]}, {"id": "62", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 577, "length": 6}]}, {"id": "63", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 588, "length": 14}]}, {"id": "64", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 614, "length": 6}]}, {"id": "65", "infons": {"identifier": "rs2740574", "type": "Mutation", "subtype": "SNP"}, "text": "rs2740574", "locations": [{"offset": 633, "length": 9}]}, {"id": "66", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 645, "length": 6}]}, {"id": "67", "infons": {"identifier": "rs776746", "type": "Mutation", "subtype": "SNP"}, "text": "rs776746", "locations": [{"offset": 664, "length": 8}]}, {"id": "68", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 675, "length": 5}]}, {"id": "69", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 693, "length": 9}]}, {"id": "70", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 705, "length": 5}]}, {"id": "71", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 723, "length": 9}]}, {"id": "72", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 738, "length": 5}]}, {"id": "73", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 758, "length": 9}]}, {"id": "74", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 935, "length": 11}]}, {"id": "75", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 951, "length": 10}]}, {"id": "76", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1127, "length": 6}]}, {"id": "77", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1183, "length": 11}]}, {"id": "78", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1198, "length": 10}]}, {"id": "79", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1241, "length": 6}]}, {"id": "80", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 1324, "length": 7}]}, {"id": "81", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1359, "length": 6}]}, {"id": "82", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1408, "length": 11}]}, {"id": "83", "infons": {"identifier": "1576", "type": "Gene", "ncbi_homologene": "111391"}, "text": "CYP3A4", "locations": [{"offset": 1462, "length": 6}]}, {"id": "84", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1504, "length": 6}]}, {"id": "85", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 1532, "length": 11}]}, {"id": "86", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1549, "length": 6}]}, {"id": "87", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1631, "length": 10}]}, {"id": "88", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1748, "length": 10}]}, {"id": "89", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1811, "length": 10}]}, {"id": "90", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1884, "length": 6}]}, {"id": "91", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1949, "length": 6}]}, {"id": "92", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 1988, "length": 6}]}, {"id": "93", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 2045, "length": 10}]}, {"id": "94", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2085, "length": 5}]}, {"id": "95", "infons": {"identifier": "MESH:D016572", "type": "Chemical"}, "text": "ciclosporin", "locations": [{"offset": 2163, "length": 11}]}, {"id": "96", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 2179, "length": 10}]}, {"id": "97", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2369, "length": 5}]}, {"id": "98", "infons": {"identifier": "1577", "type": "Gene", "ncbi_homologene": "133568"}, "text": "CYP3A5", "locations": [{"offset": 2493, "length": 6}]}, {"id": "99", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2536, "length": 8}]}, {"id": "100", "infons": {"identifier": "9606", "type": "Species"}, "text": "donor", "locations": [{"offset": 2560, "length": 5}]}, {"id": "101", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 2697, "length": 7}]}], "relations": []}], "relations": [], "pmid": 20170205, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D016572", "gene@1576", "mutation@rs1128503", "species@9606", "mutation@rs2032582", "mutation@rs776746", "mutation@rs2740574", "chemical@MESH:D016559", "gene@5243", "gene@1577", "mutation@rs1045642"], "journal": "Clin Pharmacokinet", "year": 2010, "authors": ["Staatz CE", "Goodman LK", "Tett SE"]},
{"_id": "19740399|None", "id": "19740399", "infons": {}, "passages": [{"infons": {"journal": "Br J Clin Pharmacol; 2009 Sep; 68(3) 413-21. doi:10.1111/j.1365-2125.2009.03461.x", "year": "2009", "article-id_pmc": "PMC2766481", "type": "title", "authors": "Hawwa AF, McKiernan PJ, Shields M, Millership JS, Collier PS, McElnay JC", "section": "Title"}, "offset": 0, "text": "Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 13, "length": 5}]}, {"id": "5", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 51, "length": 10}]}, {"id": "6", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 62, "length": 14}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 104, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 136, "text": "AIMS: The aim of this study was to investigate the influence of genetic polymorphisms in ABCB1 on the incidence of nephrotoxicity and tacrolimus dosage-requirements in paediatric patients following liver transplantation. METHODS: Fifty-one paediatric liver transplant recipients receiving tacrolimus were genotyped for ABCB1 C1236&gt;T, G2677&gt;T and C3435&gt;T polymorphisms. Dose-adjusted tacrolimus trough concentrations and estimated glomerular filtration rates (EGFR) indicative of renal toxicity were determined and correlated with the corresponding genotypes. RESULTS: The present study revealed a higher incidence of the ABCB1 variant-alleles examined among patients with renal dysfunction (&gt; or =30% reduction in EGFR) at 6 months post-transplantation (1236T allele: 63.3% vs 37.5% in controls, P= 0.019; 2677T allele: 63.3% vs. 35.9%, p = 0.012; 3435T allele: 60% vs. 39.1%, P= 0.057). Carriers of the G2677-&gt;T variant allele also had a significant reduction (%) in EGFR at 12 months post-transplant (mean difference = 22.6%; P= 0.031). Haplotype analysis showed a significant association between T-T-T haplotypes and an increased incidence of nephrotoxicity at 6 months post-transplantation (haplotype-frequency = 52.9% in nephrotoxic patients vs 29.4% in controls; P= 0.029). Furthermore, G2677-&gt;T and C3435-&gt;T polymorphisms and T-T-T haplotypes were significantly correlated with higher tacrolimus dose-adjusted pre-dose concentrations at various time points examined long after drug initiation. CONCLUSIONS: These findings suggest that ABCB1 polymorphisms in the native intestine significantly influence tacrolimus dosage-requirement in the stable phase after transplantation. In addition, ABCB1 polymorphisms in paediatric liver transplant recipients may predispose them to nephrotoxicity over the first year post-transplantation. Genotyping future transplant recipients for ABCB1 polymorphisms, therefore, could have the potential to individualize better tacrolimus immunosuppressive therapy and enhance drug safety.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 225, "length": 5}]}, {"id": "32", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 251, "length": 14}]}, {"id": "33", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 270, "length": 10}]}, {"id": "34", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 315, "length": 8}]}, {"id": "35", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 425, "length": 10}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 455, "length": 5}]}, {"id": "37", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 528, "length": 10}]}, {"id": "38", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "renal toxicity", "locations": [{"offset": 624, "length": 14}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 766, "length": 5}]}, {"id": "40", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 803, "length": 8}]}, {"id": "41", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "renal dysfunction", "locations": [{"offset": 817, "length": 17}]}, {"id": "42", "infons": {"identifier": "MESH:D001260", "type": "Disease"}, "text": "T-T-T", "locations": [{"offset": 1250, "length": 5}]}, {"id": "43", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 1297, "length": 14}]}, {"id": "44", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxic", "locations": [{"offset": 1377, "length": 11}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1389, "length": 8}]}, {"id": "46", "infons": {"identifier": "MESH:D001260", "type": "Disease"}, "text": "T-T-T", "locations": [{"offset": 1490, "length": 5}]}, {"id": "47", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1549, "length": 10}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1699, "length": 5}]}, {"id": "49", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1767, "length": 10}]}, {"id": "50", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1853, "length": 5}]}, {"id": "51", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 1938, "length": 14}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2039, "length": 5}]}, {"id": "53", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 2120, "length": 10}]}], "relations": []}], "relations": [], "pmid": 19740399, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D001260", "species@9606", "disease@MESH:D007674", "chemical@MESH:D016559", "gene@5243"], "journal": "Br J Clin Pharmacol", "year": 2009, "authors": ["Hawwa AF", "McKiernan PJ", "Shields M", "Millership JS", "Collier PS", "McElnay JC"]},
{"_id": "19694740|None", "id": "19694740", "infons": {}, "passages": [{"infons": {"journal": "Br J Clin Pharmacol; 2009 Aug; 68(2) 207-13. doi:10.1111/j.1365-2125.2009.03440.x", "year": "2009", "article-id_pmc": "PMC2767284", "type": "title", "authors": "Keskitalo JE, Kurkinen KJ, Neuvonen M, Backman JT, Neuvonen PJ, Niemi M", "section": "Title"}, "offset": 0, "text": "No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 25, "length": 5}]}, {"id": "6", "infons": {"identifier": "MESH:D000077340", "type": "Chemical"}, "text": "fluvastatin", "locations": [{"offset": 69, "length": 11}]}, {"id": "7", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 82, "length": 11}]}, {"id": "8", "infons": {"identifier": "MESH:D008148", "type": "Chemical"}, "text": "lovastatin", "locations": [{"offset": 95, "length": 10}]}, {"id": "9", "infons": {"identifier": "MESH:D000068718", "type": "Chemical"}, "text": "rosuvastatin", "locations": [{"offset": 111, "length": 12}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 125, "text": "AIMS: This study aimed to investigate possible effects of ABCB1 genotype on fluvastatin, pravastatin, lovastatin, and rosuvastatin pharmacokinetics. METHODS: In a fixed-order crossover study, 10 healthy volunteers with the ABCB1 c.1236C/C-c.2677G/G-c.3435C/C (CGC/CGC) genotype and 10 with the c.1236T/T-c.2677T/T-c.3435T/T (TTT/TTT) genotype ingested a single 20-mg dose of fluvastatin, pravastatin, lovastatin, and rosuvastatin. Plasma fluvastatin, pravastatin, and lovastatin concentrations were measured up to 12 h and plasma and urine rosuvastatin concentrations up to 48 and 24 h, respectively. RESULTS: The ABCB1 genotype had no significant effect on the pharmacokinetics of any of the investigated statins. The geometric mean ratio (95% confidence interval) of the area under the plasma concentration-time curve from 0 h to infinity (AUC(0-infinity)) in participants with the TTT/TTT genotype to that in those with the CGC/CGC genotype was 0.96 (0.77, 1.20; P= 0.737) for fluvastatin, 0.92 (0.53, 1.62; P= 0.772) for pravastatin, 0.83 (0.36, 1.90; P= 0.644) for lovastatin, 1.25 (0.72, 2.17; P= 0.400) for lovastatin acid, and 1.10 (0.73, 1.65; P= 0.626) for rosuvastatin. The AUC(0-infinity) of lovastatin acid correlated significantly with that of rosuvastatin (r= 0.570, P= 0.009), but none of the other AUC(0-infinity) pairs showed a significant correlation. CONCLUSIONS: These data suggest that the ABCB1 c.1236C-c.2677G-c.3435C and c.1236T-c.2677T-c.3435T haplotypes play no significant role in the interindividual variability in the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.", "sentences": [], "annotations": [{"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 183, "length": 5}]}, {"id": "36", "infons": {"identifier": "MESH:D000077340", "type": "Chemical"}, "text": "fluvastatin", "locations": [{"offset": 201, "length": 11}]}, {"id": "37", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 214, "length": 11}]}, {"id": "38", "infons": {"identifier": "MESH:D008148", "type": "Chemical"}, "text": "lovastatin", "locations": [{"offset": 227, "length": 10}]}, {"id": "39", "infons": {"identifier": "MESH:D000068718", "type": "Chemical"}, "text": "rosuvastatin", "locations": [{"offset": 243, "length": 12}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 348, "length": 5}]}, {"id": "41", "infons": {"identifier": "MESH:D000077340", "type": "Chemical"}, "text": "fluvastatin", "locations": [{"offset": 500, "length": 11}]}, {"id": "42", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 513, "length": 11}]}, {"id": "43", "infons": {"identifier": "MESH:D008148", "type": "Chemical"}, "text": "lovastatin", "locations": [{"offset": 526, "length": 10}]}, {"id": "44", "infons": {"identifier": "MESH:D000068718", "type": "Chemical"}, "text": "rosuvastatin", "locations": [{"offset": 542, "length": 12}]}, {"id": "45", "infons": {"identifier": "MESH:D000077340", "type": "Chemical"}, "text": "fluvastatin", "locations": [{"offset": 563, "length": 11}]}, {"id": "46", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 576, "length": 11}]}, {"id": "47", "infons": {"identifier": "MESH:D008148", "type": "Chemical"}, "text": "lovastatin", "locations": [{"offset": 593, "length": 10}]}, {"id": "48", "infons": {"identifier": "MESH:D000068718", "type": "Chemical"}, "text": "rosuvastatin", "locations": [{"offset": 665, "length": 12}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 739, "length": 5}]}, {"id": "50", "infons": {"identifier": "9606", "type": "Species"}, "text": "participants", "locations": [{"offset": 987, "length": 12}]}, {"id": "51", "infons": {"identifier": "MESH:C040295", "type": "Chemical"}, "text": "lovastatin acid", "locations": [{"offset": 1329, "length": 15}]}, {"id": "52", "infons": {"identifier": "MESH:D000068718", "type": "Chemical"}, "text": "rosuvastatin", "locations": [{"offset": 1383, "length": 12}]}, {"id": "53", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1537, "length": 5}]}, {"id": "54", "infons": {"identifier": "c.1236,2677,3435C,G>C", "type": "Mutation", "subtype": "DNAMutation"}, "text": "c.1236C-c.2677G-c.3435C", "locations": [{"offset": 1543, "length": 23}]}, {"id": "55", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236,.2677T,T>C;RS#:1128503", "hgvs": "c.1236,.2677T,T>C", "identifiers": ["rs1128503"]}, "text": "c.1236T-c.2677T-c", "locations": [{"offset": 1571, "length": 17}]}, {"id": "56", "infons": {"identifier": "MESH:D000077340", "type": "Chemical"}, "text": "fluvastatin", "locations": [{"offset": 1693, "length": 11}]}, {"id": "57", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 1706, "length": 11}]}, {"id": "58", "infons": {"identifier": "MESH:D008148", "type": "Chemical"}, "text": "lovastatin", "locations": [{"offset": 1719, "length": 10}]}, {"id": "59", "infons": {"identifier": "MESH:D000068718", "type": "Chemical"}, "text": "rosuvastatin", "locations": [{"offset": 1735, "length": 12}]}], "relations": []}], "relations": [], "pmid": 19694740, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D017035", "mutation@c.1236,2677,3435C,G>C", "species@9606", "chemical@MESH:D000068718", "chemical@MESH:D000077340", "gene@5243", "mutation@rs1128503", "chemical@MESH:D008148", "chemical@MESH:C040295"], "journal": "Br J Clin Pharmacol", "year": 2009, "authors": ["Keskitalo JE", "Kurkinen KJ", "Neuvonen M", "Backman JT", "Neuvonen PJ", "Niemi M"]},
{"_id": "19667110|None", "id": "19667110", "infons": {}, "passages": [{"infons": {"journal": "Arterioscler. Thromb. Vasc. Biol.; 2009 Sep; 29(9) 1310-5. doi:10.1161/ATVBAHA.109.188474", "year": "2009", "type": "title", "authors": "Mega JL, Morrow DA, Brown A, Cannon CP, Sabatine MS", "section": "Title"}, "offset": 0, "text": "Identification of genetic variants associated with response to statin therapy.", "sentences": [], "annotations": [], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 79, "text": "OBJECTIVE: The purpose of this study was to test the association between polymorphisms in genes involved in either LDL cholesterol (LDL-C) metabolism or statin pharmacokinetics and LDL-C reduction with statins. METHODS AND RESULTS: 49 tagging and candidate polymorphisms in 9 genes were genotyped in 1507 post-ACS subjects randomized to atorvastatin or pravastatin. Two polymorphisms (rs7412, rs429358) that define the epsilon2, epsilon3, and epsilon4 isoforms of apolipoprotein E were significantly associated with percent reduction in LDL-C with atorvastatin (epsilon2 carriers 53.8%, epsilon3/epsilon3 48.1%, and epsilon4 carriers 46.4%, respectively, P=0.00039) and replicated in the pravastatin arm (epsilon2 carriers 22.1%, epsilon3/epsilon3 21.8%, and epsilon4 carriers 16.6%, respectively, P=0.00038). The proportion of subjects achieving an LDL-C &lt; or =70 mg/dL at day 30 was higher for epsilon2 than epsilon4 carriers (P=1.3 x 10(-5)). In the pravastatin group, the triallelic rs2032582 variant (G2677T/A) in ABCB1 was associated with the percent reduction in LDL-C (GG 23.3%, non-G heterozygote 20.3%, and non-G homozygote 17.4%, P=0.042). CONCLUSIONS: Carriers of APOE epsilon2 versus epsilon4 had significantly greater LDL-C reduction with atorvastatin and with pravastatin, and more frequently achieved a guideline-recommended LDL-C &lt; or =70 mg/dL. Polymorphisms in triallelic G2677T/A variant in ABCB1 were associated with the degree of LDL-C lowering with pravastatin.", "sentences": [], "annotations": [{"id": "14", "infons": {"identifier": "MESH:D002784", "type": "Chemical"}, "text": "cholesterol", "locations": [{"offset": 198, "length": 11}]}, {"id": "15", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 416, "length": 12}]}, {"id": "16", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 432, "length": 11}]}, {"id": "17", "infons": {"identifier": "rs7412", "type": "Mutation", "subtype": "SNP"}, "text": "rs7412", "locations": [{"offset": 464, "length": 6}]}, {"id": "18", "infons": {"identifier": "rs429358", "type": "Mutation", "subtype": "SNP"}, "text": "rs429358", "locations": [{"offset": 472, "length": 8}]}, {"id": "19", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 1035, "length": 11}]}, {"id": "20", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1069, "length": 9}]}, {"id": "21", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 1088, "length": 8}]}, {"id": "22", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1101, "length": 5}]}, {"id": "23", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 1335, "length": 12}]}, {"id": "24", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 1357, "length": 11}]}, {"id": "25", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 1476, "length": 8}]}, {"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1496, "length": 5}]}, {"id": "27", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 1557, "length": 11}]}], "relations": []}], "relations": [], "pmid": 19667110, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs7412", "chemical@MESH:D000069059", "chemical@MESH:D017035", "mutation@c.2677G>T,A", "mutation@rs2032582", "gene@5243", "mutation@rs429358", "chemical@MESH:D002784"], "journal": "Arterioscler. Thromb. Vasc. Biol.", "year": 2009, "authors": ["Mega JL", "Morrow DA", "Brown A", "Cannon CP", "Sabatine MS"]},
{"_id": "19155191|None", "id": "19155191", "infons": {}, "passages": [{"infons": {"journal": "Curr Opin Pharmacol; 2009 Feb; 9(1) 74-80. doi:10.1016/j.coph.2008.12.016", "year": "2009", "article-id_pmc": "PMC2741727", "type": "title", "authors": "Kreek MJ, Zhou Y, Butelman ER, Levran O", "section": "Title"}, "offset": 0, "text": "Opiate and cocaine addiction: from bench to clinic and back to the bench.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D053610", "type": "Chemical"}, "text": "Opiate", "locations": [{"offset": 0, "length": 6}]}, {"id": "3", "infons": {"identifier": "MESH:D003042", "type": "Chemical"}, "text": "cocaine", "locations": [{"offset": 11, "length": 7}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 74, "text": "This review primarily focuses on our recent findings in bidirectional translational research on opiate and cocaine addictions. First, we present neurobiological and molecular studies on endogenous opioid systems (e.g. proopiomelanocortin, mu opioid receptor, dynorphin, and kappa opioid receptor), brain stress-responsive systems (e.g. orexin, arginine vasopressin, V1b receptor, and corticotropin-releasing factor), hypothalamic-pituitary-adrenal axis, and neurotransmitters (especially dopamine), in response to both chronic cocaine or opiate exposure and to drug withdrawal, using several newly developed animal models and molecular approaches. The second aspect is human molecular genetic association investigations including hypothesis-driven studies and genome-wide array studies, to define particular systems involved in vulnerability to develop specific addictions, and response to pharmacotherapy.", "sentences": [], "annotations": [{"id": "11", "infons": {"identifier": "MESH:D053610", "type": "Chemical"}, "text": "opiate", "locations": [{"offset": 170, "length": 6}]}, {"id": "12", "infons": {"identifier": "MESH:D003042", "type": "Chemical"}, "text": "cocaine", "locations": [{"offset": 181, "length": 7}]}, {"id": "13", "infons": {"identifier": "4986", "type": "Gene", "ncbi_homologene": "20253"}, "text": "mu opioid receptor, dynorphin, and kappa opioid receptor", "locations": [{"offset": 313, "length": 56}]}, {"id": "14", "infons": {"identifier": "3060", "type": "Gene", "ncbi_homologene": "1166"}, "text": "orexin", "locations": [{"offset": 410, "length": 6}]}, {"id": "15", "infons": {"identifier": "553", "type": "Gene", "ncbi_homologene": "22678"}, "text": "vasopressin, V1b receptor", "locations": [{"offset": 427, "length": 25}]}, {"id": "16", "infons": {"identifier": "MESH:D007029", "type": "Disease"}, "text": "hypothalamic-pituitary-adrenal axis", "locations": [{"offset": 491, "length": 35}]}, {"id": "17", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 743, "length": 5}]}], "relations": []}], "relations": [], "pmid": 19155191, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@3060", "gene@553", "chemical@MESH:D003042", "chemical@MESH:D053610", "species@9606", "disease@MESH:D007029", "gene@4986"], "journal": "Curr Opin Pharmacol", "year": 2009, "authors": ["Kreek MJ", "Zhou Y", "Butelman ER", "Levran O"]},
{"_id": "18854777|None", "id": "18854777", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenet. Genomics; 2008 Nov; 18(11) 955-65. doi:10.1097/FPC.0b013e32830efdd4", "year": "2008", "article-id_pmc": "PMC2665725", "type": "title", "authors": "Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, Gu J, Hong WK, Stewart D, Spitz MR", "section": "Title"}, "offset": 0, "text": "Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 90, "length": 11}]}, {"id": "3", "infons": {"identifier": "MESH:D010984", "type": "Chemical"}, "text": "platinum", "locations": [{"offset": 115, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 144, "text": "PURPOSE: Genetic polymorphisms contribute to interindividual variation in drug response. However, a single polymorphism is likely to exhibit a modest effect. Therefore, we applied a pathway-based approach to evaluate the cumulative effect of multiple polymorphisms on clinical outcome of patients with non-small cell lung cancer. METHODS: We genotyped 25 functional polymorphisms in 16 key genes involved in cisplatin metabolism and action and evaluated their associations with overall survival in 229 non-small cell lung cancer patients receiving first-line cisplatin-based chemotherapy. RESULTS: Several biologically plausible main effects were identified in individual analysis. More importantly, when six polymorphisms in nucleotide excision repair genes were analyzed jointly, a significant trend of reduced risk of death with decreasing number of putative unfavorable genotypes was observed (P for trend &lt; 0.001 and log rank P &lt; 0.001). Survival tree analysis revealed potential higher-order gene-gene interactions and categorized subgroups with dramatically different survival experiences, based on distinct genotype profiles. The median survival time was 78.5 months for terminal node 1 in the low-risk group, 15.1 months for terminal node 10 in the medium-risk group, and 6.7 months for terminal node 9 in the high-risk group (log rank P &lt; 0.001). We also constructed a prediction hazard model. The area under the curve increased from 0.71 (using clinical variables only) to 0.84 (using clinical, epidemiological, and genetic variations from survival tree analysis). CONCLUSION: Our results highlight the clinical potential of taking a pathway-based approach and using survival tree analytic approach to identify subgroups of patients with distinctly differing outcomes.", "sentences": [], "annotations": [{"id": "12", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 432, "length": 8}]}, {"id": "13", "infons": {"identifier": "MESH:D002289", "type": "Disease"}, "text": "non-small cell lung cancer", "locations": [{"offset": 446, "length": 26}]}, {"id": "14", "infons": {"identifier": "MESH:D002945", "type": "Chemical"}, "text": "cisplatin", "locations": [{"offset": 552, "length": 9}]}, {"id": "15", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "cell lung cancer", "locations": [{"offset": 656, "length": 16}]}, {"id": "16", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 673, "length": 8}]}, {"id": "17", "infons": {"identifier": "MESH:D002945", "type": "Chemical"}, "text": "cisplatin", "locations": [{"offset": 703, "length": 9}]}, {"id": "18", "infons": {"identifier": "MESH:D003643", "type": "Disease"}, "text": "death", "locations": [{"offset": 965, "length": 5}]}, {"id": "19", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1888, "length": 8}]}], "relations": []}], "relations": [], "pmid": 18854777, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D002945", "disease@MESH:D003643", "disease@MESH:D002289", "disease@MESH:D008175", "species@9606", "chemical@MESH:D010984"], "journal": "Pharmacogenet. Genomics", "year": 2008, "authors": ["Wu X", "Lu C", "Ye Y", "Chang J", "Yang H", "Lin J", "Gu J", "Hong WK", "Stewart D", "Spitz MR"]},
{"_id": "18812236|None", "id": "18812236", "infons": {}, "passages": [{"infons": {"journal": "Epilepsy Behav; 2009 Jan; 14(1) 78-82. doi:10.1016/j.yebeh.2008.08.019", "year": "2009", "type": "title", "authors": "Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B", "section": "Title"}, "offset": 0, "text": "No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 18, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 59, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 98, "text": "Multiple drug resistance is a common problem in the treatment of epilepsy, and approximately 30% of patients continue to have seizures despite all therapeutic interventions. Among various classes of drug transporters, genetic variants of P-glycoprotein (P-gp) encoded by the ABCB1 (ATP-binding cassette subfamily B member 1) gene have been associated with drug-refractory epilepsy. Our aim was to investigate the effect of the 1236C&gt;T(rs1128503), 2677G&gt;T/A(rs2032582), and 3435C&gt;T(rs1045642) single-nucleotide polymorphisms of ABCB1 (or MDR1) on drug resistance in north Indian patients with epilepsy. Genotyping was performed in 101 control subjects and 325 patients with epilepsy, of whom 94 were drug resistant and 231 drug responsive. Therapeutic drug monitoring for phenytoin, carbamazepine, phenobarbital, and valproate was also performed to confirm compliance in 20% of the patients. Genotype and haplotype frequencies of these polymorphisms did not differ between drug-resistant and drug-responsive patients. Our results demonstrate ABCB1 polymorphisms are not associated with drug resistance in north Indian epileptic patients.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 163, "length": 8}]}, {"id": "31", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 198, "length": 8}]}, {"id": "32", "infons": {"identifier": "MESH:D012640", "type": "Disease"}, "text": "seizures", "locations": [{"offset": 224, "length": 8}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 336, "length": 14}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 352, "length": 4}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 373, "length": 5}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ATP-binding cassette subfamily B member 1", "locations": [{"offset": 380, "length": 41}]}, {"id": "37", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 470, "length": 8}]}, {"id": "38", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 536, "length": 9}]}, {"id": "39", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 561, "length": 9}]}, {"id": "40", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 588, "length": 9}]}, {"id": "41", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 634, "length": 5}]}, {"id": "42", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 644, "length": 4}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 685, "length": 8}]}, {"id": "44", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 699, "length": 8}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 766, "length": 8}]}, {"id": "46", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 780, "length": 8}]}, {"id": "47", "infons": {"identifier": "MESH:D010672", "type": "Chemical"}, "text": "phenytoin", "locations": [{"offset": 878, "length": 9}]}, {"id": "48", "infons": {"identifier": "MESH:D002220", "type": "Chemical"}, "text": "carbamazepine", "locations": [{"offset": 889, "length": 13}]}, {"id": "49", "infons": {"identifier": "MESH:D010634", "type": "Chemical"}, "text": "phenobarbital", "locations": [{"offset": 904, "length": 13}]}, {"id": "50", "infons": {"identifier": "MESH:D014635", "type": "Chemical"}, "text": "valproate", "locations": [{"offset": 923, "length": 9}]}, {"id": "51", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 988, "length": 8}]}, {"id": "52", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1114, "length": 8}]}, {"id": "53", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1148, "length": 5}]}, {"id": "54", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epileptic", "locations": [{"offset": 1224, "length": 9}]}, {"id": "55", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1234, "length": 8}]}], "relations": []}], "relations": [], "pmid": 18812236, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D012640", "species@9606", "mutation@rs2032582", "chemical@MESH:D014635", "chemical@MESH:D010672", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D004827", "chemical@MESH:D010634", "chemical@MESH:D002220"], "journal": "Epilepsy Behav", "year": 2009, "authors": ["Lakhan R", "Misra UK", "Kalita J", "Pradhan S", "Gogtay NJ", "Singh MK", "Mittal B"]},
{"_id": "18784455|None", "id": "18784455", "infons": {}, "passages": [{"infons": {"journal": "AIDS; 2008 Oct 01; 22(15) 1919-27. doi:10.1097/QAD.0b013e32830e011f", "year": "2008", "article-id_pmc": "PMC2675161", "type": "title", "authors": "Gupta SK, Rosenkranz SL, Cramer YS, Koletar SL, Szczech LA, Amorosa V, Hall SD", "section": "Title"}, "offset": 0, "text": "The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "efavirenz", "locations": [{"offset": 45, "length": 9}]}, {"id": "6", "infons": {"identifier": "MESH:D061466", "type": "Chemical"}, "text": "lopinavir", "locations": [{"offset": 59, "length": 9}]}, {"id": "7", "infons": {"identifier": "MESH:D019438", "type": "Chemical"}, "text": "ritonavir", "locations": [{"offset": 69, "length": 9}]}, {"id": "8", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected", "locations": [{"offset": 82, "length": 12}]}, {"id": "9", "infons": {"identifier": "9606", "type": "Species"}, "text": "persons", "locations": [{"offset": 95, "length": 7}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 127, "text": "OBJECTIVE: To evaluate the pharmacokinetics and pharmacogenomics of efavirenz (EFV) and lopinavir/ritonavir (LPV/RTV) in HIV-infected persons requiring hemodialysis. DESIGN: Prospective, observational study of HIV-infected hemodialysis patients receiving one 600 mg tablet daily of EFV (N = 13) or three 133.3/33.3 mg capsules twice daily of LPV/RTV (N = 13). METHODS: Twenty-four-hour EFV and 12-h LPV/RTV pharmacokinetics were assessed. Geometric mean ratios were calculated using historical controls with normal renal function. The effects of several candidate gene polymorphisms were also explored. RESULTS: The geometric mean [95% confidence interval (CI); percentage of coefficient of variation (% CV)] Cmin, Cmax, and area under the curve (AUC) for the EFV group were 1.81 microg/ml (0.93, 3.53; 103%), 5.04 microg/ml (3.48, 7.29; 72%), and 71.5 microg h/ml (43.2, 118.3; 93%), respectively. These parameters were 2.76 microg/ml (1.86, 4.11; 53%), 8.45 microg/ml (6.41, 11.15; 52%), and 69.6 microg h/ml (55.6, 87.2; 37%) for LPV and 0.08 microg/ml (0.05, 0.14; 63%), 0.58 microg/ml (0.44, 0.76; 41%), and 3.74 microg h/ml (2.91, 4.80; 37%) for RTV. The AUC geometric mean ratios (90% CI) for EFV, LPV, and RTV were 132% (89, 197), 81% (67, 97), and 92% (76, 111), respectively. LPV Cmin was lower than expected in the hemodialysis group. Higher EFV concentrations were associated with the CYP2B6 516G&gt;T polymorphism. CONCLUSION: The pharmacokinetics of EFV and LPV/RTV in hemodialysis suggests that no dosing adjustments are necessary in treatment-naive patients. As HIV-infected hemodialysis patients are disproportionately black, the increased frequency of the CYP2B6 516G&gt;T polymorphism may lead to higher EFV levels. The potentially lower LPV trough levels in this population suggest that LPV/RTV should be used with caution in protease-inhibitor-experienced patients.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "efavirenz", "locations": [{"offset": 195, "length": 9}]}, {"id": "31", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 206, "length": 3}]}, {"id": "32", "infons": {"identifier": "MESH:D061466", "type": "Chemical"}, "text": "lopinavir", "locations": [{"offset": 215, "length": 9}]}, {"id": "33", "infons": {"identifier": "MESH:D019438", "type": "Chemical"}, "text": "ritonavir", "locations": [{"offset": 225, "length": 9}]}, {"id": "34", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected", "locations": [{"offset": 248, "length": 12}]}, {"id": "35", "infons": {"identifier": "9606", "type": "Species"}, "text": "persons", "locations": [{"offset": 261, "length": 7}]}, {"id": "36", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected hemodialysis", "locations": [{"offset": 337, "length": 25}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 363, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 409, "length": 3}]}, {"id": "39", "infons": {"identifier": "MESH:D061466", "type": "Chemical"}, "text": "LPV", "locations": [{"offset": 469, "length": 3}]}, {"id": "40", "infons": {"identifier": "MESH:D019438", "type": "Chemical"}, "text": "RTV", "locations": [{"offset": 473, "length": 3}]}, {"id": "41", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 513, "length": 3}]}, {"id": "42", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 887, "length": 3}]}, {"id": "43", "infons": {"identifier": "1555", "type": "Gene", "ncbi_homologene": "73894"}, "text": "CYP2B6", "locations": [{"offset": 1524, "length": 6}]}, {"id": "44", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1692, "length": 8}]}, {"id": "45", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected hemodialysis", "locations": [{"offset": 1705, "length": 25}]}, {"id": "46", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1731, "length": 8}]}, {"id": "47", "infons": {"identifier": "1555", "type": "Gene", "ncbi_homologene": "73894"}, "text": "CYP2B6", "locations": [{"offset": 1801, "length": 6}]}, {"id": "48", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 1850, "length": 3}]}, {"id": "49", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2004, "length": 8}]}], "relations": []}], "relations": [], "pmid": 18784455, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D015658", "chemical@MESH:D019438", "species@9606", "gene@1555", "chemical@MESH:C098320", "chemical@MESH:D061466"], "journal": "AIDS", "year": 2008, "authors": ["Gupta SK", "Rosenkranz SL", "Cramer YS", "Koletar SL", "Szczech LA", "Amorosa V", "Hall SD"]},
{"_id": "18725235|None", "id": "18725235", "infons": {}, "passages": [{"infons": {"journal": "Neuropharmacology; 2009; 56 Suppl 132-43. doi:10.1016/j.neuropharm.2008.07.042", "year": "2009", "article-id_pmc": "PMC2741728", "type": "title", "authors": "Kreek MJ, Schlussman SD, Reed B, Zhang Y, Nielsen DA, Levran O, Zhou Y, Butelman ER", "section": "Title"}, "offset": 0, "text": "Bidirectional translational research: Progress in understanding addictive diseases.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D000437", "type": "Disease"}, "text": "addictive diseases", "locations": [{"offset": 64, "length": 18}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 84, "text": "The focus of this review is primarily on recent developments in bidirectional translational research on the addictions, within the Laboratory of the Biology of Addictive Diseases at The Rockefeller University. This review is subdivided into major interacting aspects, including (a) Investigation of neurobiological and molecular adaptations (e.g., in genes for the opioid receptors or endogenous neuropeptides) in response to cocaine or opiates, administered under laboratory conditions modeling chronic patterns of human self-exposure (e.g., chronic escalating \"binge\"). (b) The impact of such drug exposure on the hypothalamic-pituitary-adrenal (HPA) axis and interacting neuropeptidergic systems (e.g., opioid, orexin and vasopressin). (c) Molecular genetic association studies using candidate gene and whole genome approaches, to define particular systems involved in vulnerability to develop specific addictions, and response to pharmacotherapy. (d) Neuroendocrine challenge studies in normal volunteers and current addictive disease patients along with former addicts in treatment, to investigate differential pharmacodynamics and responsiveness of molecular targets, in particular those also investigated in the experimental and molecular genetic approaches as described above.", "sentences": [], "annotations": [{"id": "9", "infons": {"identifier": "MESH:D003042", "type": "Chemical"}, "text": "cocaine", "locations": [{"offset": 510, "length": 7}]}, {"id": "10", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 600, "length": 5}]}, {"id": "11", "infons": {"identifier": "MESH:D007029", "type": "Disease"}, "text": "hypothalamic-pituitary-adrenal (HPA) axis", "locations": [{"offset": 700, "length": 41}]}, {"id": "12", "infons": {"identifier": "3060", "type": "Gene", "ncbi_homologene": "1166"}, "text": "orexin", "locations": [{"offset": 798, "length": 6}]}, {"id": "13", "infons": {"identifier": "551", "type": "Gene", "ncbi_homologene": "417"}, "text": "vasopressin", "locations": [{"offset": 809, "length": 11}]}, {"id": "14", "infons": {"identifier": "MESH:D000437", "type": "Disease"}, "text": "addictive disease", "locations": [{"offset": 1105, "length": 17}]}, {"id": "15", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1123, "length": 8}]}], "relations": []}], "relations": [], "pmid": 18725235, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@3060", "chemical@MESH:D003042", "species@9606", "gene@551", "disease@MESH:D007029", "disease@MESH:D000437"], "journal": "Neuropharmacology", "year": 2009, "authors": ["Kreek MJ", "Schlussman SD", "Reed B", "Zhang Y", "Nielsen DA", "Levran O", "Zhou Y", "Butelman ER"]},
{"_id": "18698231|None", "id": "18698231", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenet. Genomics; 2008 Sep; 18(9) 781-91. doi:10.1097/FPC.0b013e3283050107", "year": "2008", "article-id_pmc": "PMC2779843", "type": "title", "authors": "Johnson AD, Zhang Y, Papp AC, Pinsonneault JK, Lim JE, Saffen D, Dai Z, Wang D, Sad\u00e9e W", "section": "Title"}, "offset": 0, "text": "Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 149, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 171, "text": "BACKGROUND: Genetic variation in mRNA expression plays a critical role in human phenotypic diversity, but it has proven difficult to detect regulatory polymorphisms - mostly single nucleotide polymorphisms (rSNPs). Additionally, variants in the transcribed region, termed here 'structural RNA SNPs' (srSNPs), can affect mRNA processing and turnover. Both rSNPs and srSNPs cause allelic mRNA expression imbalance (AEI) in heterozygous individuals. We have used AEI to discover and characterize regulatory polymorphisms in OPRM1, TPH2, MDR1, DRD2, and VKORC1. The objective of this study was to use AEI to determine the extent of cis-regulatory factors in pharmacogenetic genes. METHODS: We applied a rapid and accurate AEI methodology for testing 42 genes implicated in cardiovascular and central nervous system diseases, and affecting drug metabolism and transport. Each gene was analyzed in physiologically relevant human autopsy tissues, including brain, heart, liver, intestines, and lymphocytes. RESULTS: Substantial AEI was observed in approximately 55% of the surveyed genes. Focusing on cardiovascular candidate genes in human hearts, AEI analysis revealed frequent cis-acting regulatory factors in ACE and SOD2 mRNA expression, having potential clinical significance. SNP scanning to locate regulatory polymorphisms in a number of genes failed to support several previously proposed promoter SNPs discovered with use of reporter gene assays in heterologous tissues, while srSNPs appear more frequent than expected. Computational analysis of mRNA folding indicates that approximately 90% of srSNPs affect mRNA folding, and hence potentially function. CONCLUSION: Our results indicate that both rSNPs and srSNPs represent a still largely untapped reservoir of variants that contribute to human phenotypic diversity.", "sentences": [], "annotations": [{"id": "14", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 245, "length": 5}]}, {"id": "15", "infons": {"identifier": "4988", "type": "Gene", "ncbi_homologene": "37368"}, "text": "OPRM1", "locations": [{"offset": 692, "length": 5}]}, {"id": "16", "infons": {"identifier": "121278", "type": "Gene", "ncbi_homologene": "27831"}, "text": "TPH2", "locations": [{"offset": 699, "length": 4}]}, {"id": "17", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 705, "length": 4}]}, {"id": "18", "infons": {"identifier": "1813", "type": "Gene", "ncbi_homologene": "22561"}, "text": "DRD2", "locations": [{"offset": 711, "length": 4}]}, {"id": "19", "infons": {"identifier": "79001", "type": "Gene", "ncbi_homologene": "11416"}, "text": "VKORC1", "locations": [{"offset": 721, "length": 6}]}, {"id": "20", "infons": {"identifier": "MESH:D002318", "type": "Disease"}, "text": "cardiovascular and central nervous system diseases", "locations": [{"offset": 940, "length": 50}]}, {"id": "21", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 1088, "length": 5}]}, {"id": "22", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 1299, "length": 5}]}, {"id": "23", "infons": {"identifier": "1636", "type": "Gene", "ncbi_homologene": "37351"}, "text": "ACE", "locations": [{"offset": 1377, "length": 3}]}, {"id": "24", "infons": {"identifier": "6648", "type": "Gene", "ncbi_homologene": "530"}, "text": "SOD2", "locations": [{"offset": 1385, "length": 4}]}, {"id": "25", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 1965, "length": 5}]}], "relations": []}], "relations": [], "pmid": 18698231, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["gene@6648", "gene@1636", "gene@1813", "gene@121278", "gene@79001", "species@9606", "gene@4988", "gene@5243", "disease@MESH:D002318"], "journal": "Pharmacogenet. Genomics", "year": 2008, "authors": ["Johnson AD", "Zhang Y", "Papp AC", "Pinsonneault JK", "Lim JE", "Saffen D", "Dai Z", "Wang D", "Sad\u00e9e W"]},
{"_id": "18518969|None", "id": "18518969", "infons": {}, "passages": [{"infons": {"journal": "BMC Med Genomics; 2008 Jun 02; 121. doi:10.1186/1755-8794-1-21", "year": "2008", "article-id_pmc": "PMC2424071", "type": "title", "authors": "Bochud M, Eap CB, Maillard M, Johnson T, Vollenweider P, Bovet P, Elston RC, Bergmann S, Beckmann JS, Waterworth DM, Mooser V, Gabriel A, Burnier M", "section": "Title"}, "offset": 0, "text": "Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 15, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 89, "text": "BACKGROUND: The P-glycoprotein, encoded by the ABCB1 gene, is expressed in human endothelial and mesangial cells, which contribute to control renal plasma flow and glomerular filtration rate. We investigated the association of ABCB1 variants with renal function in African and Caucasian subjects. METHODS: In Africans (290 subjects from 62 pedigrees), we genotyped the 2677G&gt;T and 3435 C&gt;T ABCB1 polymorphisms. Glomerular filtration rate (GFR) was measured using inulin clearance and effective renal plasma flow (ERPF) using para-aminohippurate clearance. In Caucasians (5382 unrelated subjects), we analyzed 30 SNPs located within and around ABCB1, using data from the Affymetrix 500 K chip. GFR was estimated using the simplified Modification of the Diet in Renal Disease (MDRD) and Cockcroft-Gault equations. RESULTS: In Africans, compared to the reference genotype (GG or CC), each copy of the 2677T and 3435T allele was associated, respectively, with: GFR higher by 10.6 +/- 2.9 (P &lt; 0.001) and 4.4 +/- 2.3 (P = 0.06) mL/min; ERPF higher by 47.5 +/- 11.6 (P &lt; 0.001) and 28.1 +/- 10.5 (P = 0.007) mL/min; and renal resistances lower by 0.016 +/- 0.004 (P &lt; 0.001) and 0.011 +/- 0.004 (P = 0.004) mm Hg/mL/min. In Caucasians, we identified 3 polymorphisms in the ABCB1 gene that were strongly associated with all estimates of GFR (smallest P value = 0.0006, overall P = 0.014 after multiple testing correction). CONCLUSION: Variants of the ABCB1 gene were associated with renal function in both Africans and Caucasians and may therefore confer susceptibility to nephropathy in humans. If confirmed in other studies, these results point toward a new candidate gene for nephropathy in humans.", "sentences": [], "annotations": [{"id": "17", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 105, "length": 14}]}, {"id": "18", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 136, "length": 5}]}, {"id": "19", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 164, "length": 5}]}, {"id": "20", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 316, "length": 5}]}, {"id": "21", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 485, "length": 5}]}, {"id": "22", "infons": {"identifier": "MESH:D010130", "type": "Chemical"}, "text": "para-aminohippurate", "locations": [{"offset": 620, "length": 19}]}, {"id": "23", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 738, "length": 5}]}, {"id": "24", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "Renal Disease", "locations": [{"offset": 855, "length": 13}]}, {"id": "25", "infons": {"type": "Disease", "identifier": null, "db": null}, "text": "MDRD", "locations": [{"offset": 870, "length": 4}]}, {"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1371, "length": 5}]}, {"id": "27", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1548, "length": 5}]}, {"id": "28", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephropathy", "locations": [{"offset": 1670, "length": 11}]}, {"id": "29", "infons": {"identifier": "9606", "type": "Species"}, "text": "humans", "locations": [{"offset": 1685, "length": 6}]}, {"id": "30", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephropathy", "locations": [{"offset": 1776, "length": 11}]}, {"id": "31", "infons": {"identifier": "9606", "type": "Species"}, "text": "humans", "locations": [{"offset": 1791, "length": 6}]}], "relations": []}], "relations": [], "pmid": 18518969, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D010130", "species@9606", "gene@5243", "disease@MESH:D007674"], "journal": "BMC Med Genomics", "year": 2008, "authors": ["Bochud M", "Eap CB", "Maillard M", "Johnson T", "Vollenweider P", "Bovet P", "Elston RC", "Bergmann S", "Beckmann JS", "Waterworth DM", "Mooser V", "Gabriel A", "Burnier M"]},
{"_id": "18442890|None", "id": "18442890", "infons": {}, "passages": [{"infons": {"journal": "Genomics; 2008 Jun; 91(6) 512-6. doi:10.1016/j.ygeno.2008.03.004", "year": "2008", "type": "title", "authors": "Ichihara S, Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Kojima T, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y", "section": "Title"}, "offset": 0, "text": "Association of a polymorphism of ABCB1 with obesity in Japanese individuals.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 33, "length": 5}]}, {"id": "3", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 44, "length": 7}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 77, "text": "The aim of the present study was to identify gene polymorphisms that confer susceptibility to obesity. A total of 5448 unrelated Japanese individuals from two independent populations were examined: subject panel A comprised 4252 individuals who visited participating hospitals; subject panel B comprised 1196 community-dwelling elderly individuals. The genotypes for 95 polymorphisms of 67 candidate genes were determined. The chi(2) test revealed that six polymorphisms were related (p&lt;0.05) to the prevalence of obesity in subject panel A; after application of Bonferroni's correction, however, only the 2677G --&gt; A/T polymorphism (rs2032582) of the ATP-binding cassette, subfamily B, member 1 gene (ABCB1) was significantly associated (p=0.0003) with obesity. Subsequent multivariable logistic regression analysis also revealed that the 2677G --&gt; A/T polymorphism of ABCB1 was significantly associated with obesity. For validation of this association, the 2677G --&gt; A/T polymorphism of ABCB1 was examined in subject panel B and again found to be significantly associated with obesity. Body mass index was significantly (p=0.01) greater for individuals with the variant T allele of this polymorphism than for those with the GG genotype in the combined subject panels A and B. Our results suggest that the ABCB1 genotype may prove informative for assessment of genetic risk for obesity in Japanese individuals.", "sentences": [], "annotations": [{"id": "16", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 171, "length": 7}]}, {"id": "17", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 594, "length": 7}]}, {"id": "18", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 717, "length": 9}]}, {"id": "19", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ATP-binding cassette, subfamily B, member 1", "locations": [{"offset": 735, "length": 43}]}, {"id": "20", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 785, "length": 5}]}, {"id": "21", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 837, "length": 7}]}, {"id": "22", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 956, "length": 5}]}, {"id": "23", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 996, "length": 7}]}, {"id": "24", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1078, "length": 5}]}, {"id": "25", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 1168, "length": 7}]}, {"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1396, "length": 5}]}, {"id": "27", "infons": {"identifier": "MESH:D009765", "type": "Disease"}, "text": "obesity", "locations": [{"offset": 1468, "length": 7}]}], "relations": []}], "relations": [], "pmid": 18442890, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["mutation@rs2032582", "disease@MESH:D009765", "gene@5243"], "journal": "Genomics", "year": 2008, "authors": ["Ichihara S", "Yamada Y", "Kato K", "Hibino T", "Yokoi K", "Matsuo H", "Kojima T", "Watanabe S", "Metoki N", "Yoshida H", "Satoh K", "Aoyagi Y", "Yasunaga A", "Park H", "Tanaka M", "Nozawa Y"]},
{"_id": "18424454|None", "id": "18424454", "infons": {}, "passages": [{"infons": {"journal": "Hum. Mol. Genet.; 2008 Jul 15; 17(14) 2219-27. doi:10.1093/hmg/ddn122", "year": "2008", "article-id_pmc": "PMC2599947", "type": "title", "authors": "Levran O, O Hara K, Peles E, Li D, Barral S, Ray B, Borg L, Ott J, Adelson M, Kreek MJ", "section": "Title"}, "offset": 0, "text": "ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.", "sentences": [], "annotations": [{"id": "3", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 7, "length": 4}]}, {"id": "5", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 50, "length": 9}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 121, "text": "Methadone is a mu-opioid receptor agonist used for treating opiate dependence. The range of effective methadone doses is broad. Part of the large inter-individual variability in efficacy may be accounted for by genetic factors. Methadone is a substrate of the transporter P-glycoprotein (P-gp) 170 that is encoded by the ABCB1 (MDR1) gene. Thus, P-gp variants may play a role in methadone absorption and distribution. We assessed the association between ABCB1 polymorphisms and methadone dose requirements in 98 methadone-maintained patients. The stabilizing methadone doses were normally distributed with a mean and median dose of 160 mg/day (range 30-280 mg/day). Statistical analysis showed significant difference in genotype frequencies between the 'higher' (&gt;150 mg/day) and 'lower' (&lt; or =150 mg/day) methadone dose groups for single nucleotide polymorphism (SNP) 1236C&gt;T (rs1128503) (experiment-wise P = 0.0325). Furthermore, individuals bearing the 3-locus genotype pattern TT-TT-TT (rs1045642, rs2032582 and rs1128503) have an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise P-value = 0.026). These data suggest that specific ABCB1 variants may have clinical relevance by influencing the methadone dose required to prevent withdrawal symptoms and relapse in this population.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "Methadone", "locations": [{"offset": 121, "length": 9}]}, {"id": "31", "infons": {"identifier": "MESH:D009293", "type": "Disease"}, "text": "opiate dependence", "locations": [{"offset": 181, "length": 17}]}, {"id": "32", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 223, "length": 9}]}, {"id": "33", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "Methadone", "locations": [{"offset": 349, "length": 9}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 393, "length": 14}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 409, "length": 4}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 442, "length": 5}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 449, "length": 4}]}, {"id": "38", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 467, "length": 4}]}, {"id": "39", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 500, "length": 9}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 575, "length": 5}]}, {"id": "41", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 599, "length": 9}]}, {"id": "42", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 633, "length": 9}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 654, "length": 8}]}, {"id": "44", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 680, "length": 9}]}, {"id": "45", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 934, "length": 9}]}, {"id": "46", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1009, "length": 9}]}, {"id": "47", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1122, "length": 9}]}, {"id": "48", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1133, "length": 9}]}, {"id": "49", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 1147, "length": 9}]}, {"id": "50", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 1220, "length": 9}]}, {"id": "51", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 1354, "length": 9}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1432, "length": 5}]}, {"id": "53", "infons": {"identifier": "MESH:D008691", "type": "Chemical"}, "text": "methadone", "locations": [{"offset": 1494, "length": 9}]}], "relations": []}], "relations": [], "pmid": 18424454, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D008691", "disease@MESH:D009293", "species@9606", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "mutation@rs1045642"], "journal": "Hum. Mol. Genet.", "year": 2008, "authors": ["Levran O", "O Hara K", "Peles E", "Li D", "Barral S", "Ray B", "Borg L", "Ott J", "Adelson M", "Kreek MJ"]},
{"_id": "18213362|None", "id": "18213362", "infons": {}, "passages": [{"infons": {"journal": "Biol Proced Online; 2007 Nov 01; 927-42. doi:10.1251/bpo131", "year": "2007", "article-id_pmc": "PMC2211573", "type": "title", "authors": "Koo SH, Ong TC, Chong KT, Lee CG, Chew FT, Lee EJ", "section": "Title"}, "offset": 0, "text": "Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array.", "sentences": [], "annotations": [], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 91, "text": "We have developed and validated a consolidated bead-based genotyping platform, the Bioplex suspension array for simultaneous detection of multiple single nucleotide polymorphisms (SNPs) of the ATP-binding cassette transporters. Genetic polymorphisms have been known to influence therapeutic response and risk of disease pathologies. Genetic screening for therapeutic and diagnostic applications thus holds great promise in clinical management. The allele-specific primer extension (ASPE) reaction was used to assay 22 multiplexed SNPs for eight subjects. Comparison of the microsphere-based ASPE assay results to sequencing results showed complete concordance in genotype assignments. The Bioplex suspension array thus proves to be a reliable, cost-effective and high-throughput technological platform for genotyping. It can be easily adapted to customized SNP panels for specific applications involving large-scale mutation screening of clinically relevant markers.", "sentences": [], "annotations": [], "relations": []}], "relations": [], "pmid": 18213362, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": [], "journal": "Biol Proced Online", "year": 2007, "authors": ["Koo SH", "Ong TC", "Chong KT", "Lee CG", "Chew FT", "Lee EJ"]},
{"_id": "17674045|None", "id": "17674045", "infons": {}, "passages": [{"infons": {"journal": "J. Cancer Res. Clin. Oncol.; 2008 Mar; 134(3) 317-22", "year": "2008", "type": "title", "authors": "Petrova DT, Nedeva P, Maslyankov S, Toshev S, Yaramov N, Atanasova S, Toncheva D, Oellerich M, von Ahsen N", "section": "Title"}, "offset": 0, "text": "No association between MDR1 (ABCB1) 2677G&gt;T and 3435C&gt;T polymorphism and sporadic colorectal cancer among Bulgarian patients.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 23, "length": 4}]}, {"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 29, "length": 5}]}, {"id": "6", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 88, "length": 17}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 122, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 132, "text": "PURPOSE: Variation in genetic factors together with xenobiotic exposure may result in increased risk of colorectal cancer. The P-glycoprotein (P-gp) is highly expressed in the apical membrane of enterocytes, where it pumps xenobiotics from the enterocytes back into the intestinal lumen. Thus, polymorphisms that reduce the activity of the MDR1 (ABCB1) efflux pump are potential risk factors for colorectal carcinogenesis. The aim of the present study is to genotype the MDR1 2677G&gt;T (rs2032582) and 3435C&gt;T (rs1045642) polymorphism in patients with colorectal cancer and controls and to identify a possible association between individual genetic variation and susceptibility to colorectal cancer. METHODS: In the present study, 146 Bulgarian patients with sporadic colorectal cancer and 160 healthy Bulgarian volunteers were evaluated for the two polymorphisms in MDR1. Polymorphisms were identified using rapid-cycle real-time amplification with allele-specific probes and subsequent melting curve analyses on a LightCyclertrade mark (Roche Diagnostics, Mannheim, Germany). RESULTS: No differences were found between the frequencies of the two mutant alleles in the tumor tissue from the cases and lymphocytes from the controls [frequencies of 2677T: 43.5% in patients and 44.1% in controls; frequencies of 3435T: 48.3% in patients and 50.9% in controls (both P &gt; 0.05)]. The MDR1 polymorphic sequence of the tumor tissue always matched that of normal intestinal tissue from the same patient. Consequently, genotyping of DNA from archived tumor tissues is a valid alternative to the use of leukocyte DNA. CONCLUSIONS: The present study suggests that MDR1 2677G&gt;T and 3435C&gt;T polymorphism is not a risk factor for sporadic colon cancer among Bulgarians and that somatic mutation at these sites is not involved in the genesis of colon tumors. Further examination using larger number of samples must be necessary to reach to more reliable conclusions.", "sentences": [], "annotations": [{"id": "33", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 236, "length": 17}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 259, "length": 14}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 275, "length": 4}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 472, "length": 4}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 478, "length": 5}]}, {"id": "38", "infons": {"identifier": "MESH:D063646", "type": "Disease"}, "text": "colorectal carcinogenesis", "locations": [{"offset": 528, "length": 25}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 603, "length": 4}]}, {"id": "40", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 620, "length": 9}]}, {"id": "41", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 647, "length": 9}]}, {"id": "42", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 674, "length": 8}]}, {"id": "43", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 688, "length": 17}]}, {"id": "44", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 817, "length": 17}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 881, "length": 8}]}, {"id": "46", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "sporadic colorectal cancer", "locations": [{"offset": 895, "length": 26}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1003, "length": 4}]}, {"id": "48", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1306, "length": 5}]}, {"id": "49", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1400, "length": 8}]}, {"id": "50", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1463, "length": 8}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1519, "length": 4}]}, {"id": "52", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1552, "length": 5}]}, {"id": "53", "infons": {"identifier": "9606", "type": "Species"}, "text": "patient", "locations": [{"offset": 1627, "length": 7}]}, {"id": "54", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1682, "length": 5}]}, {"id": "55", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1793, "length": 4}]}, {"id": "56", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "sporadic colon cancer", "locations": [{"offset": 1862, "length": 21}]}, {"id": "57", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colon tumors", "locations": [{"offset": 1976, "length": 12}]}], "relations": []}], "relations": [], "pmid": 17674045, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D063646", "species@9606", "disease@MESH:D015179", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "disease@MESH:D009369"], "journal": "J. Cancer Res. Clin. Oncol.", "year": 2008, "authors": ["Petrova DT", "Nedeva P", "Maslyankov S", "Toshev S", "Yaramov N", "Atanasova S", "Toncheva D", "Oellerich M", "von Ahsen N"]},
{"_id": "17548681|None", "id": "17548681", "infons": {}, "passages": [{"infons": {"journal": "Cancer Epidemiol. Biomarkers Prev.; 2007 Jun; 16(6) 1172-7", "year": "2007", "type": "title", "authors": "Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL", "section": "Title"}, "offset": 0, "text": "MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 0, "length": 4}]}, {"id": "3", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "acute lymphoblastic leukemia", "locations": [{"offset": 75, "length": 28}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 105, "text": "OBJECTIVE: The multidrug resistance (MDR) 1 gene encodes a membrane transporter called P-glycoprotein, which plays an important role in protecting cells against lipophilic xenobiotics by way of an ATP-dependent cellular efflux mechanism. Among children enrolled in the Northern California Childhood Leukemia Study, we examined the susceptibility conferred by MDR1 single nucleotide polymorphisms (SNP) and predicted haplotypes and whether they modify the association between indoor insecticide exposure and risk of childhood acute lymphoblastic leukemia (ALL). METHODS: Buccal cell DNA from ALL cases (n = 294) and controls (n = 369) individually matched on gender, date of birth, Hispanic status, and maternal race were whole genome amplified and genotyped for four MDR1 SNPs, T-129C (rs3213619), C1236T (rs1128503), G2677T/A (rs2032582), and C3435T (rs1045642). Detailed and time-specific information on household pesticide use was obtained using in-home interviews with the mother. RESULTS: Allele frequencies in non-Hispanic White and Hispanic controls were similar, and with the exception of T-129C, seemed to be in strong linkage disequilibrium. Overall, the SNPs considered individually or within haplotypes (C1236T-G2677T/A-C3435T) were not significantly associated with childhood ALL. However, we observed strong evidence of a differential effect of indoor insecticide exposure (interaction odds ratio, 0.31; 95% confidence interval, 0.15-0.64; P = 0.025) on risk of ALL between carriers and noncarriers of haplotype CGC. CONCLUSION: These preliminary data suggest that children carrying the haplotype CGC may be less susceptible to the leukemogenic effects of indoor insecticide exposures. Future studies are needed to confirm these findings.", "sentences": [], "annotations": [{"id": "24", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "multidrug resistance (MDR) 1", "locations": [{"offset": 120, "length": 28}]}, {"id": "25", "infons": {"identifier": "MESH:D000255", "type": "Chemical"}, "text": "ATP", "locations": [{"offset": 302, "length": 3}]}, {"id": "26", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 349, "length": 8}]}, {"id": "27", "infons": {"identifier": "MESH:D004670", "type": "Disease"}, "text": "California Childhood Leukemia", "locations": [{"offset": 383, "length": 29}]}, {"id": "28", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 464, "length": 4}]}, {"id": "29", "infons": {"identifier": "MESH:D054198", "type": "Disease"}, "text": "acute lymphoblastic leukemia", "locations": [{"offset": 630, "length": 28}]}, {"id": "30", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 872, "length": 4}]}, {"id": "31", "infons": {"identifier": "rs3213619", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.-129T>C;RS#:3213619", "hgvs": "c.-129T>C", "identifiers": ["rs3213619"]}, "text": "T-129C", "locations": [{"offset": 883, "length": 6}]}, {"id": "32", "infons": {"identifier": "rs3213619", "type": "Mutation", "subtype": "SNP"}, "text": "rs3213619", "locations": [{"offset": 891, "length": 9}]}, {"id": "33", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 903, "length": 6}]}, {"id": "34", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "SNP"}, "text": "rs1128503", "locations": [{"offset": 911, "length": 9}]}, {"id": "35", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation"}, "text": "G2677T/A", "locations": [{"offset": 923, "length": 8}]}, {"id": "36", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 933, "length": 9}]}, {"id": "37", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 949, "length": 6}]}, {"id": "38", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 957, "length": 9}]}, {"id": "39", "infons": {"identifier": "rs3213619", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.-129T>C;RS#:3213619", "hgvs": "c.-129T>C", "identifiers": ["rs3213619"]}, "text": "T-129C", "locations": [{"offset": 1202, "length": 6}]}, {"id": "40", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 1321, "length": 6}]}, {"id": "41", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "DNAMutation"}, "text": "G2677T/A", "locations": [{"offset": 1328, "length": 8}]}, {"id": "42", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 1337, "length": 6}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 1684, "length": 8}]}], "relations": []}], "relations": [], "pmid": 17548681, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "mutation@c.2677G>T,A", "mutation@rs3213619", "mutation@rs2032582", "gene@5243", "mutation@rs1128503", "disease@MESH:D054198", "chemical@MESH:D000255", "mutation@rs1045642", "disease@MESH:D004670"], "journal": "Cancer Epidemiol. Biomarkers Prev.", "year": 2007, "authors": ["Urayama KY", "Wiencke JK", "Buffler PA", "Chokkalingam AP", "Metayer C", "Wiemels JL"]},
{"_id": "17146660|None", "id": "17146660", "infons": {}, "passages": [{"infons": {"journal": "Eur. J. Clin. Pharmacol.; 2007 Jan; 63(1) 9-16", "year": "2007", "type": "title", "authors": "Osswald E, Johne A, Laschinski G, Arjomand-Nahad F, Malzahn U, Kirchheiner J, Gerloff T, Meisel C, Mrozikiewicz PM, Chernov J, Roots I, K\u00f6pke K", "section": "Title"}, "offset": 0, "text": "Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 15, "length": 4}]}, {"id": "3", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 53, "length": 17}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 93, "text": "OBJECTIVE: The multidrug resistance gene 1 (MDR1) seems to play a role in the carcinogenesis of colorectal tumors. The importance of MDR1 SNPs 2677G &gt; T/A in exon 21 and 3435C &gt; T in exon 26 for cancer susceptibility, however, has not yet been clearly defined. METHODS: Two hundred and eighty-five colorectal cancer patients and 275 controls from five hospitals in the European part of Russia were genotyped for the polymorphisms -129T &gt; C (rs3213619) in exon 1b, 2677G &gt; T/A (rs2032582), and 3435C &gt; T (rs1045642) in this population-based case-control study. Genotype-phenotype analysis was performed with simultaneous consideration of lifestyle risk factors. RESULTS: Our analysis confirmed the preponderate impact of smoking on colorectal cancer development. The risk of heavy smokers (&gt;/=60 pack years) to develop colorectal cancer by far exceeded that of lifelong non-smokers (OR = 3.9, 95% CI: 1.4 to 10.6). Smoking is a more potent risk factor than is the genetic influence of MDR1 in our study. However, a smoking and age-stratified analysis, revealed a statistically significant association between MDR1 genotypes and colorectal cancer in life-long non-smokers with an age &gt; or =63 years (the median age in our sample). The association was stronger for rectal cancer than for colon cancer. Patients who carried the genotypes (-129TT; 2677GG; 3435CC) or (-129TT; 2677TT; 3435TT) developed more frequently colorectal cancer than others (OR = 3.9; 95% CI: 2.0 to 7.7). CONCLUSIONS: Our results show that the interaction of genetic and lifestyle risk factors should be taken into account to elucidate the genetic influence of MDR1 variability on cancer susceptibility.", "sentences": [], "annotations": [{"id": "26", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "multidrug resistance gene 1", "locations": [{"offset": 108, "length": 27}]}, {"id": "27", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 137, "length": 4}]}, {"id": "28", "infons": {"identifier": "MESH:D063646", "type": "Disease"}, "text": "carcinogenesis of colorectal tumors", "locations": [{"offset": 171, "length": 35}]}, {"id": "29", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 226, "length": 4}]}, {"id": "30", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 294, "length": 6}]}, {"id": "31", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 397, "length": 17}]}, {"id": "32", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 415, "length": 8}]}, {"id": "33", "infons": {"identifier": "rs3213619", "type": "Mutation", "subtype": "SNP"}, "text": "rs3213619", "locations": [{"offset": 543, "length": 9}]}, {"id": "34", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 582, "length": 9}]}, {"id": "35", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 612, "length": 9}]}, {"id": "36", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 839, "length": 17}]}, {"id": "37", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 929, "length": 17}]}, {"id": "38", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1095, "length": 4}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1219, "length": 4}]}, {"id": "40", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 1238, "length": 17}]}, {"id": "41", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 1383, "length": 6}]}, {"id": "42", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colon cancer", "locations": [{"offset": 1399, "length": 12}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 1413, "length": 8}]}, {"id": "44", "infons": {"identifier": "MESH:D015179", "type": "Disease"}, "text": "colorectal cancer", "locations": [{"offset": 1527, "length": 17}]}, {"id": "45", "infons": {"identifier": "1214577", "type": "Species"}, "text": "to 7", "locations": [{"offset": 1580, "length": 4}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "MDR1", "locations": [{"offset": 1745, "length": 4}]}, {"id": "47", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "cancer", "locations": [{"offset": 1765, "length": 6}]}], "relations": []}], "relations": [], "pmid": 17146660, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "disease@MESH:D063646", "species@1214577", "disease@MESH:D015179", "mutation@rs3213619", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "disease@MESH:D009369"], "journal": "Eur. J. Clin. Pharmacol.", "year": 2007, "authors": ["Osswald E", "Johne A", "Laschinski G", "Arjomand-Nahad F", "Malzahn U", "Kirchheiner J", "Gerloff T", "Meisel C", "Mrozikiewicz PM", "Chernov J", "Roots I", "K\u00f6pke K"]},
{"_id": "17120199|None", "id": "17120199", "infons": {}, "passages": [{"infons": {"journal": "Cancer; 2006 Dec 15; 107(12) 2850-7", "year": "2006", "type": "title", "authors": "Gervasini G, Carrillo JA, Garcia M, San Jose C, Cabanillas A, Benitez J", "section": "Title"}, "offset": 0, "text": "Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "Adenosine triphosphate-binding cassette B1", "locations": [{"offset": 0, "length": 42}]}, {"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 44, "length": 5}]}, {"id": "7", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "multidrug resistance 1", "locations": [{"offset": 52, "length": 22}]}, {"id": "8", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 76, "length": 8}]}, {"id": "9", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 135, "length": 11}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 148, "text": "BACKGROUND: P-glycoprotein (P-gp) is a transmembrane transporter that is encoded by the adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) gene, which plays a role in cell defense against environmental attacks, like those generated by xenobiotics. P-gp is expressed in the lung, where it has been suggested to transport these compounds from the interstitium into the lumen. METHODS: Two functional ABCB1 polymorphisms were examined, G2677T/A (in exon 21) and C3435T (in exon 26), in a group of lung cancer patients and in a control group. RESULTS: Whereas 3435T allelic and genotype frequencies were unchanged between both study groups, lung cancer patients showed higher frequency of the 2677T variant allele compared with the control group (0.67 vs. 0.43; P &lt; .001; odds ratio, [OR], 2.6; 95% confidence interval [95% CI], 1.7-4.0). Among the histologic tumor types that were included in the study, squamous cell carcinoma was associated most strongly with the presence of the 2677T allele (OR, 3.92; 95% CI, 2.2-6.9) and especially was associated with the 2677 TT genotype (OR, 6.75; 95% CI, 3.0-15.2). In a haplotype analysis, homozygous wild-type alleles were classified as genotype A, heterozygous alleles were classified as genotype B, and homozygous mutant allele were classified as genotype C both in exon 21 (first letter) and in exon 26 (second letter) loci. The haplotype CB displayed the highest association with lung cancer (OR, 18.09; 95% CI, 2.4-139.2). CONCLUSIONS: The current results taken together suggest that, aside from other known causes of lung cancer, such as tobacco smoke, the existence of polymorphisms in the ABCB1 gene and, specifically, the presence of the G2677T mutation can be crucial in conferring susceptibility to lung cancer. Further studies comprising larger populations are needed to confirm these preliminary findings.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 160, "length": 14}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 176, "length": 4}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "adenosine triphosphate-binding cassette B1", "locations": [{"offset": 236, "length": 42}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 280, "length": 5}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "multidrug resistance 1", "locations": [{"offset": 288, "length": 22}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 421, "length": 4}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 571, "length": 5}]}, {"id": "38", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 606, "length": 8}]}, {"id": "39", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 632, "length": 6}]}, {"id": "40", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 667, "length": 11}]}, {"id": "41", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 679, "length": 8}]}, {"id": "42", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 810, "length": 11}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 822, "length": 8}]}, {"id": "44", "infons": {"identifier": "MESH:D009369", "type": "Disease"}, "text": "tumor", "locations": [{"offset": 1032, "length": 5}]}, {"id": "45", "infons": {"identifier": "MESH:D002294", "type": "Disease"}, "text": "squamous cell carcinoma", "locations": [{"offset": 1077, "length": 23}]}, {"id": "46", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 1602, "length": 11}]}, {"id": "47", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 1741, "length": 11}]}, {"id": "48", "infons": {"identifier": "4097", "type": "Species"}, "text": "tobacco", "locations": [{"offset": 1762, "length": 7}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1815, "length": 5}]}, {"id": "50", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.2677G>T;RS#:2032582", "hgvs": "c.2677G>T", "identifiers": ["rs2032582"]}, "text": "G2677T", "locations": [{"offset": 1865, "length": 6}]}, {"id": "51", "infons": {"identifier": "MESH:D008175", "type": "Disease"}, "text": "lung cancer", "locations": [{"offset": 1928, "length": 11}]}], "relations": []}], "relations": [], "pmid": 17120199, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@4097", "disease@MESH:D008175", "species@9606", "mutation@c.2677G>T,A", "disease@MESH:D002294", "mutation@rs2032582", "mutation@rs1045642", "gene@5243", "disease@MESH:D009369"], "journal": "Cancer", "year": 2006, "authors": ["Gervasini G", "Carrillo JA", "Garcia M", "San Jose C", "Cabanillas A", "Benitez J"]},
{"_id": "16999857|None", "id": "16999857", "infons": {}, "passages": [{"infons": {"journal": "Mol Neurodegener; 2006 Sep 25; 113", "year": "2006", "article-id_pmc": "PMC1586192", "type": "title", "authors": "Frankfort SV, Doodeman VD, Bakker R, Tulner LR, van Campen JP, Smits PH, Beijnen JH", "section": "Title"}, "offset": 0, "text": "ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "5", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 34, "length": 8}]}, {"id": "6", "infons": {"identifier": "MESH:D003704", "type": "Disease"}, "text": "dementia", "locations": [{"offset": 48, "length": 8}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 94, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 104, "text": "Amyloid beta is an in vitro substrate for P-glycoprotein (P-gp), an efflux pump at the blood brain barrier (BBB). The Multi Drug Resistance (ABCB1) gene, encoding for P-gp, is highly polymorphic and this may result in a changed function of P-gp and may possibly interfere with the pathogenesis of Alzheimer's disease. This study investigates to what extent ABCB1 Single Nucleotide Polymorphisms (SNPs; C1236T in exon 12, G2677T/A in exon 21 and C3435T in exon 26) and inferred haplotypes exist in an elderly population and if these SNPs and haplotypes differ between patients with dementia and age-matched non-demented control patients. ABCB1 genotype, allele and haplotype frequencies were neither significantly different between patients with dementia and age-matched controls, nor between subgroups of different types of dementia nor age-matched controls. This study shows ABCB1 genotype frequencies to be comparable with described younger populations. To our knowledge this is the first study on ABCB1 genotypes in dementia. ABCB1 genotypes are presently not useful as a biomarker for dementia, as they were not significantly different between demented patients and age-matched control subjects.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-glycoprotein", "locations": [{"offset": 146, "length": 14}]}, {"id": "32", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 162, "length": 4}]}, {"id": "33", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 245, "length": 5}]}, {"id": "34", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 271, "length": 4}]}, {"id": "35", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "P-gp", "locations": [{"offset": 344, "length": 4}]}, {"id": "36", "infons": {"identifier": "MESH:D000544", "type": "Disease"}, "text": "Alzheimer's disease", "locations": [{"offset": 401, "length": 19}]}, {"id": "37", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 461, "length": 5}]}, {"id": "38", "infons": {"identifier": "rs1128503", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "c.1236C>T;RS#:1128503", "hgvs": "c.1236C>T", "identifiers": ["rs1128503"]}, "text": "C1236T", "locations": [{"offset": 506, "length": 6}]}, {"id": "39", "infons": {"identifier": "c.2677G>T,A", "type": "Mutation", "subtype": "ProteinMutation"}, "text": "G2677T/A", "locations": [{"offset": 525, "length": 8}]}, {"id": "40", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "DNAMutation", "originalIdentifier": "g.3435C>T;RS#:1045642", "hgvs": "g.3435C>T", "identifiers": ["rs1045642"]}, "text": "C3435T", "locations": [{"offset": 549, "length": 6}]}, {"id": "41", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 671, "length": 8}]}, {"id": "42", "infons": {"identifier": "MESH:D003704", "type": "Disease"}, "text": "dementia", "locations": [{"offset": 685, "length": 8}]}, {"id": "43", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 731, "length": 8}]}, {"id": "44", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 741, "length": 5}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 835, "length": 8}]}, {"id": "46", "infons": {"identifier": "MESH:D003704", "type": "Disease"}, "text": "dementia", "locations": [{"offset": 849, "length": 8}]}, {"id": "47", "infons": {"identifier": "MESH:D003704", "type": "Disease"}, "text": "dementia", "locations": [{"offset": 928, "length": 8}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 980, "length": 5}]}, {"id": "49", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1104, "length": 5}]}, {"id": "50", "infons": {"identifier": "MESH:D003704", "type": "Disease"}, "text": "dementia", "locations": [{"offset": 1123, "length": 8}]}, {"id": "51", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1133, "length": 5}]}, {"id": "52", "infons": {"identifier": "MESH:D003704", "type": "Disease"}, "text": "dementia", "locations": [{"offset": 1193, "length": 8}]}, {"id": "53", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1261, "length": 8}]}], "relations": []}], "relations": [], "pmid": 16999857, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["species@9606", "mutation@c.2677G>T,A", "disease@MESH:D000544", "gene@5243", "mutation@rs1128503", "mutation@rs1045642", "disease@MESH:D003704"], "journal": "Mol Neurodegener", "year": 2006, "authors": ["Frankfort SV", "Doodeman VD", "Bakker R", "Tulner LR", "van Campen JP", "Smits PH", "Beijnen JH"]},
{"_id": "16103896|None", "id": "16103896", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenomics J.; 2005; 5(6) 352-8", "year": "2005", "type": "title", "authors": "Thompson JF, Man M, Johnson KJ, Wood LS, Lira ME, Lloyd DB, Banerjee P, Milos PM, Myrand SP, Paulauskis J, Milad MA, Sasiela WJ", "section": "Title"}, "offset": 0, "text": "An association study of 43 SNPs in 16 candidate genes with atorvastatin response.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 59, "length": 12}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 82, "text": "Variation in individual response to statin therapy has been widely studied for a potential genetic component. Multiple genes have been identified as potential modulators of statin response, but few study findings have replicated. To further examine these associations, 2735 individuals on statin therapy, half on atorvastatin and the other half divided among fluvastatin, lovastatin, pravastatin and simvastatin were genotyped for 43 SNPs in 16 genes that have been implicated in statin response. Associations with low-density lipoprotein cholesterol (LDL-C) lowering, total cholesterol lowering, HDL-C elevation and triglyceride lowering were examined. The only significant associations with LDL-C lowering were found with apoE2 in which carriers of the rare allele who took atorvastatin lowered their LDL-C by 3.5% more than those homozygous for the common allele and with rs2032582 (S893A in ABCB1) in which the two groups of homozygotes differed by 3% in LDL-C lowering. These genetic effects were smaller than those observed with the demographic variables of age and gender. The magnitude of all the differences found is sufficiently small that genetic data from these genes should not influence clinical decisions on statin administration.", "sentences": [], "annotations": [{"id": "14", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 395, "length": 12}]}, {"id": "15", "infons": {"identifier": "MESH:D000077340", "type": "Chemical"}, "text": "fluvastatin", "locations": [{"offset": 441, "length": 11}]}, {"id": "16", "infons": {"identifier": "MESH:D008148", "type": "Chemical"}, "text": "lovastatin", "locations": [{"offset": 454, "length": 10}]}, {"id": "17", "infons": {"identifier": "MESH:D017035", "type": "Chemical"}, "text": "pravastatin", "locations": [{"offset": 466, "length": 11}]}, {"id": "18", "infons": {"identifier": "MESH:D019821", "type": "Chemical"}, "text": "simvastatin", "locations": [{"offset": 482, "length": 11}]}, {"id": "19", "infons": {"identifier": "MESH:D002784", "type": "Chemical"}, "text": "cholesterol", "locations": [{"offset": 657, "length": 11}]}, {"id": "20", "infons": {"identifier": "MESH:D014280", "type": "Chemical"}, "text": "triglyceride", "locations": [{"offset": 699, "length": 12}]}, {"id": "21", "infons": {"identifier": "348", "type": "Gene", "ncbi_homologene": "30951"}, "text": "apoE2", "locations": [{"offset": 806, "length": 5}]}, {"id": "22", "infons": {"identifier": "MESH:D000069059", "type": "Chemical"}, "text": "atorvastatin", "locations": [{"offset": 858, "length": 12}]}, {"id": "23", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 957, "length": 9}]}, {"id": "24", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "ProteinMutation", "originalIdentifier": "p.S893A;RS#:2032582", "hgvs": "p.S893A", "identifiers": ["rs2032582"]}, "text": "S893A", "locations": [{"offset": 968, "length": 5}]}, {"id": "25", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 977, "length": 5}]}], "relations": []}], "relations": [], "pmid": 16103896, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["chemical@MESH:D019821", "chemical@MESH:D017035", "mutation@rs2032582", "chemical@MESH:D000077340", "gene@5243", "chemical@MESH:D014280", "chemical@MESH:D008148", "chemical@MESH:D000069059", "gene@348", "chemical@MESH:D002784"], "journal": "Pharmacogenomics J.", "year": 2005, "authors": ["Thompson JF", "Man M", "Johnson KJ", "Wood LS", "Lira ME", "Lloyd DB", "Banerjee P", "Milos PM", "Myrand SP", "Paulauskis J", "Milad MA", "Sasiela WJ"]},
{"_id": "15197162|None", "id": "15197162", "infons": {}, "passages": [{"infons": {"journal": "Genome Res.; 2004 Jul; 14(7) 1333-44", "year": "2004", "article-id_pmc": "PMC442149", "type": "title", "authors": "Soranzo N, Cavalleri GL, Weale ME, Wood NW, Depondt C, Marguerie R, Sisodiya SM, Goldstein DB", "section": "Title"}, "offset": 0, "text": "Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 78, "length": 5}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 111, "text": "The difficulty of fine localizing the polymorphisms responsible for genotype-phenotype correlations is emerging as an important constraint in the implementation and interpretation of genetic association studies, and calls for the definition of protocols for the follow-up of associated variants. One recent example is the 3435C&gt;T polymorphism in the multidrug transporter gene ABCB1, associated with protein expression and activity, and with several clinical conditions. Available data suggest that 3435C&gt;T may not directly cause altered transport activity, but may be associated with one or more causal variants in the poorly characterized stretch of linkage disequilibrium (LD) surrounding it. Here we describe a strategy for the follow-up of reported associations, including a Bayesian formalization of the associated interval concept previously described by Goldstein. We focus on the region of high LD around 3435C&gt;T to compile an exhaustive list of variants by (1) using a relatively coarse set of marker typings to assess the pattern of LD, and (2) resequencing derived and ancestral chromosomes at 3435C&gt;T through the associated interval. We identified three intronic sites that are strongly associated with the 3435C&gt;T polymorphism. One of them is associated with multidrug resistance in patients with epilepsy (chi2 = 3.78, P = 0.052), and sits within a stretch of significant evolutionary conservation. We argue that these variants represent additional candidates for influencing multidrug resistance due to P-glycoprotein activity, with the IVS 26+80 T&gt;C being the best candidate among the three intronic sites. Finally, we describe a set of six haplotype tagging single-nucleotide polymorphisms that represent common ABCB1 variation surrounding 3435C&gt;T in Europeans.", "sentences": [], "annotations": [{"id": "6", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 491, "length": 5}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1423, "length": 8}]}, {"id": "8", "infons": {"identifier": "MESH:D004827", "type": "Disease"}, "text": "epilepsy", "locations": [{"offset": 1437, "length": 8}]}, {"id": "9", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1859, "length": 5}]}], "relations": []}], "relations": [], "pmid": 15197162, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D004827", "species@9606", "gene@5243"], "journal": "Genome Res.", "year": 2004, "authors": ["Soranzo N", "Cavalleri GL", "Weale ME", "Wood NW", "Depondt C", "Marguerie R", "Sisodiya SM", "Goldstein DB"]}
]